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A b s t r a c t
Oesophageal atresia (OA) and tracheo-oesophageal fistula (TOF) are important human 
malformations of the foregut, the development of which is poorly understood. In this 
thesis, the mechanisms that underlie the development of OA/TOF, as well as normal 
tracheo-oesophageal development, were investigated. The rat model of OA/TOF, based 
on exposure of embryos to the anticancer agent Adriamycin, was adapted to the mouse in 
order to allow more in depth study of the cellular and molecular events that underlie the 
malformations. The Adriamycin-treated mouse was shown to have persistence of an 
undivided foregut at El 1.5, in contrast to saline controls in which the foregut was in the 
process of separating into a ventral structure (trachea) and a dorsal structure 
(oesophagus). This failure of tracheo-oesophageal separation was also a feature of the 
Sonic hedgehog (Shh) null mutant mouse. The study of the respiratory marker Nkx2.1 
confirmed that the foregut normally divides along the dorsoventral boundary of 
respiratory/ gastrointestinal specification and that the fundamental defect in both the 
Adriamycin-treated and Shh null mutant mice is persistence of an undivided foregut in 
which both the respiratory and gastrointestinal lineages are represented, with a 
preservation of the dorsoventral pattern of expression of that marker. The study of 
expression of Shh showed this to have a dorsoventral pattern that was closely related to 
the separation boundary and which changed as separation progressed. Moreover, this 
dorsoventral expression pattern was disturbed in those Adriamycin-treated embryos that 
had failed to separate the trachea and oesophagus. The process of tracheo-oesophageal 
separation was also found to be associated with a distinct pattern of programmed cell 
death (PCD) in the dorsal foregut and at the dorsoventral boundary. PCD cells were 
present before any morphological evidence of separation, suggesting a possible role for
4
PCD in controlling the separation process. When a PCD inhibitor was applied to an in 
vitro, whole embryo, culture system, the process of tracheo-oesophageal separation was 
arrested, suggesting that PCD is a requirement and not just a consequence of separation.
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A b b r e v ia t io n s
ABC = avidin-biotin peroxidase complex
Aip = anterior intestinal portal
BCIP = 5-bromo-4-chloro-3-indoyl-phosphate
cDNA = complementary deoxyribonucleic acid
Cip = caudal intestinal portal
DAB = diaminobenzadine tetrahydrochloride
DEPC = diethylpyrocarbonate
DIG = Digoxygenin
DMEM = Dulbecco’s Modified Eagles Medium 
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DNA = deoxyribonucleic acid 
DPX = dextropropoxyphene 
E = embryonic day
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IMS = industrial methylated spirits
JPEG = Joint Photographic Experts Group
LiCl = lithium chloride
MilliQ = ultrapure-deionised water
MilliRO = deionised water
mRNA = messenger RNA
NBT = 4-nitroblue tetrazolium chloride
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OA = oesophageal atresia 
PBS = phosphate buffered saline 
PCD = programmed cell death 
PFA = paraformaldehyde 
RNA = ribonucleic acid 
Rnase = ribonuclease 
SDS = sodium dodecyl sulphate 
Shh = sonic hedgehog
SSC = sodium chloride/ sodium citrate buffer
TBS-TX = Tris buffered saline/Triton-XlOO
TESPA = 3-aminopropyltriethoxy silane
TOF = tracheo-oesophageal fistula
TUNEL = TdT-mediated dUTP nick end labelling
zVAD-fmk = benyloxycarbonyl-valine-alanine-aspartate fluoromethylketone
7
T a b l e  o f  c o n t e n t s
A c k n o w l e d g e m e n t s  3
A b s t r a c t  4
A b b r e v ia t io n s  6
T a b l e  o f  c o n t e n t s  8
L is t  o f  t a b l e s  17
L is t  o f  f ig u r e s  18
CHAPTER 1 -  G e n e r a l  in t r o d u c t io n  22
1.1 -  Development of the foregut and its derivatives 22
1.1.1- Gastrulation 22
1.1.2- Specification of the definitive endoderm 23
1.1.3- General endodermal patterning 24
1.1.4 -  Formation of the gut tube from a sheet of cells 25
1.1.5- Formation of the foregut derivatives 28
1.1.5.1 -  Regionalisation -  defining endodermal regions 28
1.1.5.2 -  Organ budding 32
1.1.5.3 -  Definitive organogenesis 33
1.1.5.4 -  Differentiation of organ-specific cell types within the developing buds 35
1.2 -  Development of the trachea and the oesophagus 37
1.2.1 -The morphology of respiratory development 37
1.2.2 -  Controversial aspects of tracheo-oesophageal development 38
1.2.3 -  Molecular aspects of tracheo-oesophageal development 43
1.2.3.1 -  Mechanisms of respiratory field specification 43
8
1.2.3.2 -  Epithelial- mesenchymal interactions in the respiratory foregut 45
1.3 -  Malformations of the trachea and the oesophagus 47
1.3.1 -  Types of human tracheo-oesophageal malformations 47
1.3.2 -  Associations with malformations in other systems 50
1.3.3 -  Aetiology of tracheo-oesophageal malformations 51
1.3.4 -  Clinical history, prognosis and management 53
1.3.5 -  Animal models of tracheo-oesophageal malformations 54
1.3.5.1 -  History of animal models 54
1.3.5.2 -  The Adriamycin rat model 56
1.3.5.3 -  Genetic models 62
1.4 -  Aims of the thesis 65
CHAPTER 2 -  M a t e r ia l s  a n d  m e t h o d s  67
2.1 -  General considerations 67
2.2 -  Maintenance of mouse colonies 67
2.2.1 -  Mouse strains 67
2.2.2 -  Colony conditions 67
2.2.3 -  Embryo generation from timed pregnancies 67
2.3 -  Teratogenic manipulation of pregnant mice 68
2.3.1 -  The teratogenic agent 68
2.3.2 -  Administration of agent 69
2.4 -  Embryo harvest and processing 69
2.4.1 -  Timing of harvesting 69
2.4.2 -  Technique of harvesting 70
2.4.3 -  Dissection of conceptuses 70
9
2.4.4 -  Assessment of embryos 71
2.4.5 -  Embryo processing, fixation and embedding 71
2.5 -  Whole embryo culture 73
2.5 .1- Preparation of rat serum 73
2.5.2 -  Embryo harvest and dissection of uterus 73
2.5.3 -  Microscopic dissection 74
2.5.4 -  Culture conditions 75
2.5.4.1 -  Preparation of the culture medium 75
2.5.4.2- Culture technique 75
2.5.4.3 -  Embryo assessment 76
2.6 -  Embryo sectioning 77
2.6.1 -  Equipment used 77
2.6.2 -  Preparation of slides 77
2.6.3 -  Sectioning technique 78
2.6.4 -  Use of the vibratome 78
2.7 -  Staining techniques 79
2.7.1 -  Haematoxylin & eosin staining 79
2.7.2. -  Methyl Green staining 79
2.7.3 -  Periodic Acid Schiff (PAS) staining 80
2.8 -  Immunohistochemistry 80
2.8.1 -  General principles 80
2.8.2 -  Antibodies used 82
2.9 -  In situ hybridisation (Ish) 83
2.9.1 -  Preparation of gene probes 83
2.9.1.1- Transformation of bacteria 83
10
2.9.1.2- Isolation of plasmid DNA/ DNA purification 83
2.9.1.3 -  Digestion of plasmid DNA 85
2.9.1.4 -  Synthesis of digoxygenin-labelled RNA probes 85
2.9.2 -  Whole mount ish 86
2.9.2.1 -  Embryo pre-treatment and hybridisation 86
2.9.2.2 -  Post-hybridisation 87
2.9.2.3 -  Post-antibody development 88
2.9.3 -  Ish on sections 89
2.9.3.1 -  Pre-hybridisation treatment 89
2.9.3.2 -  Post-hybridisation treatment 90
2.9.3.3 -  Antibody detection 90
2.10 -  Photography & image processing 91
2.10.1- Photography of whole embryos 91
2.10.2- Digital photography and image analysis 91
2.11 -  Data analysis and statistics 92
2.11.1- Graph creation 92
2.11.2- Statistical analysis 92
CHAPTER 3 -  M o u s e  m o d e l s  o f  t r a c h e o - o e s o p h a g e a l  m a l f o r m a t io n s  93
3.1 -  Introduction 93
3.2 -  Results 95
3.2.1 - The Adriamycin mouse model of tracheo-oesophageal malformations 95
3.2.1.1 - Normal tracheo-oesophageal development 95
• Stages of tracheo-oesophageal separation 95
• Development of the larynx 98
• Length analysis of foregut components 101
11
3.2.1.2 - Establishing the model 105
• Optimising the dose of Adriamycin 105
• Aberrations of tracheo-oesophageal development 111
• Effect of Adriamycin on other organ systems 123
3.2.2 -  The Shh'1' mutant model 132
3.2.2.1 -  General growth patterns of the Shh'1' mutant 132
3.2.2.2 -  Stages of tracheo-oesophageal development in the mutant 135
3.3 -  Discussion 142
3.3.1 -  Importance of the mouse adaptation 142
3.3.2 -  Resolving the controversy of normal tracheo-oesophageal development 142
3.3.3 -  The early defect in the Adriamycin model 144
3 .3 .4 - Specificity of the Adriamycin-generated defect 145
3.3.5 -  The late rearrangements of the tracheo-oeosphageal phenotype 147
3.3.6 -  Fundamental defect in the Shh mutant 149
3.3.7 -  Importance of analysing the two models together 150
3.4 -  Summary 152
CHAPTER 4 - D e v e l o p m e n t  o f  t h e  r e s p ir a t o r y  e n d o d e r m  153
4.1 -  Introduction 153
4.2 -  Results 155
4.2.1 -  Expression of the endodermal marker Hnf3p 155
4.2.2 -The role of Nkx2.1 in respiratory development 158
4.2.2.1 -  Expression patterns in normal development 158
4.2.2.2 -  Expression patterns in the Adriamycin mouse model 159
4.2.2.3 -  Tracheo-oesophageal fistula in the Adriamycin mouse model 171
4.2.2.4 -  Respiratory development in the Shh1' embryo 171
12
4.3 -  Discussion 182
4.3.1 -Respiratory field specification and development. 182
4.3.2 -  Does Adriamycin disturb endodermal and/or respiratory development? 182
4.3.3 -  Does the epithelial commitment of the tracheo-oesophageal fistula give 185
us clues as to a possible underlying imbalance in fates during the 
embryogenesis of Adriamycin -induced malformations?
4.3.4 -  Does loss of Shh function affect respiratory specification? 186
4.3.5 -  Suggested mechanisms of tracheo-oesophageal malformations 187
4.4 -  Summary 189
CHAPTER 5 -  R o l e  o f  s o n ic  h e d g e h o g  in  f o r e g u t  d e v e l o p m e n t  190
5.1 -  Introduction 190
5 .2 -  Results 192
5.2.1 -  Pattern of Sonic hedgehog (Shh) expression 192
5.2.1.1 -  Normal expression pattern 192
5.2.1.2 -  Expression in the Adriamycin-treated embryo 201
5.2.2 -  Pattern of distribution of Shh protein 201
5.2.3 -  Expression pattern of the Shh receptor Ptcl 206
5.3 -  Discussion 208
5.3.1 -  Dynamic Shh expression and the separation process 208
5.3.2 -  The Shh mRNA/ protein pattern difference 209
5.3.3 -  How does Shh act in the foregut? 210
5.3.4 -  Control of Shh expression 212
5.3.5 -  The Shh expression pattern in the Adriamycin-treated embryo 214
5.3.6 -  Factors underlying the disturbance of Shh expression in Adriamycin- 216
13
treated embryos 
5.4 -  Summary 219
CHAPTER 6 - M e c h a n is m s  o f  t r a c h e o - o e s o p h a g e a l  s e p a r a t io n  a n d  220
DEVELOPMENT
6.1 -  Introduction 220
6 .1 .1- Separation mechanisms in development 220
6 .1 .2 - Mechanisms of tracheo-oesophageal separation 221
6 .1 .3 - Questions about tracheo-oesophageal separation 223
6.2 -  Results 224
6.2.1 -  Programmed cell death (PCD) in the developing foregut 224
6.2.1.1- Patterns of programmed cell death during normal foregut development 224
6.2.1.2 -  Quantitation of PCD 234
• Defining the levels for the study of the apoptotic index 234
• Defining the dorsoventral segments for the study of the apoptotic index 237
• Data analysis 238
6.2.1.3 -  Patterns of PCD in models of abnormal tracheo-oesophageal 243
development
• PCD in the Adriamycin-treated embryo 243
• PCD in the foregut of Shh'1' embryo 247
6.2.2 -  Cell proliferation in the developing foregut 251
6.2.2.1 -  Patterns of mitosis during normal foregut development 251
• Defining the anatomical levels for the study of mitotic index 251
• Defining the dorsoventral segments for the study of mitotic index 252
• Data analysis 257
14
6.3 -  Discussion 267
6.3.1 -  Programmed cell death and separation 267
6.3.1.1 -  PCD and tracheo-oesophageal separation in the E11.5 foregut 268
6.3.1.2 -  PCD in the caudal foregut at E11.5 269
6.3.1.3 -  PCD in the pre-separation foregut (E10.5) 270
6.3.1.4 -  Defining the PCD pattern 273
6.3.1.5 -  PCD in models of abnormal tracheo-oesophageal separation 275
6.3.2 -  Proliferation and separation 277
6.3.3 -  Mechanisms of separation 278
6.4 -  Summary 280
CHAPTER 7 -  IN VITRO MODEL OF TRACHEO-OESOPHAGEAL DEVELOPMENT 281
7.1 -  Introduction 281
7.1 .1- Testing the hypothesis 281
7.1 .2- The use of whole-embryo culture 281
7.1 .3- Interfering with programmed cell death 282
7.2 -  Results 283
7.2.1 -  Establishing the in vitro model 283
7.2.1.1- Defining the culture period 283
7.2.1.2- Choice of culture medium 283
7.2.1.3- Assessment of cultured embryos and embryo survival 284
7.2.1.4 -  Growth and development of cultured embryos 285
7.2.2 -  Foregut development in cultured embryos 285
7.2.2.1 -  Tracheo-oesophageal development in cultured embryos 285
• Tracheo-oesophageal morphology 285
15
• Quantitative analysis 291
1 2 2 2  -  Programmed cell death in cultured embryos 294
7.3 -  Discussion 298
7.3.1 -  Is the in vitro model reliable for the study of tracheo-oesophageal 298
development?
7.3.2 -  Can we be confident about the inhibitory effect of z-vad? 299
7.3.3 -  What is the significance of the effect of z-vad on foregut morphology? 300
7.3.4 -  How specific is the effect of z-vad? 302
7.4 -  Summary 305
CHAPTER 8 -  G e n e r a l  d is c u s s io n  306
8.1 -  General remarks 306
8.2 -  Potential pitfalls/ possible improvements 307
8.2.1 -  Experimental techniques 307
8.2.1.1 - Genotyping of Shh mice 307
8.2.1.2 - Immunohistochemistry controls 308
8.2.2 -  Interpretation of findings 308
8.2.2.1 -  Interpreting tracheo-oesophageal malformations in the mouse 308
8.2.2.2 -  Describing morphogenetic events 309
8.3 -  Future work 310
8.4 -  Conclusion 312
B ib l io g r a p h y  3 1 3
16
76
82
106
107
110
122
131
135
240
259
260
284
L ist  o f  t a b l e s
Composition of explanting and culture solutions 
Antibody details
Adriamycin dose-response experiment, with dosing at E7.5 
and E8.5
Mean numbers of live embryos in saline-treated and Adriamycin- 
treated (4 mg/kg) pregnancies analysed on different days of 
gestation
Prevalence of OA/TOF in Adriamycin-treated litters
Types of tracheo-oesophageal malformations in Adriamycin-
treated embryos/fetuses (all gestations)
Associated malformations in Adriamycin-treated (4 mg/kg) 
embryos and fetuses
Number of Shh mutant embryos examined
PCD patterns in the E l2.5/E 13.5 respiratory foregut (CBA/Ca
embryo)
Numbers of mitotic (H3 positive cells), total cells and mitotic 
index in the normal E l0.5 CBA/Ca foregut 
Levels of mitosis (H3 positive cells) in the normal El 1.5 
CBA/Ca foregut
Summary of cultured embryos and their treatment
17
L ist  o f  f ig u r e s
F ig u r e
Figure 1.1 
Figure 1.2
Figure 1.3 
Figure 1.4 
Figure 1.5
Figure 3.1
Figure 3.2 
Figure 3.3
Figure 3.4
Figure 3.5
Figure 3.6
Figure 3.7
Figure 3.8
Pag e
The formation of the endodermal cell layer and gut tube 26
Derivatives of the foregut endoderm and regional expression 
of transcription factors in the endoderm 29
Models of tracheo-oesophageal separation 40
Main types of human tracheo-oesophageal malformations 48
Theories on the development of oesophageal atresia and tracheo- 
oesophageal fistula 59
Tracheo-oesophageal development in the CBA/Ca mouse (E l0.5 -  
E12.5) 96
Stages of normal laryngeal development 99
Analysis of foregut lengths: undivided versus divided segments of 103 
the foregut during normal development
Crown-rump (CR) length and somite number in saline- and 108
Adriamycin-treated embryos (4 mg/kg)
Saline and Adriamycin-treated embryos are morphologically 112
indistinguishable at E l0.5
Failure of separation of oesophagus and trachea during 114
development of OA/TOF in Adriamycin-treated embryos 
Variable level of origin of the tracheo-oesophageal fistula in 116
Adriamycin-treated embryos
The oesophagotrachea in late gestation and near-term embryos/ 118
fetuses
18
Figure 3.9 
Figure 3.10 
Figure 3.11
Figure 3.12
Figure 3.13 
Figure 3.14 
Figure 3.15 
Figure 4.1
Figure 4.2
Figure 4.3
Figure 4.4
A rare case of oesophageal atresia in an Adriamycin-treated 120
embryo
Disturbance in the length of undivided versus divided foregut 124
segments in affected Adriamycin-treated embryos 
Comparing foregut growth in control and affected Adriamycin- 126
treated embryos: total length of the respiratory foregut does not 
differ between saline controls and affected Adriamycin-treated 
embryos
Malformations in other organ systems of Adriamycin-treated 129
embryos
Development and growth of embryos of different Shh genotypes 133 
Foregut anatomy in the E l0.5 Shh null embryo 136
Foregut anatomy in the E l3.5 Shh null embryo 139
The transcription factor Hnf3p is uniformly expressed in the 156
foregut endoderm
The expression pattern of the respiratory marker Nkx2.1 is not 160
disturbed in Adriamycin-treated embryos at E l0.5 
Failure of foregut separation in Adriamycin-treated embryos is 162
not associated with a disturbance in the dorsoventral pattern of 
Nkx2.1 expression
The dorsoventral pattern of Nkx2.1 expression is maintained in 164
both saline- and Adriamycin-treated embryos at E l2.5
19
166
168
172
175
177
179
193
195
197
199
203
225
228
231
235
Following tracheo-oesophageal separation, at E14.5, the trachea 
loses most of its Nkx2.1 expression in contrast to the lungs 
Changes in the dorsoventral balance of Nkx2.1 expression of 
the undivided foregut
The origin and Nkx2.1 status of the tracheo-oesophageal fistula 
Expression of Nkx2.1 is not disturbed in E l0.5 Shh'1' null mutant 
Embryos
Expression of Nkx2.1 in the El 1.5 Shh null mutant embryo 
The trifurcation in E l2.5 Shh/' mutant embryos displays a 
distinct dorso-ventral pattern of Nkx2.1 expression in contrast to 
the undivided oesophagotrachea
Expression of Shh and Ptcl in the El 0.5 CBA/Ca embryo 
Expression of Shh and Ptcl in the El 1.5 CBA/Ca embryo 
Expression of Shh in El 2.5 saline-control and Adriamycin- 
treated CBA/Ca embryos
Ventro-dorsal Shh switch in saline-treated embryos and 
disturbance of this pattern in Adriamycin-treated embryos at 
E10.5 and El 1.5
Distribution of Shh protein in the developing foregut 
PCD patterns in the E l0.5 respiratory foregut (CBA/Ca embryo) 
PCD patterns in the El 1.5 respiratory foregut (CBA/Ca embryo) 
PCD patterns in the E12.5/E13.5 respiratory foregut (CBA/Ca 
embryo)
PCD patterns in the El 1.5 respiratory foregut (CBA/Ca 
embryo)
20
Figure 6.5 PCD quantitation in the El 1.5 foregut (CBA/Ca embryo) 241
Figure 6.6 PCD patterns in affected Adriamycin-treated El 1.5 CBA/Ca 244
embryos
Figure 6.7 PCD patterns in the foregut of El 0.5 Shh null-mutant embryos 248
Figure 6.8 Mitotic activity in the foregut of El 0.5 CBA/Ca embryos 253
Figure 6.9 Mitotic activity in the foregut of El 1.5 CBA/Ca embryos 255
Figure 6.10 Dorsoventral distribution of mitosis in El 0.5 control CBA/Ca 261
embryos
Figure 6.11 Dorsoventral distribution of mitosis in El 1.5 control CBA/Ca 263
embryos
Figure 6.12 Mesenchymal mitosis in El 1.5 control CBA/Ca embryos 265
Figure 7.1 Summary of developmental and growth data for embryos in utero 286
and following culture for 18 hours from E l0.5
Figure 7.2 Tracheo-oesophageal morphology in cultured embryos 289
Figure 7.3 Quantitative analysis of foregut components in El 0.5 embryos 292
cultured for 18 hours
Figure 7.4 Programmed cell death in cultured embryos 295
21
CHAPTER 1 -  G e n e r a l  i n t r o d u c t io n
1.1 -  D e v e l o p m e n t  o f  t h e  f o r e g u t  a n d  it s  d e r iv a t iv e s
1.1.1 -  Gastrulation
Gastrulation is the process by which the cells of the early embryo are allocated to the 
three principal germ layers: ectoderm, mesoderm and endoderm. The ectoderm gives rise 
to the skin and central nervous system, the mesoderm to muscle, bone and blood and the 
endoderm to the digestive tract and a variety of other organs. These endodermally-derived 
structures include organs associated with the digestive tract such as the liver and pancreas 
and others that serve a diverse range of functions such as the respiratory tract, thyroid 
gland, thymus and the tympanic cavities. Gastrulation takes place during the third week 
of development of the human embryo. The cells of the three germ layers are derived from 
the totipotent cells of the epiblast. The ectoderm is derived from epiblast cells that do not 
migrate. The mesoderm and definitive endoderm are derived from epiblast cells that 
migrate through the primitive streak, a midline structure in the epiblast at the posterior 
end of the bilaminar germ disc (Fig. l.la,b). Mapping of cells passing through the 
primitive streak has shown that cells of the definitive endoderm are derived from the 
anterior primitive streak (Lawson et al., 1991). Following their migration, these cells 
displace the cells of the visceral endoderm (hypoblast) (Lin et al., 1994). The visceral 
endoderm forms the yolk sac and does not contribute to the development of the gut, apart 
from some limited regions at the extreme anterior end and extreme posterior end of the 
foregut. The migration of epiblast cells through the primitive streak has been shown to be 
dependant on FGF receptor-1 (FGFR1) function in the mouse. Embryos lacking FGFR1 
function have defects in the endoderm and anterior mesoderm (Ciruna et al., 1997).
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1.1.2 -  Specification of the definitive endoderm
The mechanisms that underlie the specification of endodermal fate are not well 
understood. One important question that needs to be addressed is the temporal 
relationship between the migration through the primitive streak and endodermal 
specification. It is possible that the fate of epiblast cells is determined before migration. 
Fate mapping studies showing that anterior primitive streak cells contribute to the 
endoderm are consistent with this hypothesis (Lawson et al., 1991; Lawson et al., 1986). 
Furthermore, the transcription factor and endodermal marker HnftP  is expressed in 
epiblast cells at the anterior tip of the primitive streak at the very early primitive streak 
stage (Ang et al., 1993). Alternatively, epiblast cells might become specified during their 
migration through a specific part of the primitive streak. This theory is supported by the 
observation that some epiblast cells start expressing Fgf3 as they exit the primitive streak 
and become committed to a mesodermal fate (Niswander & Martin, 1992). It is even 
possible that cells acquire their fate only after their migration. The molecular signals 
involved in the specification process are not well understood. Studies in frogs have 
identified a signaling pathway involving the genes Mixer and (Sox)l 7a/p that can drive 
endoderm formation (Henry & Melton, 1998; Hudson et al., 1997). It has been shown that 
Mixer function is required for the expression of (Sox)l 7a/p  which in turn mediate an 
activin-induced endoderm differentiation pathway. In the zebrafish, embryos that have a 
loss-of-function mutation for the locus casanova do not form a gut tube and lack any 
endodermal differentiation with absence of expression of early endodermal markers 
(Alexander et al., 1999). There is, however, no evidence of a role for these genes in mice 
or other higher vertebrates. Certain growth factors, including members of the F gf family, 
have been associated with primitive streak formation and patterning in higher vertebrate 
embryos, but not with endodermal specification itself.
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1.1.3 -  General endodermal patterning
Following gastrulation, but before the flat sheet of definitive endoderm has folded to form 
the gut tube, the process of endoderm patterning takes place. The result of this process is 
the establishment of an anteroposterior axis in the endoderm, in line with a similar axis in 
the other two germ layers. The anteroposterior axis of the embryo has already been 
established by the formation of the primitive streak at its caudal end. The migration of 
cells through the primitive streak initiates endodermal anteroposterior patterning, as those 
that first migrate through the streak contribute to the anterior endoderm, whereas later 
migrating cells are directed towards the posterior endoderm (Lawson & Pedersen, 1987). 
Anteroposterior patterning of the endoderm is reflected in differential gene expression, 
with the establishment of anteroposterior boundaries for certain factors. Anterior 
endodermal markers include Hesxl (Thomas & Beddington, 1996) and Otxl (Rhinn et al., 
1998), whereas posterior markers include Cdx2 (Beck et al., 1995) and IFABP. The exact 
mechanisms that underlie this differential expression are poorly understood, but one 
possibility is that it relies on signals from the adjacent, already specified, mesoderm and 
ectoderm. There is also evidence that factors expressed in the early (visceral) endoderm 
have an indirect effect on patterning of the definitive endoderm by influencing gene 
expression on adjacent endoderm. Lineage tracing studies have demonstrated that the 
anterior marker Hesxl is first expressed in the anterior primitive endoderm before the 
onset of gastrulation. These cells are replaced by migrating epiblast cells during 
gastrulation and the cells of the definitive anterior endoderm also express Hesxl. The 
anterior pattern may be relayed from primitive to definitive endoderm by the adjacent 
anterior neuroectoderm, which also expresses Hesxl (Thomas & Beddington, 1996).
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1.1.4 -  Formation of the gut tube from a sheet of cells
A series of morphogenetic movements converts the flat endodermal layer into the 
primitive gut tube. In the mouse and chicken embryos, this process involves the formation 
of two crescent-shaped folds at the anterior and posterior tips of the embryo, known as the 
anterior intestinal portal (Aip) and caudal intestinal portal (Cip) (Fig. 1.1c). The Aip 
moves posteriorly, whereas the Cip moves anteriorly, with the two folds meeting at the 
yolk stalk, which provides an entrance into the yolk sac. Embryonic turning, which is the 
process in which a change of embryo configuration brings the anterior and posterior tips 
of the embryo closer together, leads to the convergence of the two portals (Fig. 1.1c). 
Embryonic turning is a feature of mouse development and does not occur in the chicken. 
The folding of the endoderm in a lateral to ventral direction also contributes to formation 
of the primitive gut tube (Fig. 1 .Id). The processes of lateral to ventral and rostral-to- 
caudal folding of the gut have a bearing on the establishment of a dorsoventral (DV) axis 
in the gut tube. The cells of the anterior endoderm contribute to the ventral gut rostral to 
the yolk sac whereas the cells of the posterior endoderm contribute to the ventral gut 
caudal to the yolk sac. The dorsal part of the gut tube is derived from the original midline 
endoderm. The transcription factor GATA4, which is expressed in the endoderm and 
mesoderm of the Aip and the endoderm of the yolk sac, plays an important role in 
embryonic folding with GATA4-/- embryos displaying severe disruption of the ventral 
body pattern as a result of failure of both lateral-to-ventral and rostral-to-caudal folding 
(Molkentin et al., 1997; Kuo et al., 1997). Bone morphogenetic proteins (Bmps) 2,4,5 and 
7 are also expressed in the Aip and contribute to ventral convergence and ventral closure.
25
Fig. 1.1 The formation of the endodermal cell layer and gut tube
Schematic representations of gastrulation (a,b) and embryonic folding (c,d). (<*) The 
primitive streak (Ps) is a midline structure that appears in the epiblast (Eb) at the caudal 
end of the bilaminar germ disc. It comprises the primitive groove (Pg) and a depression at 
its rostral end, the primitive pit (Pp). (A) The bilaminar germ disc is seen in cross section 
at the level of the primitive streak as indicated by the dotted line in (a). During 
gastrulation, epiblast cells migrate through the primitive streak and either displace the 
original cells of the hyboblast (Hb) in the midline to form the definitive endoderm 
(double arrowheads) or occupy the space between the two original germ layers 
(arrowheads) to form the mesoderm, (c) The formation of the gut tube involves the 
development of two crescent-shaped folds in the endoderm at the two ends of the embryo. 
The anterior intestinal portal (Aip) grows posteriorly and caudal intestinal portal (Cip) 
moves anteriorly (double arrowheads). In the mouse, Aip and Cip movements are 
minimised by the dorsal concavity of the embryo. The two endodermal folds meet at the 
yolk stalk (Ys), which leads into the yolk sac. Embryonic turning (arrows) contributes to 
the convergence of the two endodermal folds. Following this rostrocaudal folding, the 
anterior endoderm will come to represent the ventral endoderm rostral to the yolk sac 
(orange line) and the posterior endoderm the ventral endoderm caudal to the yolk sac 
(green line), (d) Seen in cross section, lateral to ventral endodermal folding (arrows) also 
contributes to the formation of the gut tube. As a result of this folding, the original 
midline endoderm (blue lines) will from the dorsal endoderm. En -  endoderm, A -  
anterior, P -  posterior, V -  ventral, D - dorsal
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1.1.5 — Formation of the foregut derivatives
1.1.5.1 - Regionalisation -  defining endodermal regions
The process of organogenesis that follows the formation of the gut tube relies on changes 
in distinct regions of the endodermal layer (Wells & Melton, 1999; Grapin-Botton & 
Melton, 2000). A correlation exists between changes in these endodermal regions and the 
development of specific organs, which has been studied using fate-mapping techniques 
(Lawson et al., 1986; Matsushita, 1999; Warga &
Nusslein-Volhard, 1999). Endoderm cells were injected with intracellular tracers at the 
pre-folding stage and the embryos cultured until after the formation of the foregut and 
hindgut. Experiments of this type have been performed in chick, zebrafish and Xenopus 
embryos, but the difficulties encountered when culturing mouse embryos for long periods 
of time have precluded similar studies being carried out in the mouse. Such studies have 
indicated that distinct regions of the early gut can be mapped to specific organs later in 
development, although there is some degree of overlap between these regions. 
Specifically, cells of the anterior endoderm map to the ventral foregut and subsequently to 
lungs and liver whereas cells of the posterior endoderm map to the hindgut and large 
intestine. Cells of the original midline endoderm map to the dorsal endoderm and organs 
like the oesophagus. As mentioned in section 1.1.3, gastrulation is associated with the 
establishment of a basic anteroposterior pattern of endodermal expression. This basic 
pattern becomes progressively refined and the presumptive organ fields that emerge in the 
early gut are characterised by the expression of specific transcription factors (Fig. 1.2).
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Fig. 1.2 Derivatives of the foregut endoderm and regional expression of transcription 
factors in the endoderm
Schematic representation of the foregut and its derivatives. The foregut endoderm gives 
rise to the pharynx (Ph), oesophagus (Oe), stomach (St) and duodenum (Du). In addition 
to these parts of the gastrointestinal tract, a number of organs bud off the main gut tube. 
Organ budding and cytodifferentiation are associated with region-specific expression of 
endodermal transcription factors. In the pharynx, the thyroid gland (Thr) develops from a 
ventral midline evagination before assuming its position in the neck. Thyroid 
development is associated with expression of Nkx2.1 (Ttfl) and Foxel (Ttf2). The 
pharyngeal pouches (Php) are paired, lateral evaginations of the pharyngeal endoderm 
and give rise to the external auditory canal (1st), tonsils (2nd), inferior parathyroid and 
thymus (Thm) (3rd), superior parathyroid (4th) and ultimobranchial body (5th). The thyroid 
gland and the derivatives of pouches 3 to 5 lose their original connection to the gut tube 
as shown by the dotted lines. The development of these pouch derivatives is associated 
with the expression of Pax9 and Hoxa3 with Paxl being an additional thymus-specific 
marker. The respiratory system comprising the trachea (Tr), bronchial structures (Br) and 
lungs (Lu) is associated with the expression of Nkx2.1, Irxl and Irx2. The liver (Li) and 
pancreas (Pa) also maintain their connection to the gut tube and are associated with 
expression of Hexl and Hnf6 (liver) and HesJ, Pdxl and Hlxb9 (pancreas). There is some 
anteroposterior overlap in gut tube expression of transcription factors. The oesophagus is 
associated with Sox2 expression, the stomach with expression of Sox2, GATA4 and Tcf4 
and the duodenum with expression of Tcf4 and Pdxl.
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Whereas the correlation between gene expression and specific organ fields has been well 
characterised, less is known about the factors that control regional expression. 
Furthermore, regional gene expression in the early endoderm does not always 
predetermine cell fates. In the chicken, the genes Cdx and Sox2 are expressed in 
endoderm that will form the small bowel and stomach respectively, with the rostral 
boundary of Cdx expression coinciding with the caudal limit of Sox2 expression. Both 
Cdx and Sox2 expression could be altered by recombining the endoderm with mesoderm 
from other gut regions up to embryonic day 4 (Ishii et al., 1997; Ishii et al., 1998). In 
contrast, cell fate in other endodermal regions is determined at an earlier stage. Signals 
from cardiac mesoderm induce ventral foregut endoderm to express the liver gene 
albumin (Gualdi et al., 1996). The expression of the transcription factor Hexl in the same 
subset of cells precedes any mesodermal signals and persists in fully differentiated 
hepatic epithelium (Thomas et al., 1998). These pre-hepatic markers (e.g. Hexl) may 
make ventral foregut endoderm susceptible to the effects of mesodermal factors. The 
process by which endodermal cells commit to specific fates is progressive and involves 
interactions with adjacent mesoderm.
Permissive and instructive signals from the mesoderm are involved in endodermal 
regionalisation and specification. One possibility is that mesodermal factors directly 
control endodermal gene expression. This appears to be the case in Drosophila, where 
regional mesodermal expression of Hox genes controls regional endodermal gene 
expression. This control is mediated by other, regionally expressed, mesodermal factors 
like Decapentaplegic (Dpp) and Wingless (Wg) (Bienz, 1997). It has not been possible to 
demonstrate a similar pattern in vertebrate embryos, even though Hox genes are known to 
have anteroposterior patterns of expression in all three germ layers (Bilder & Scott,
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1998). There is evidence that endodermal factors like Shh control mesodermal expression 
of some Hox genes (Roberts et al., 1998). Some Hox genes expressed in the endoderm 
share anteroposterior expression boundaries with some organ specific endodermal signals 
like the pancreatic specific Pdxl. It is also possible that factors that originate in the 
endoderm themselves provide positional information for gene expression in neighbouring 
endodermal cells.
1.1.5.2 - Organ budding
Regionalisation and early gut tube patterning are followed by a process of 
cytodifferentiation of the gut endoderm. This morphological differentiation leads to the 
development of the columnar epithelium that will line the gastrointestinal tract.
In addition to giving rise to the gastrointestinal epithelium, the gut endoderm will form a 
number of diverse organs that will bud off the main gut tube. The organs derived from the 
foregut include the thyroid and parathyroid glands, the thymus and ultimobranchial body 
(the precursor of the calcitonin-producing cells of the thyroid), the respiratory system, the 
external auditory canal, the pancreas, liver and gall bladder.
The first sign of development of these organs is localised thickening of the epithelium. 
The thyroid, respiratory system, liver and gallbladder all originate from subsets of ventral 
endodermal cells whereas the pancreas has a dorsal origin. In contrast, the auditory canal, 
thymus, parathyroids and the ultimobranchial body are derived from the endoderm of 
lateral evaginations of the foregut in the region of the pharynx known as pharyngeal 
pouches. The organs can either become completely separated from the main gut tube 
(thyroid, thymus, parathyroids, ultimobranchial body) or maintain a connection 
(respiratory system, liver, gallbladder and pancreas). As described in section 1.1.5.1,
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epithelial thickening and the emergence of organ buds are associated with the expression 
of genes that are specific for that organ. Whereas the precise signals that control the 
expression of these genes or the budding process itself are not well understood, these 
organ specific factors are required for the budding process to proceed. The transcription 
factor Nkx2.1 is expressed in the thyroid and respiratory primordia and a loss of function 
mutation in this gene results in agenesis of the thyroid gland and profound respiratory 
hypoplasia (Minoo, 2000; Yuan et al., 2000; Minoo et al., 1999). Similarly, mutation in 
the paired box gene Pax 9, which is expressed in the endoderm of the pharyngeal 
pouches, leads to agenesis of pharyngeal pouch derivatives (Peters et al., 1998). 
Expression of the transcription factor Pdxl in the dorsal foregut endoderm is also 
required for the development of the dorsal pancreatic bud (Wilding & Gannon, 2004; 
Edlund, 1998).
1.1.5.3 - Definitive organogenesis
Following the specification of organ forming fields and the emergence of organ buds, 
definitive organogenesis is the result of a complex choreography of cellular processes 
including cell proliferation, cell death and variations in cell adhesion and cell mobility. 
Cell proliferation contributes to organ development in two ways. Firstly, general cellular 
proliferation is responsible for the overall growth of an organ. For example, mice with a 
loss of function mutation for genes controlling epithelial cell proliferation in the liver 
(e.g. hepatocyte growth factor) exhibit a normally specified and differentiated liver which 
is, however, significantly smaller in size (Zaret, 1998). As is the case with endodermal 
field specification, epithelial/ mesenchymal interactions play a central role in the control 
of cell proliferation. Examples include the mitogenic effect of the secreted endodermal 
factor Shh on the lung mesenchyme, and the effect of growth factors such as fibroblast
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growth factors (FGF) and epidermal growth factors (EGF) on epithelial cell proliferation. 
Furthermore, factors originating in the endoderm also have an effect on the proliferation 
of endodermal cells. An example is the pancreatic transcription factor Pdxl which 
controls the proliferation of pancreatic endocrine cells (Wilding & Gannon, 2004). Loss 
of function mutations in Pdxl leads to arrest of pancreatic development at a very early 
stage (Ahlgren et al., 1996).
Cell proliferation also plays a role in shaping the developing organs, with differential cell 
proliferation in different subsets of endodermal cells. An example is provided by the 
process of branching morphogenesis in the developing lung buds during which the 
epithelium at the tips of the lung buds grows at a higher rate than the rest of the 
endoderm. The result of this is lengthening of the bronchial structures and the 
establishment of an elaborate conducting system (Goldin et al., 1984; Goldin & Wessells, 
1979; Bellusci et al., 1997a; Bellusci et al., 1997b).
Programmed cell death plays an important role in organ development (Jacobson et al.,
1997). It contributes to sculpting as demonstrated by the elimination of cells between the 
developing digits (Milligan et al., 1995), the hollowing out of solid structures to create a 
lumen (Coucouvanis & Martin, 1995) and in the invagination and fusion of epithelial 
sheets (Cuervo et al., 2002). It is also involved in deleting vestigial structures, adjusting 
cell numbers (Barde, 1989) and eliminating abnormal cells (Clarke et al., 1993).
Cell movement and the rearrangement of cellular architecture is central to the 
development of many endodermal organs and in particular to the development of the
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endodermal glands. The ability of cells to become associated and adhere to other 
neighbouring cells is known as cell adhesion and plays a role in many developmental 
processes. Cell adhesion is mediated by molecules that are expressed on the cell surface 
and which establish interactions with similar molecules on neighbouring cells. The 
cadherins are an important family of cell adhesion molecules. Specifically, the epidermal 
cadherin (E-cadherin) is expressed on the surface of all budding endodermal cells 
suggesting that it plays a role in the budding process (Levi et al., 1991; Thiery et al., 
1984). Another process involved in organ formation is the establishment of a pattern of 
attractive and repulsive cues that direct growth and branching. One such mesenchymal 
factor is FgflO which provides attractive cues to proliferating epithelial cells .
1.1.5.4 - Differentiation o f organ-specific cell types within the developing organ buds 
Cellular differentiation in developing endodermal organs is a gradual process, with 
cellular differentiation markers being expressed early in endodermal regionalisation and a 
gradual commitment of cells to a specific fate according to reciprocal interactions with 
surrounding cells. Gene inactivation studies have demonstrated the role of specific factors 
within organ forming fields. For example, inactivation of Pax8 leads to failure of 
development of the thyroxine producing follicular cells of the thyroid, which are a 
specific subset of the cells of the thyroid (Kang et al., 2001). On the other hand, 
inactivation of the respiratory-specific transcription factor Nkx2.1 leads to failure of 
development of all pulmonary cell types (Yuan et al., 2000; Minoo et al., 1999). 
Interestingly, Nfcx2.7, which is expressed in the entire respiratory primordium at early 
stages of development (E9 in the mouse), gradually becomes restricted to a specific 
subset of pulmonary cells (type II pneumocytes) (Minoo et al., 1999). This probably 
suggests that the cells within an organ-forming field are initially pluripotent and become
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gradually specified to a specific role. The signals that dictate this transition, as well as the 
changes in the receptiveness of endodermal cells to these signals, are not well understood. 
Available evidence suggests that these signals originate in the mesenchyme. In the case of 
the pancreas, which consists of both endocrine and exocrine cell populations, it has been 
shown that inactivation of the mesenchymal factor Isll leads to failure of exocrine 
development (Apelqvist et al., 1997). Finally, as is the case with most epithelial 
mesenchymal interactions, the endoderm also plays a role in mesodermal specification, 
with the secreted endodermal glycoprotein Shh controlling muscular differentiation in the 
cells of the mesoderm that are arranged around the gut epithelium.
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1.2 -  D e v e l o p m e n t  o f  t h e  t r a c h e a  a n d  t h e  o e so p h a g u s
1.2.1 -  The morphology of respiratory development
Development of the respiratory system begins in the mouse on embryonic day (E) 9.5 
(day 19 in the human) with the appearance of the laryngo-tracheal groove (the 
primordium of the subglottic larynx and trachea) in the ventral floor of the anterior 
foregut, just caudal to the level of the pharynx (Ten Have-Opbroek, 1981). During a 
period of rapid longitudinal growth of the foregut, the ventral trachea becomes separated 
from the dorsal oesophagus, with the separation process starting at the caudal end of the 
groove and proceeding in a cranial direction. The precise mode of separation of the 
trachea from the oesophagus remains controversial; is it primarily a process of division of 
the foregut into trachea and oesophagus or a process of active tracheal outgrowth (Fig. 
1.3)? Tracheal and bronchopulmonary development should be regarded as distinct, but 
concurrent aspects of the development of the respiratory system. The initial foregut 
evagination at the laryngotracheal groove represents the tracheal primordium, but soon 
after its appearance, a bifurcation appears at its caudal end and the two primitive 
bronchopulmonary buds appear and start growing in a ventro-caudal direction. These 
buds are the primordia of the two lungs and the two primary bronchi. From that point 
onwards, pulmonary development can be largely viewed as a process of progressive 
lengthening and branching of the primitive bronchopulmonary buds (Warburton et al., 
2000). Traditionally, the process of branching morphogenesis has been divided into five 
stages (Have-Opbroek, 1981). The embryonic stage (26 days to 6 weeks in the human) 
comprises, as well as the emergence of the two primary bronchopulmonary buds, further
tVistages of branching which produce the secondary bronchopulmonary buds (5 week in 
the human) and the tertiary bronchopulmonary buds (6th week in the human). The
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secondary buds will yield the lung lobes and the tertiary ones the bronchopulmonary 
segments. During the pseudoglandular stage of pulmonary development (6-16 weeks in 
the human), there are 14 more stages of branching that result in the formation of small 
branches known as terminal bronchioles. The_canalicular stage (16-28 weeks in the 
human) is characterised by the division of the terminal bronchioles into at least two 
respiratory bronchioles and the beginning of the development of the respiratory 
vasculature with increasing vascularisation of the mesenchyme that surrounds the 
developing respiratory structures. During the saccular stage (28-36 weeks), the respiratory 
bronchioles divide further to yield terminal sacs. Finally, during the alveolar stage (36 
weeks to term), the alveoli become increasingly mature.
1.2.2 -  Controversial aspects of tracheo-oesophageal development
Despite intense interest in the mechanisms of lung development, the events underlying 
the morphogenesis of the anterior respiratory structures have been the subject of 
continuing debate. In broad terms, there have been two contrasting theories to explain 
how the respiratory foregut, anterior to the point of origin of the bronchopulmonary buds, 
separates from the gastrointestinal (oesophageal) foregut. One theory suggests that there 
is active growth of a mesenchymal septum which develops in the coronal plane and as a 
result separates the foregut lumen into ventral (respiratory) and dorsal (gastrointestinal) 
structures (Fig. 1.3a,b) (Arey, 1966; Gray & Scandalakis, 1972). This theory postulates 
that the septum is formed by opposing epithelio-mesenchymal ridges that grow medially 
and meet in the midline, resulting in separation (Fig. 1.3c). Furthermore, the septum has 
been described as ascending, with the separation first being established distally, at the 
level of the bronchopulmonary buds. Direct evidence of septum formation has, however, 
been lacking, casting doubt on this theory and most studies of tracheo-oesophageal
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development have failed to identify such a structure (Zaw-Tun, 1982; O'Rahilly &
Muller, 1984; Kluth et al., 1987). Other theories support the notion of fusion of the lateral 
foregut walls that results in separation of the trachea from the oesophagus. Separation 
progresses in a caudo-rostral direction but does not involve the development of a septum 
(Qi & Beasley, 2000; Duan et al., 2003).
An alternative theory suggests that the respiratory system develops as a result of rapid 
outgrowth from the original foregut tube (Sasaki et al., 2001a). This would be in keeping 
with the mode of development of other foregut derivatives, both midline and lateral. For 
example, the thyroid, thymus and parathyroid glands all bud off the foregut and rapidly 
grow away from it, eventually losing their original connection to it. The outgrowth theory 
is also consistent with the accepted pattern of rapid longitudinal growth at the distal tips 
of the developing bronchopulmonary structures. Applied to the trachea, this theory 
suggests that the tracheal primordium buds off the ventral foregut and remains a separate 
structure from the foregut during the subsequent stages of development. This has been 
likened to the way a column of water forms after a tap is switched on (the so-called tap 
and water theory) (Fig. 1.3d,e).
A third theory, has been formulated by a group in Germany which combines elements of 
both main theories and uses scanning electron microscope images of chick embryos to 
suggest that tracheo-oesophageal separation is the result of the development of foregut 
folds (Kluth & Fiegel, 2003; Kluth et al., 1987). This theory describes three foregut folds: 
anterocranial or laryngeal, dorsal or pharyngo-oesophageal and inferior or tracheo- 
oesophageal (Fig. 1.3f,g). The paired laryngeal and single tracheo-oesophageal folds
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Fig. 1.3 Models of tracheo-oesophageal separation
Schematic representation of the foregut illustrating theories of tracheo-oesophageal 
separation. Sagittal sections of the foregut (Fo) in a, b, d, e, f  and g  and transverse section 
in c at levels indicated in a and b. (a-c) One theory suggests that the foregut initially 
elongates as an undivided structure having a ventral (tracheal) and a dorsal (oesophageal) 
components (dotted line demarcates components in a and b). This theory suggests that the 
foregut then separates into the trachea (Tr) and oesophagus (Oe) as a result of the growth, 
in the coronal plane, of lateral mesenchymal ridges (arrowheads in c) which fuse to form 
a mesenchymal septum. Separation initially occurs at the level of the origin of the lung 
buds (Lb) and progresses in a rostral direction (arrows in a and b). A parallel theory 
supports the caudo-rostral progression of separation although it postulates that the lateral 
walls collapse and fuse, resulting in separation. This theory rejects the development of a 
septum (d,e) Another theory considers the respiratory diverticulum (Rd) to appear as a 
ventral evagination from the foregut with the two lung buds (Lb) at its caudal limit. It has 
been postulated that the trachea becomes separated from the oesophagus as a result of 
rapid downward growth (arrow in e) of the respiratory diverticulum. According to this 
theory, the trachea is never part of an undivided foregut and this model has been likened 
to a column of water following the switching on of a tap (tap and water theory), (fig) The 
paired laryngeal (L) and single inferior (I) folds define the tracheo-oesophageal space 
(Tos). Subsequent approximation (arrows) of these folds defines the separate trachea and 
oesophagus. The dorsal (D) fold marks the boundary between the pharynx and 
oesophagus.
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appear first (day 2.5) defining between them the tracheo-oesophageal space.
Subsequently, caudal movement of the laryngeal folds and cranial movement of the 
tracheo-oesophageal folds results in reduction of the tracheo-oesophageal space and the 
definition of a separate trachea and oesophagus. At the same time (day 3.5), the 
pharyngo-oesphageal fold appears dorsally and marks the boundary between pharynx and 
oesophagus. The approximation of the folds and tracheo-oesophageal separation are 
followed by rapid longitudinal growth of the trachea and oesophagus.
A recent study aimed to resolve the controversy by measuring the foregut lengths 
between reproducible reference points (last pharyngeal pouch, respiratory primordium, 
tracheo-oesophageal separation and tracheal bifurcation) at various stages of foregut 
development (Qi & Beasley, 2000). It suggested that both proliferation and lengthening as 
well as active separation contribute to the emergence of a separate trachea and 
oesophagus. Specifically, it suggests that the formation of a tracheo-oesophageal groove 
and the fusion of the lateral epithelial walls of the foregut result in separation.
Lengthening and proliferation play a role in the completion of separation at the level of 
the larynx. Other studies that support the outgrowth theory (tap and water theory) have 
shown that the point of tracheo-oesophageal divergence remains constant relative to 
specific vertebral bodies and specifically at the level of the first cervical vertebra 
(O'Rahilly & Muller, 1984). This observation is not consistent with the theory of active 
tracheo-oesophageal separation that progresses in a caudal to cranial direction. This 
apparent conundrum has been addressed by a recent study that uses digitised three- 
dimensional reconstructions of the foregut based on sequential transverse sections. The 
study suggests that the trachea does separate from the undivided foregut in a caudocranial 
direction and that the distance between the separation point and the pharynx appears
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constant as a result of the ongoing lengthening of the cranial foregut (Williams et al., 
2003).
1.2.3 -  Molecular aspects of tracheo-oesophageal development
1.2.3.1 - Mechanisms o f respiratory field specification
The process that directs the positioning and establishment of the lung primordium in the 
ventral foregut is less well understood than the subsequent processes of branching 
morphogenesis and cytodifferentiation of the pulmonary epithelium. A number of studies 
have identified the homeodomain transcription factor Nkx2.7 as an early respiratory 
marker expressed in the ventral, prospective-respiratory epithelium of the foregut. 
Although it is the earliest detected marker of respiratory specification, Nkx2.1 is not likely 
to be required for the initial specification of the respiratory primordium. Mouse embryos 
that carry a homozygous targeted disruption of the Nkx2.1 locus do develop respiratory 
structures although they are very rudimentary, with pulmonary branching morphogenesis 
being severely disrupted (Yuan et al., 2000; Minoo et al., 1999). These observations 
indicate the critical role of Nkx2.1 in respiratory development, but rule out a requirement 
of this transcription factor for respiratory specification.
The upstream events that control the timing and the anteroposterior and dorsoventral 
positioning of the Nkx2.1- positive domain are not well understood. Studies of the 
development of the hepatic and pancreatic endoderm have thrown up possible clues as to 
the induction/ regulation of Nkx2.1 and respiratory-specific expression. Posterior foregut 
endoderm, destined for hepatopancreatic development, expresses Nkx2.1 when 
recombined with cardiac mesoderm in culture, demonstrating a role for cardiac mesoderm
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in inducing this respiratory epithelial marker (Deutsch et al., 2001). A more recent study 
of lung bud formation in the chicken embryo has identified specific mesodermal factors 
that may play role in respiratory specification. Expression of Tbx4, a member of the T- 
box transcription factor gene family, in the mesoderm correlates closely, both temporally 
and spatially, with the anteroposterior regionalisation of the respiratory primordium 
within the foregut (Sakiyama et al., 2003). Gene expression studies demonstrate that the 
posterior boundaries of Tbx4 and Nkx2.1 are identical. Furthermore, ectopic expression of 
Tbx4 was shown to induce ectopic Nkx2.1 expression albeit only in the ventral foregut 
endoderm. This would suggest that Tbx4 contributes to the specification of the Nkx2.1 
domain in the ventral foregut endoderm. However, the initiation of Nkx2.1 expression 
may be under the control of a different system as ventral Nkx2.1 expression precedes that 
of Tbx4. The action of Tbx4 could be mediated by FgflO, as Tbx4 defines an FgflO 
mesodermal expression domain during early respiratory development. Interestingly,
FgflO null mutants develop a trachea but lack any subsequent pulmonary branching 
morphogenesis (Sekine et al., 1999).
Other factors potentially involved in the specification of the lung primordium include the 
mesodermally expressed Gli family of transcription factors. Double homozygous Gli2'''\ 
Gli3 embryos completely fail to develop respiratory structures and show a reduction in 
the endodermal expression of Hnf3f (Motoyama et al., 1998). The gene Sonic hedgehog 
(iShh), which encodes an important signaling molecule with multiple morphogenetic roles 
in the developing embryo, is also specifically expressed in the ventral foregut endoderm 
as early as E9.5 when the laryngotracheal groove is formed (Litingtung et al., 1998). In 
the foregut, the Shh signal is thought to be mediated through the transmembrane receptor 
Patched (Ptch) and the Gli family of transcription factors and the Shh transduction
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pathway is highly conserved between drosophila and mouse (Platt et al., 1997; Litingtung 
et al., 1998; Muller & Basler, 2000; Methot & Basler, 2001). The upstream factors that 
control the ventral expression of Shh are not known. The proximity of the shh-producing 
notochord to the foregut makes it a good candidate for a source of inductive signals 
although there is no evidence that it is involved in respiratory specification. The 
mechanisms of pancreatic specification provide an interesting analogy. In this case, it has 
been shown that the default expression pattern of the early foregut is of dorsal Shh 
expression which is inhibited by activin originating from the notochord (Kim et al., 2000; 
Hebrok et al., 1998). In contrast, ventral Shh expression is induced by ventral mesodermal 
factors and is likely to involve the pathway (Deutsch et al., 2001).
1.2.3.2 -  Epithelial-mesenchymal interactions in the respiratory foregut 
The morphogenetic events that follow the specification of the respiratory primordium 
constitute two separate processes. The first is the morphogenesis of the primary 
respiratory bud that leads to the development of the anterior respiratory structures (larynx 
and trachea). The second is the progressive elongation and branching of the primitive 
bronchopulmonary buds, a process known as branching morphogenesis, that leads to the 
development of an elaborate bronchial network and the alveoli. These two processes are 
heavily dependent on a signaling crosstalk between the endoderm and mesoderm.
Little is known about the molecular events that underlie tracheal development. The 
factors that have so far been implicated in this process are the transcription factor 
Nkx2.1 in the endoderm and the growth factors FgflO and Tbx4 in the mesoderm.
Loss of function of Nkx2.1 leads to the development of a common tracheo-oesophageal 
channel and grossly abnormal bronchopulmonary structures (Li et al., 2000a; Minoo et
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al., 1999; Yuan et al., 2000). A disturbance in the normal Nkx2.1 expression pattern, 
caused by ectopic Tbx4 and FgflO expression, leads to ectopic lung bud formation as well 
as failure of tracheo-oesophageal septation and separation (Sakiyama et al., 2003).
Branching morphogenesis is dependant on epithelial-mesenchymal interactions involving 
peptide growth factors, transcription factors and extracellular matrix proteins and their 
receptors (Costa et al., 2001). The most important epithelial factors are BMP-4, PDGF, 
Shh and Nkx2.1. Loss of function of Shh or Nkx2.1 in mutant embryos, leads to severe 
disruption in the development of distal lung (Minoo et al., 1999; Litingtung et al., 1998; 
Yuan et al., 2000). The key mesenchymal mediator of lung development is the FGF 
signaling pathway. Development of distal lung structures is completely dependant on this 
pathway and failure of formation of structures distal to the mainstem bronchi is seen in 
embryos with targeted disruption of Fgf-10 (Sekine et al., 1999). Transcription factors of 
the Hox family and the Gli family also play crucial roles in branching and epithelial 
differentiation (Motoyama et al., 1998; Aubin et al., 1997; Grindley et al., 1997). The 
FGF and PDGF signaling pathways play an important role in the development of the 
alveoli (Bostrom et al., 2002; Bostrom et al., 1996; Weinstein et al., 1998). Pulmonary 
cell specification is also dependant on Nkx2.7 as it activates promoters of lung-specific 
surfactant protein genes such as Sp-B and, as a result, controls development of alveolar 
type II cells (Minoo et al., 1999).
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1.3 -  M a l f o r m a t io n s  o f  t h e  t r a c h e a  a n d  t h e  o e so p h a g u s
1.3.1 — Types of human tracheo-oesophageal malformations
Malformations of the trachea and the oesophagus are best studied together because the 
developmental processes involved are closely associated (as described in section 2.1), 
even though the two structures belong to different systems (respiratory and 
gastrointestinal). The commonest types of tracheo-oesophageal malformations are 
grouped under the umbrella terms oesophageal atresia and tracheo-oesophageal fistula 
(OA/TOF) and occur in about 1 in 2500 to 3000 live births (Ashcraft & Holder, 1969). 
The grouping together of these malformations as OA/TOF is rather arbitrary but they 
broadly involve a combination of discontinuity of the oesophagus (atresia) and abnormal 
tracheo-oesophageal communication (fistula). Of the five main types of OA/TOF, by far 
the commonest is the association of atresia of the proximal oesophagus with a fistula 
between the trachea and the distal oesophagus and stomach (Fig. 1.4a-e). Arguably, the 
OA/TOF group should also include the exceedingly rare malformations characterized by 
atresia of the trachea associated with tracheo-oesophageal fistula. Other, less well-defined 
groups of tracheo-oesophageal malformations include tracheal and oesophageal stenoses 
and the presence of oesophageal webs, although some of these malformations could be 
considered under the atresia heading. Laryngotracheo-oesophageal clefts are a rare group 
of malformations characterized by a variable degree of continuity between the ventral 
respiratory structures and the dorsal gastrointestinal structures (Wolfson et al., 1984). In 
the mildest form, the cleft involves only the subglottic larynx and the oesophagus whereas 
at the other end of the spectrum it extends distally beyond the tracheal carina and into the 
main bronchi (Fig. 1.4f).
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Fig. 1.4 Main types of human tracheo-oesophageal malformations
Schematic representation of the main types of human tracheo-oesophageal malformations, 
(ia-e) These five types of malformations are grouped together under the term oesophageal 
atresia and tracheo-oesophageal fistula (OA/TOF). (a) The commonest type (about 85% 
of OA/TOF) is the association of atresia of the proximal oesophagus (Oe) (arrowhead in 
a) with an abnormal fistulous connection (Fi) between the trachea (Tr) and the distal 
oesophagus. The origin of the fistula is usually from the area of the tracheal bifurcation 
into the two bronchi (Br). (A) An additional fistula exists between the atretic proximal 
oesophagus and the trachea (arrowhead in b). (c) Only a proximal tracheo-oesophageal 
fistula exists and the distal oesophagus is blind ending (arrowhead in c). (d) Oesophageal 
atresia without tracheo-oesophageal fistula. In this type of defect, the gap between the 
two blind ends of the oesophagus is usually long. (e) The oesophagus is not atretic and 
there is a fistula between the trachea and the oesophagus (arrowhead in e). This type of 
OA/TOF is also known as H-type fistula because of its appearance. The length and 
position of the fistula vary, (f) Tracheo-oesophageal cleft is characterised by a 
communication between the posterior aspect of the trachea and the anterior aspect of the 
oesophagus (dotted line). The communication is of variable length and can extend from 
the larynx in the mildest form to the main bronchi in the most severe form.
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1.3.2 -  Associations of OA/TOF with malformations in other systems
As OA/TOF represents the vast majority of tracheo-oesophageal malformations, the focus 
of this study will be on these defects. A significant proportion of neonates bom with 
OA/TOF have malformations in other organ systems. The reported incidence of 
associated congenital malformations ranges from 40 to 60% and it has been reported that 
isolated oesophageal atresia is more likely to be associated with such malformations 
(Chittmittrapap et al., 1989). The cardiovascular system is most commonly involved and 
the severity of the associated cardiovascular malformations is one of the most important 
determinants of survival of neonates with OA/TOF (Spitz, 1996; Spitz et al., 1994; 
Iuchtman et al., 1992). Other malformations include vertebral, skeletal, anorectal, renal, 
genitourinary, limb, other gastrointestinal atresias, intestinal rotation abnormalities, 
abdominal wall defects, pulmonary malformations and cleft palate. The presence of 
multiple malformations represents an association. These are called non-random 
associations and their significance is that the presence of one malformation makes the 
presence of another more likely. They should be distinguished from syndromes because 
the number of component malformations present in any particular case varies 
significantly. The best-described association is the VACTERL association, which 
includes vertebral, anorectal, cardiac, tracheo-esophageal, renal and limb malformations 
(Brown et al., 1999). Tracheo-oesophageal malformations are present in 20-67% of 
patients with the VACTERL association and conversely 5-17% of neonates with OA/TOF 
fulfill the criteria for the association (Chittmittrapap et al., 1989). Oesophageal atresia and 
tracheo-oesophageal fistula are also associated with other rare syndromes and 
associations including the SCHISIS association (cleft lip and palate, omphalocoele and 
hypogenitalism) (Czeizel, 1981), POTTER syndrome (renal agenesis) (Curry et al., 1984)
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and the CHARGE association (Coloboma, heart defects, choanal atresia, renal, 
genitourinary and ear malformations) association (Koletzko & Majewski, 1984).
1.3.3 -  Aetiology of tracheo-oesophageal malformations
The aetiology of OA/TOF is likely to be multifactorial and remains unknown. The 
overwhelming majority of cases are sporadic/ non-syndromic, although a small number 
within this non-familial group are associated with chromosomal abnormalities. Familial/ 
syndromic cases of OA/TOF are very rare, representing less than 1% of the total.
In the case of sporadic/ non-syndromic OA/TOF, the likely cause is an insult that occurs 
during the narrow gestational window of tracheo-oesophageal organogenesis. This is 
illustrated in the reported cases of human OA/TOF that are associated with maternal 
intake of chemotherapeutic agents as is the case with the thioamide Methimazole 
(Clementi et al., 1999). That said, the nature of the insult in the vast majority of sporadic 
cases remains ill defined and may be a non-specific event such as a threatened abortion. 
Twin pregnancy may also disturb organogenesis and OA/TOF is 2 to 3 times more 
common in twins (Orford et al., 2000). Genetic susceptibility could also be involved as 
illustrated by the few reported cases of non-syndromic OA/TOF occurring in multiple 
members of the same family (Kashuk & Lilly, 1983; Lipson & Berry, 1984; Van Staey et 
al., 1984). The overall risk of non-syndromic OA/TOF in a sibling of an affected child is 
about 1%.
The presence of associated malformations in other organ-systems could provide clues as 
to the possible aetiology of OA/TOF. These malformations occur in distinct patterns, 
known as non-random associations, as described above. The pattern of these non-random
51
associations is likely to be dictated by the timing of a possible insult that affects multiple 
morphogenetic events. The insult could act by transiently disturbing a specific 
developmental signalling pathway. In the mouse, loss of function mutations for genes of 
the Shh pathway lead to a spectrum of anomalies that is similar to those of VACTERL, 
implicating the pathway in the embryogenesis of the malformations (Kim et al., 2001). In 
the human, the evidence is less conclusive with the SHH and PATCHED-1 (PTC-1) 
mutations leading to holoprosencephaly, a malformation not associated with OA/TOF 
(Ming et al., 2002; Ming et al., 1998; Roessler et al., 1996). Tracheo-oesophageal fistula 
and other features of VACTERL have however been described in patients with a mutation 
of GLI3 (Kang et al., 1997), a gene participating in the SHH signalling pathway.
Chromosomal abnormalities such as trisomies (18 and 21) (Beasley et al., 1997) and 
deletions (22ql 1 and 17q22q23.3) (Digilio et al., 1999; Marsh et al., 2000) are known to 
be associated with OA/TOF and have been reported in up to 6% of patients who have 
associated malformations in other systems (Brunner & Winter, 1991). The presence of 
many of the features of the non-random associations described above in cases of 
chromosomal deletions (e.g. 22ql 1) has led to the study of all chromosomal aberrations 
in search of a genetic region that is likely to be involved in OA/TOF susceptibility. No 
such region has been identified linked to chromosomal abnormalities (Brewer et al.,
1998). The recent development of comparative genomic hybridisation (CGH) using 
microarray technology enables the detection of cytogenetically invisible microdeletions 
(Oostlander et al., 2004). It will be very interesting to apply this technology to a panel of 
patients’ DNA with OA/TOF to determine whether genetic loss is common in this group 
of malformations.
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Finally, familial/syndromic OA/TOF is very rare. A well-studied example is Feingold 
syndrome (oculodigitoesophagoduodenal syndrome) which is a rare autosomal dominant 
disorder that includes oesophageal atresia (Courtens et al., 1997; Feingold et al., 1997). 
Studies of affected families have localised the defect to chromosome 2 (2p23-p24) and 
have shown that haploinsufficiency of a gene or genes in that region is associated with 
syndromic OA/TOF (Celli et al., 2000). Further characterisation of the genes involved 
could contribute to the study of the molecular basis of OA/TOF.
1.3.4 -  Clinical history, prognosis and management
The evolution of surgical techniques and of neonatal intensive care has resulted 
in the survival of the vast majority of neonates with OA/TOF. The mortality still 
associated with OA/TOF can be largely attributed to the presence of malformations in 
other organ systems. In this respect, the most important are cardiac malformations that 
have been shown to be, together with low birth weight, the most important predictors of 
mortality (Spitz, 1996; Spitz et al., 1994; Spitz, 1993; Iuchtman et al., 1992). The 
management of OA/TOF is surgical and the aim is to establish oesophageal continuity 
either primarily or in a staged procedure. In the presence of other malformations, the aim 
is also surgical correction of the malformations. Although OA/TOF repair is relatively 
straight forward, infants with repaired OA/TOF continue to suffer morbidity associated 
either with abnormal oesophageal function or respiratory dysfunction (Brown et al., 1999; 
Romeo et al., 1987; Biller et al., 1987; Chetcuti et al., 1992; Robertson et al., 1995; 
Somppi et al., 1998; Koivusalo et al., 2005). These residual problems are attributed either 
to primary defects in the oesophagus, trachea or lungs or are secondary to events early in 
life such as aspiration pneumonia (LeSouef et al., 1987).
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1.3.5 -  Animal models of tracheo-oesophageal malformations
1.3.5.1 - The history o f animal models
In recent years, congenital malformations have become one of the leading causes of 
neonatal mortality in the Western world . This can be explained by the dramatic decrease 
in the number of deaths caused by neonatal infection as a result of effective antibiotic 
treatment and the general improvement in the care of extremely low birth weight babies 
in neonatal units. In contrast, mortality rates for several major congenital malformations 
remain unacceptably high. The mortality data are even worse when rates of intrauterine 
death are taken into account. This reflects the lack of progress in understanding the 
embryological basis of malformations or in turning this improving knowledge into 
preventive therapies (Kluth & Lambrecht, 1997a).
This is particularly true in the case of OA/TOF. Although very significant progress has 
been made in recent years in the clinical management of these malformations, there is still 
significant morbidity and even mortality, especially in the presence of associated 
malformations (e.g. heart). The detailed embryological events that underlie the 
development of OA/TOF are not well understood. One reason is the lack of any 
significant number of human embryos with OA/TOF that are available for study at the 
appropriate stages of gestation; it should be pointed out that tracheo-oesophageal 
development takes place in the 3rd and 4th weeks of gestation. Furthermore, there are no 
satisfactory alternative techniques for the study of these defects, such as in vitro culture 
models or computer generated three dimensional reconstructions.
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In view of these shortcomings, the development of a reliable and reproducible animal 
model of these malformations has been a goal of paediatric surgical researchers for 
decades. A number of mechanical techniques were initially used to produce tracheo- 
oesophageal malformations. Rabbit and sheep foetuses were operated in utero and had 
their oesophagus ligated, but this did little more than to offer a model for the study of 
some aspects the pathophysiology of oesophageal atresia (Trahair et al., 1995; Wesson et 
al., 1984). A model that was based on causing malformations by inducing hyperflexion of 
chick embryos met with limited success (Kleckner et al., 1984). The major drawback of 
these approaches was that they assumed a mechanistic embryological basis for tracheo- 
oesophageal malformations and certainly ignored any cellular and molecular aspects of 
the aetiology of these anomalies. Moreover, none of these techniques attempted to 
understand OA/TOF in terms of an aberration of normal tracheo-oesophageal 
development. Depleting vitamin A or riboflavin from the diet of pregnant rats caused 
tracheo-oesophageal malformations including OA/TOF, but these were not consistent 
(WILSON et al., 1953; KALTER & WARKANY, 1957). The study of the effect of 
teratogenic agents on embryo development appeared more promising. In 1978, Thompson 
et al, described a number of malformations, including OA/TOF, in rat and rabbit foetuses 
exposed in utero to the anticancer agent Adriamycin (doxorubicin hydrochloride) 
(Thompson et al., 1978). This observation was not followed up until 20 years later when 
Diez-Pardo et al (1996) described in detail the first reproducible model of tracheo- 
oesophageal malformations based on exposure to this particular teratogenic agent.
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1.3.5.2  -  The Adriamycin rat model
Adriamycin is an anthracycline antibiotic used in anticancer chemotherapy. Its action is 
based on its ability to enter the nucleus of cells and intercalate into DNA, interfering with 
DNA replication and transcription. It also has mutagenic properties and interferes with 
the function of the cell membrane and other cell organelles. Diez-Pardo et al (1996) found 
that daily intraperitoneal injections of pregnant rats with 1.75 mg/ kg body weight of 
Adriamycin from E6 to E9 produced tracheo-oesophageal malformations in 45% of the 
exposed embryos. Subsequent studies confirmed the reproducibility of the model either at 
the same dose (Possogel et al., 1998a)or at slightly higher doses (2 and 2.2 mg/ kg)
(Merei et al., 1997a; Merei et al., 1998a; Crisera et al., 1999a). Subsequent modifications 
of the model were aimed at reducing the exposure of embryos to Adriamycin by 
manipulating days of injection, while at the same time maintaining the reproducibility of 
the malformations. Injections on days 8 and 9 only, were associated with reduced embryo 
mortality whereas the frequency of malformations was not significantly altered (41%) (Qi 
et al., 1996).
The great advantage of the Adriamycin rat model is the close phenotypic similarity 
between the rat and human malformations. The commonest type of human malformation 
(oesophageal atresia with distal tracheo-oesophageal fistula) is also the commonest type 
of experimental defect (Ashcraft & Holder, 1969). This similarity validates the model and 
makes it extremely useful for the study of faulty organogenesis. Furthermore, 
Adriamycin-treated rat embryos exhibit malformations in other systems, in addition to 
OA/TOF. The spectrum of associated malformations in the model is similar to the 
VACTERL association seen in humans (Merei et al., 1999), although the frequency and 
severity of the rat-associated malformations is greater. These include vertebral, radial and
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other skeletal (Kotsios et al., 1998; Merei et al., 1998; Xia et al., 1999a; Abu-Hijleh et al., 
2000; Kolker et al., 2000), anorectal (Liu & Hutson, 2000), cardiovascular (Qi et al., 
1997a; Otten et al., 2000), tracheo-bronchial {other than OA/TOF) (Qi et al., 1997b; Xia 
et al., 1999b) and renal tract (Temelcos & Hutson, 2004a; Temelcos & Hutson, 2004b; 
Merei et al., 2001) malformations. Foregut malformations in the Adriamycin-treated have 
been also associated with disturbance in the development of organs with neural crest 
contribution. These associated defects include cardiovascular, thymic and parathyroid 
malformations, as well as abnormal development of the parafollicular cells of the 
thyroid.(Otten et al., 2000; Martinez et al., 2004)
The association between tracheo-oesophageal malformations and malformations of the 
notochord has been studied in detail. Notochordal malformations include thickening and 
hypertrophy, abnormal position of the notochord in relation to the foregut and bifurcation 
and presence of abnormal branches (Qi & Beasley, 1999; Possoegel et al., 1999; Williams 
et al., 2001; Vleesch, V et al., 2002; Gillick et al., 2003; Mortell et al., 2004). The 
adherence of either an abnormal, ventrally position ectopic notochord, or a ventral branch 
of a notochordal bifurcation to the foregut has been seen as evidence that the notochord is 
involved in the embryogenesis of tracheo-oesophageal malformations by exerting traction 
on the developing foregut (Williams et al., 2001; Qi & Beasley, 1999). Apart from the 
mechanical effects of an abnormal notochord on the developing foregut, the persistence 
of Shh expression in the abnormal notochord branches has formed the basis for molecular 
explanations for the embryogenesis of tracheo-oesophageal malformations (Gillick et al., 
2003; Mortell et al., 2004).
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The analysis of the rat model has contributed significantly to our understanding of the 
embryogenesis of tracheo-oesophageal malformations. A number of theories have been 
put forward which themselves reflect the theories of normal development. One of these 
theories assumes that normal tracheal development and tracheo-oesophageal separation is 
the result of rapid longitudinal growth of the tracheal primordium away from the foregut. 
According to this theory, tracheo-oesophageal malformations are fundamentally caused 
by a failure of tracheal growth, the result of which is a compensatory overgrowth of the 
undivided foregut with the bronchopulmonary buds originating directly from the foregut 
(Fig. 1.5a,b) (Possogel et al., 1998a; Merei et al., 1997b; Sasaki et al., 2001a; Merei et al., 
1998a). According to a second theory, normal development depends on an active 
separation process that divides the foregut into a ventral trachea and a dorsal oesophagus 
and it is this process that fails (Fig. 1.5c,d) (Qi & Beasley, 2000; Williams et al., 2003). 
Interestingly, both these theories share one important point. Atresia of the proximal 
oesophagus is not part of the initial malformation. Both theories suggest that the atretic 
oesophagus is a result of late rearrangement of the cranial foregut resulting in a blind 
ending structure in the dorsal mesenchyme. According to both theories, the tracheo- 
oesophageal fistula represents the primitive foregut distal to the origin of the 
bronchopulmonary buds, which connects the undivided foregut to the stomach. The near 
term arrangement is completed by trachealisation of the undivided foregut. A third theory 
is in sharp contrast with the two described above. It proposes that the oesophagus does 
initially develop as a separate structure which then becomes atretic secondary to an, as yet 
undetermined, event. According to this theory, the tracheo-oesophageal fistula grows 
from the trachea at the level of the lung buds and reconnects with the stomach in order to 
re-establish the continuity of the gastrointestinal tract (Fig. 1.5e,f) (Crisera et al., 1999a; 
Crisera et al., 2000a). None of the theories described above are based on experimental
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Fig. 1.5 Theories on the development of oesophageal atresia and tracheo-oesophageal 
fistula
Schematic representations (sagittal sections) of the foregut illustrating the theories to 
explain the faulty organogenesis in oesophageal atresia (OA) and tracheo-oesophageal 
fistula (TOF). (a,b) In the first theory, the respiratory diverticulum (Rd) fails to elongate 
resulting in failure of the trachea to grow (tracheal agenesis) in contrast to the lung buds 
that develop normally. The overall growth and elongation of the foregut continues with 
the bronchial structures originating directly from the foregut. At a later stage, the foregut 
rostral to the bronchi assumes tracheal (Tr) histological characteristics whereas the 
foregut distal to the bronchial origin connects to the stomach and is described as the 
fistula (Fi). The upper atretic oesophagus (Ao) results from rearrangement of the anterior 
foregut (arrow in b). (c,d) In the second theory, the process of tracheo-oesophageal 
separation becomes arrested (arrows in c and d). If the failure is partial, a small length of 
oesophagus (Oe) does separate from the trachea. Following the arrest of separation, the 
undivided foregut assumes the histological characteristics of trachea whereas the initially 
separated oesophagus becomes the fistula that connects the trachea to the stomach. The 
upper atretic oesophagus forms, as in the first theory, by late rearrangement of the 
anterior foregut. {ej) In contrast to the first two theories, the third postulates that normal 
tracheo-oesophageal separation does take place. An insult to the embryo (possibly 
ischaemic) results in loss of part of the oesophagus (dotted line in J) resulting in an atretic 
upper oesophageal pouch. The development of the fistula from the trachea (arrow in f i  
compensates for the oesophageal loss by reconnecting to the stomach. This theory 
suggests that the fistula is a structure of respiratory origin.
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evidence from Adriamycin-treated mice. Finally, proponents of the foregut fold theory 
(section 1.2.2) have suggested that OA/TOF is caused by abnormal movement of the 
pharyngo-oesophageal fold which comes to lie too far ventrally, leading to failure of 
division of the tracheo-oesophageal space and subsequent trachealisation of the undivided 
structure (Kluth et al., 1987). However, this theory is based on observations of normal 
chick development rather than study of a model of tracheo-oesophageal malformations.
Recently, study of the Adriamycin rat model has suggested possible molecular 
mechanisms in the embryogenesis of tracheo-oesophageal malformations. One group 
studied the expression of the respiratory marker Nkx2.1 and found it to be expressed in 
the tracheo-oesophageal fistula throughout gestation, leading to the conclusion that it is a 
respiratory structure (Crisera et al., 1999b). In this particular study, the trachea was found 
to trifurcate into three Nkx2.1-positive structures (two bronchi and a fistula). The 
conclusion was that an imbalance between respiratory and gastrointestinal fates underlies 
the development of OA/TOF. The same group addressed the question of the difference in 
the branching characteristics between the three Nkx2.1-positive branches of the trachea. 
Although Nkx2.1-positive, the fistula did not develop branches but connected the trachea 
to the stomach. They found a difference in the activity of the FGF signalling pathway in 
the epithelium and mesenchyme of the fistula compared to the epithelium and 
mesenchyme of the bronchi and attributed to this the failure of the fistula to develop 
branches. Specifically, reduced levels of FGF1 and FGF7 mRNA were detected in the 
fistula mesenchyme and there was absence of transcripts of the FGF7 and FGF10 receptor 
FGF2R-IIIb in the fistula epithelium (Spilde et al., 2003a; Crisera et al., 2000a; Crisera et 
al., 2000b). More recently, Sonic hedgehog has been implicated in the development of 
Adriamycin-induced malformations. In one study, reduced levels of Shh protein have
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been found in the foregut of Adriamycin-treated embryos developing OA/TOF (Arsic et 
al., 2003). In another, reduced levels of Gli-2 (a key member of the Shh signalling 
cascade) mRNA have been found in the mesenchyme of the fistula (Spilde et al., 2003b). 
Another study reported a disturbance in the spatial pattern of Shh expression in the 
foregut of Adriamycin-treated embryos, showing failure of downregulation of Shh at the 
site of tracheo-oesophageal separation, although these findings were poorly illustrated in 
the associated paper (Orford et al., 2001a). A recent study of human neonates with 
OA/TOF has shown that Shh protein is absent from the epithelium of the fistula but 
present in the epithelium of the atretic oesophagus (Spilde et al., 2003c). Despite these 
findings, the role of Shh in the development of Adriamycin-induced tracheo-oesophageal 
malformations remains unclear.
1.3.5.3 - Genetic mouse models
Loss of function mutations in foregut patterning genes have been generated in mice in 
order to study the role of these genes in development. The developmental defects caused 
by these mutations include tracheo-oesophageal malformations. Although the tracheo- 
oesophageal phenotype differs from that described in the rat, these defects represent a 
unique opportunity to gain an insight into the molecular mechanisms that underlie the 
development of tracheo-oesophageal malformations in contrast to the Adriamycin model, 
whose molecular basis is unknown and could include a multitude of molecular effects. 
The genes whose mutation yields foregut defects include those associated with the Shh 
pathway.
Sonic hedgehog (Shh) null mutant embryos are grossly abnormal, in keeping with the key 
role of this secreted glycoprotein in a number of developmental processes (Riddle et al.,
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1993; Johnson et al., 1994; Roelink et al., 1995; Mango et al., 1996; Litingtung et al., 
1998; Chuong et al., 2000). These embryos have major forebrain malformations 
(holoprosencephaly), severely curtailed limb development and significant cardiovascular 
malformations (Chiang et al., 1996). In the foregut, the literature describes an abnormal 
tracheo-oesophageal development with the trachea and oesophagus having separate 
lumens but being very closely juxtaposed (Litingtung et al., 1998; Pepicelli et al., 1998). 
The description of the caudal foregut in Shh'1' embryos includes a communication 
between the lungs and the stomach, and an atresia of the oesophagus, although these 
phenotypic arrangements are not illustrated in detail (Litingtung et al., 1998). What is 
clear, however, is that the lungs themselves are abnormal, consisting of dilated sacs with 
reduced branching (Litingtung et al., 1998). The foregut phenotype of the double mutant: 
Gli2'AGli3+A is better defined. There is an undivided foregut ending in a trifurcation of 
two lung buds and a fistula to the stomach and the lungs are fused with significantly 
reduced epithelial branching (Motoyama et al., 1998). Both the Shh'1' and Gli2'AGli3+A 
embryos have malformations in other organ-systems. A number of these conform to the 
VACTERL association supporting the involvement of the Shh pathway in its 
embryogenesis (Kim et al., 2001). An almost identical foregut phenotype to the Gli2'A 
Gli3+A mutants is produced by a loss of function mutation of the transcription factor and 
respiratory marker Nkx2.1f which is not a member of the Shh pathway (Yuan et al., 2000; 
Minoo et al., 1999). In these embryos, there is failure of tracheo-oesophageal septation 
and an undivided oesophagotrachea connects the pharynx to the stomach. The bronchi 
originate from this undivided tube and the lungs are markedly hypoplastic. Finally, 
haploinsufficiency of Foxfl (also known as FREAC1 or HFH8), a transcriptional target of 
Shh also causes tracheo-oesophageal malformations including oesophageal atresia and
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tracheo-oesophageal fistula as well as lung hypoplasia and fusion of the lung lobes 
(Mahlapuu et al., 2001a).
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1.4 -  A im s  o f  t h e  t h e sis
Despite intense clinical interest in oesophageal atresia (OA) and tracheo-oesophageal 
fistula (TOF), the abnormal embryogenesis that underlies the development of these 
foregut malformations remains controversial. This can be largely attributed to the 
incomplete understanding of normal tracheo-oesophageal development, at both gross 
morphological and cellular and molecular levels.
The overall aim of this work was to study the mechanisms of normal tracheo-oesophageal 
development and the underlying cellular and molecular events in the context of foregut 
morphogenesis and to understand how disturbance of these mechanisms can lead to the 
development of tracheo-oesophageal malformations.
The initial specific aims of the study were
1. To develop an Adriamycin-based mouse model of tracheo-oesophageal malformations
2. To study and compare at the morphological level, normal mouse tracheo-oesophageal 
development and abnormal organogenesis in both the Adriamycin-treated and Sonic 
hedgehog mouse models of tracheo-oesophageal malformations.
3. Given that the molecular disturbance in the Shh model of tracheo-oesophageal 
malformations is known (loss of Shh function), I aimed to study the role of Shh in 
normal tracheo-oesophageal development and in the development of the Adriamycin- 
induced malformations.
In Chapter 3, normal tracheo-oesophageal morphology was studied in saline-treated 
CBA/Ca embryos and abnormal tracheo-oesophageal morphology in Adriamycin-treated
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CBA/ Ca and homozygous mutant (Shhv ) embryos. Then, in Chapter 4, dorsoventral 
separation of the foregut along the boundary of respiratory specification was studied both 
in normal and abnormal development. Next, in Chapter 5, the role of Shh in foregut 
development and tracheo-oesophageal separation was studied in the saline-treated and 
Adriamycin-treated CBA/Ca embryos. Having identified tracheo-oesophageal separation 
as a fundamental process in the development of the anterior foregut, the roles of 
programmed cell death and cell proliferation were studied in Chapter 6. Finally, in 
Chapter 7, the hypothesis that programmed cell death is a requirement for tracheo- 
oesophageal separation, was tested using an in vitro culture system of foregut 
development.
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CHAPTER 2 -  M a t e r i a l s  a n d  m e t h o d s
2.1 -  G e n e r a l  c o n sid e r a t io n s
All chemicals used were obtained from Sigma-Aldrich unless stated otherwise. All 
experiments were carried out at room temperature unless stated otherwise.
2.2 -  M a in t e n a n c e  o f  m o u se  c o l o n ie s
2.2.1 -  Mouse strains
The inbred CBA/Ca mouse (Harlan, UK) was used as the ‘normal’ strain. A colony of 
heterozygous Shh+I' mice (Chiang et al., 1996) was established in our laboratory. Embryos 
homozygous for the loss of function mutation for Shh were generated by mating 
heterozygous mice. Homozygous embryo generation largely followed Mendelian ratios 
(25%). Genotyping for breeding purposes was as described in Chiang et al. (1996).
2.2.2 -  Colony conditions
Mice were housed in an established animal facility according to Home Office regulation, 
with an alternating light/ dark cycle of 16 and 8 hours respectively.
2.2.3 -  Embryo generation from timed pregnancies
Mice were mated overnight and the females were checked in the morning for the presence 
of a copulation plug. The presence of such a plug was taken as evidence of pregnancy and 
the female was taken to a different cage and started on a special pregnancy diet. The day
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of discovery of a copulation plug was regarded as day 0 of gestation and 12:00 (midday) 
was designated as E0.5.
2.3 -  T e r a t o g e n ic  m a n ip u l a t io n  o f  p r e g n a n t  m ic e
2.3.1 -  The teratogenic agent
Adriamycin (doxorubicin hydrochloride) is an anthracycline antibiotic that has been 
extensively used in anticancer chemotherapy (Arcamone et al., 1969; Bonadonna et al., 
1969). During extensive animal testing, multiple teratogenic and other toxic effects of the 
agent have been described, including damage to the cell membrane, generalised 
restriction of growth, mutagenic effects and interference with the processes of DNA 
replication and transcription (Ross et al., 1978). Adriamycin was obtained from 
Pharmacia & Upjohn (UK), in vials containing 5 ml of a 2 mg/ml solution (10 mg of 
Adriamycin) which were diluted with normal saline to a working concentration according 
to the required dose for injection: 0.4 mg/ml for the 4 mg/kg body weight dose, 0.3 mg/ml 
for the 3 mg/kg dose, 0.2 mg/ml for the 2 mg/kg dose etc etc. The vials were stored at 4
°C and, once the seal was breached in order to dilute the agent, it was used within two 
weeks.
Due to the known toxic effects of Adriamycin, stringent safety regulations were followed 
during usage or when exposure was possible. It was stored was in a designated fridge. 
Whenever the solution was handled, the user wore safety goggles, face mask and gloves, 
and work on the agent was carried out in an extraction hood. Any material that became 
soiled with Adriamycin (e.g. tissue paper) was disposed of in a double yellow bag, before 
being incinerated. Within the animal facility, mice that were administered Adriamycin
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were kept in separate cages that were clearly marked and were not handled by laboratory 
staff other than for changing food and water supplies. At the end of the experiment, the 
carcasses of Adriamycin-treated mice were disposed off separately in clearly labeled bags 
before incineration. It was the responsibility of the license holder to dispose of the 
bedding of the cage in double yellow bag, as well as to wash the cage by hand before 
normal machine washing.
2.3.2 -  Administration of agent
Adriamycin was administered to pregnant mice on days 7.5 and 8.5 of gestation by an 
intraperitoneal injection at a dose of 2, 3, 3.5, 4,4.5, 5 or 6 mg/kg body weight. The 
working Adriamycin solution used for each dose ensured that the mice received the same 
volume of solution per body weight irrespective of the dose used. The mice were 
subsequently monitored for any signs of ill health and the license holder was contacted 
immediately if such signs developed. In this case, the animal was humanely killed by 
cervical dislocation and disposed of appropriately.
2.4 -  E m b ryo  h a r v e s t  an d  p r o c e s s in g
2.4.1 -  Timing of harvest
Pregnant mice were sacrificed between 12:00 and 13:00 so that embryos from different 
litters were of comparable gestation. None of the injected mice were allowed to proceed 
to term, with the embryos harvested at E l7.5 and E l8.5 used as ‘near-term’ substitutes 
for the study of development at term.
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2.4.2 -  Techniques of harvesting
The mice were killed by cervical dislocation. The abdomen was then cleaned with alcohol 
and access was gained to the peritoneal cavity by tenting the lower abdominal wall with 
forceps and cutting through with scissors. From that initial access point, a slightly curved, 
transverse incision was fashioned across the lower abdominal wall. The uterine horns 
were readily identified and each was separated from the corresponding ovary. Each horn 
was dissected free, having been put under tension, and finally the attachment of the two 
horns at the cervix was divided and the uterus removed from the abdominal cavity. This 
was immediately transferred into a dish containing 10% fetal calf serum (FCS) diluted in 
Dulbecco’s Modified Eagle Medium (DMEM/ Gibco BRL)) where remaining pieces of 
fat and other tissue were removed. No further dissection was performed at this stage and 
the uterus was transferred in the FCS/DMEM solution to the dissection room for further 
manipulation under a dissecting microscope.
2.4.3 -  Dissection of conceptuses
Under a dissecting microscope, two sharp dissecting forceps (watchmaker’s no 5) were 
used to split the uterine wall at the end of each uterine horn. Once the initial opening was 
made, the forceps were again used to extend the opening along the length of each horn, 
taking particular care not to damage the conceptuses. Once the uterine wall was opened, 
each conceptus was gently pushed free into the medium using the blunt edge of the 
forceps. The conceptuses were then transferred to fresh medium (FCS/DMEM) for 
continuing dissection. The decidua and amniotic cavity were opened and the umbilical 
vessels severed in order to free the embryo. Any residual pieces of amniotic membrane 
were carefully removed. The embryos were then carefully transferred, using pipettes,
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through three different ice cold phosphate buffered saline (PBS) solutions to be washed 
free of blood and other debris and in order to be assessed for growth and development.
2.4.4 -  Assessment of embryos
The embryos were first assessed for any gross morphological abnormalities. If any were 
present, the embryos were photographed (section 2.10.1). The developmental stage of the 
embryos was then determined by counting somite pairs. This was done by first identifying 
the limb buds and taking the first somite beyond the fore limb bud to be somite 11 and the 
first somite beyond the hind limb bud to be somite 27. The total number of somites were 
then counted on from those reference points. The determination of somite number could 
only be accurately achieved up to E l2.5. The size (and by implication the growth) of 
embryos was assessed by measuring the crown-rump length using an eyepiece graticule at 
constant magnification.
2.4.5 -  Embryo fixation and embedding
Following the three PBS washes, the embryos were processed and fixed appropriately 
depending on their subsequent use. Embryos solely intended for histological analysis
were fixed in Bouin’s fixative. These embryos were kept in Bouin’s at 4 °C until they
were ready for embedding. Embryos that were intended for any other use, including in 
situ hybridisation and immunohistochemistry, were fixed with 4% paraformaldehyde 
(PFA) in PBS. The length of the fixation period depended on the embryo size. Embryos at 
E9.5 and 10.5 were fixed for 24 hours whilst bigger embryos were maintained in fixative 
for 48 hours. At the end of the fixation period, the embryos were taken through three PBS 
washes and were dehydrated through a series of ethanol solutions (30%, 50%, 70%, 85%, 
95%, and 100% in DEPC-H2O) for 30 minutes each. The dehydration process could be
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stopped when the embryos were in the 70% ethanol solution and the embryos could then 
be stored at 4 °C to continue the process at a later date. Following the 100% ethanol,
embryos were taken through one 15 minute wash with 50% ethanol in Histoclear 
(National Diagnostics) and two 15 minute washes in Histoclear. They were then put for
20 minutes in a 55 °C oven in 50% Histoclear in wax and then taken through two 30
minute paraffin wax (Raymond Lamb) solutions in the oven before being embedded in 
paraffin wax. Embryos at El 1.5 or older were embedded using plastic moulds whereas 
smaller embryos were embedded in glass moulds using a dissecting microscope to ensure 
the appropriate orientation. Alternatively, embryos that were destined for use in whole- 
mount in situ hybridisation experiments were dehydrated using methanol rather than 
ethanol. Following the three PBS washes, these embryos were processed through four 30 
minute washes (25%, 50%, 75% and 100% methanol) and were then stored in 100%
methanol at -20 °C until their intended use.
An alternative embedding protocol was used for embryos that had been stained after a 
whole-mount in situ hybridisation experiment. If vibratome sectioning of these embryos 
was required (section 2.6.4), these embryos were embedded using a special vibratome 
embedding mixture. This was prepared by dissolving 4.5 g of gelatin in 800 ml of PBS 
and adding 270 g of albumin and 180 g of sucrose to the solution. The mix was then
aliquoted in 20 ml tubes and stored at -20 °C. The embryos to be embedded were
equilibrated with the mix and placed on the side of the embedding mould. The final 
embedding mixture was prepared by diluting 25% glutaraldehyde 1/10 in the original 
mix. The final mix was stirred vigorously and the embryos orientated in the solution. The 
embryo orientation had to be carried out quickly as the solution set within approximately
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one minute. The blocks were kept at 4 °C for one hour and could then be cut or stored by 
wrapping in clingfilm or by removing from mould and placing in sterile PBS at 4 °C.
2.5 -  W h o le  em b ry o  c u l t u r e
2.5.1 -  Preparation of rat serum
Rat serum was used as a key component of the culture medium. It was prepared from 
blood obtained from old, male rats. The animals were anaesthetised by being placed in a 
dessicator containing ether. Anaesthesia was maintained by placing a paper cone, 
containing ether-soaked tissue paper, over the animal’s head during dissection. The 
abdominal wall was cleaned using 70% industrial methylated spirit (IMS) and the 
abdomen opened using a midline incision. The aorta was identified in the retroperitoneum 
and the blood was removed from the aorta using a 10-ml syringe until the animal died of 
exanguination. The blood was then centrifuged at 3500 g for 5 minutes. This resulted in 
pelleting of the red blood cells and the formation of a fibrin clot in the supernatant. The 
fibrin clot was squeezed using sterile forceps and the solution centrifuged again. The 
serum in the supernatant was then pooled from different tubes and centrifuged again to
remove any remaining red cells. The serum was then heat inactivated at 56 °C for 30 
minutes and then aliquoted into 5-ml tubes and stored at -20 °C until required.
2.5.2 -  Embryo harvest
The embryos for culture were harvested on E10.5 between 12:00 and 13:00. All 
dissection instruments were cleaned with 70% IMS. After killing the pregnant mice by 
cervical dislocation, the uterus was exposed with a curved, transverse, lower abdominal
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incision as described in section 2.4.2. From that point onwards, the technique for 
harvesting embryos for culture was modified from that described in section 2.4.2 as 
follows. Each uterine horn was separately freed from the associated ovary and cleaned 
from fat before being held with tension away from the abdomen, still attached to the 
cervix. The tension allowed opening of the uterine wall using fine, iridectomy scissors 
without damaging the conceptuses. After making a small initial opening at the end of the 
uterine horn, the uterine wall was opened along the length of the horn by inserting the tip 
of one blade into that opening and moving the blade towards the cervix. Damage to the 
underlying conceptuses was avoided by maintaining the horn under tension and the tip of 
the blade pointing away from the conceptus. Once the entire length of the uterine horn 
was opened, the conceptuses were teased off the uterus using the blunt edge of a forceps
blade and transferred into prewarmed (at 37 °C) 10% FCS (in DMEM) in order to be 
transported to the dissection room for further dissection under the microscope.
2.5.3 -  Microscopic dissection
Subsequent dissection took place in freshly prepared explanting solution (Table 2.1) 
under a dissecting microscope. Using fine dissecting forceps, the decidua was carefully 
removed, followed by the fine Reichert’s membrane to expose the yolk sac. A hole was 
then made in the yolk sac, near its junction with the placenta, towards the caudal end of 
the embryo. Continuing to use the forceps, the tear in the yolk sac was extended along the 
equator of the conceptus. This extension was made by picking up the free edge of the 
yolk sac with forceps and pulling in opposing directions. In this way, the risk of severing 
major yolk sac blood vessels was reduced. The yolk sac was opened for about three 
quarters of its circumference so that the embryo could be exteriorised. The yolk sac was 
then tucked under the caudal end of the embryo. Finally, the embryo was fully
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exteriorised by removing the fine amniotic membrane, that is adherent to the embryo, by 
careful dissection (Cockroft, 1990).
2.5.4 -  Culture conditions
2.5.4.1 - Preparation o f the culture medium
The embryos were cultured in 25% rat serum diluted in freshly prepared culture solution 
(Table 2.1). Before use, the thawed rat serum was filtered using a 0.45 pm filter. Each 
embryo was cultured in individual culture tubes in 2.5 ml of culture medium. For some 
embryos, either 10 pi of dimethylsulphoxide (DMSO) or 10 pi of 50 mM z-vad-FMK in 
DMSO (giving a final z-vad-FMK concentration of 200 pM), were added to the culture 
medium.
2.5.4.2 - Culture technique
The culture medium was prepared in special culture tubes (Nunc 10 ml plastic tubes) 
before the final stage of embryo dissection and equilibrated in the culture incubator at 37 
°C. Before being placed in the incubator, the medium was pre-oxygenated as follows. 
Forty per cent oxygen (5% CO2 , 55% N2) was delivered for two minutes using a glass 
pipette the tip of which was kept away from the wall of the tube and the surface of the 
medium. This gave enough flow so that it did not create bubbles in the medium, but 
ruffled the surface of the media continuously. The aim of this was to saturate the tube 
with the oxygen/ CO2 mixture. In order to minimise gas leaks, grease was applied to the 
top of the tube, and during subsequent gassings the tube top was only minimally 
displaced to allow introduction of the glass pipette. This method of gassing was used 
during all subsequent gassings in the presence of the embryos. Following dissection, the
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Table 2.1 Composition of explanting and culture solutions
Reagent Explanting solution g/1 Culture solution g/1
NaCl 6.9 6.9
KC1 0.3 0.3
MgS04.7H20 0.1 0.1
MgCl2.6H20 0.05 0.05
NaH2 P 04.H20 0.1 0.1
CaCl2.2H20 0.27 0.27
NaHC03 * 0.5 2
Glucose * 1.5 2
* The solution was prepared and autoclaved before the addition of the glucose and the 
sodium bicarbonate. When either solution was required, the appropriate amounts of the 
two reagents were added to the autoclaved solution and the resulting solution was filtered 
through a 0.45 pm filter.
embryos were carefully transferred using a pipette into the prewarmed medium and 
gassed again. They were then placed onto rotating rollers in the incubator (at 38 °C) and 
gassed again at 6 and at 16 hours.
2.5.4.3 - Embryo assessment
During dissection, embryos were discarded if major yolk sac blood vessels were 
damaged, leading to significant haemorrhage and exsanguination. Embryos were included 
in the culture experiment if they satisfied the following criteria at the time of dissection 
and at the first check at 30 minutes after the beginning of the culture: (i) the presence of a
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regular and vigorous heartbeat with a minimum rate of 60 beats per minute and (ii) the 
presence of blood flow in the umbilical, head and neck vessels. The same criteria were 
used in the final assessment at 18 hours in order to determine which embryos would be 
included in the experimental analysis. Embryos failing either criterion were discarded 
without analysis. Those that showed milder signs of ill health at the final assessment, for 
example a mild degree of oedema, but which satisfied criteria (i) and (ii) above, were 
judged to be alive and were included in the study.
2 .6  -  E m b ryo  s e c t io n in g
2.6.1 -  Equipment used
An Optech instruments model HM 330 rotary microtome was used to section wax 
embedded embryos. For sectioning whole-mount in situ hybridisation embryos, a 
Vibratome 1000 from Technical Products International was used.
2.6.2 -  Preparation of slides
Glass slides were coated with 3-aminopropyltriethoxysilane (TESPA) before use in order 
to improve adherence of tissue sections. Slides were placed in racks and immersed forlO 
seconds in of 8% TESPA in acetone. This was followed by two 10 second washes in 
acetone before washing in MilliRo water and drying overnight in a 30 °C oven. The 
following day, the slides were removed from the racks, put back in their container and 
stored at 4 °C. Newly TESPA-coated slides were used within two months or were 
recoated for maximal effect. If the slides were required for ISH, then the glass jars used 
for the TESPA-coating as well as the racks loaded with the slides were baked first in a 
180 °C oven for four hours. In this case, the water used for the slide preparation was
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DEPC treated (0.5-1 ml DEPC per litre of MilliQ water). The DEPC/water solution was 
allowed to settle overnight before autoclaving. After TESPA coating, the slides were kept 
in their racks, wrapped in aluminium foil, until used.
2.6.3 -  Sectioning technique
For the majority of embryos, only the relevant parts of the embryo were sectioned and 
analysed. Thickness of sections varied between 5 and 10 micrometres and sequences of 
sections were transferred onto slides with water that had been prewarmed on a hot-plate 
(25 °C). As soon as the wax wrinkles disappeared, the water was drained using a pipette 
and any excess moisture was removed with tissue. The slides were then placed onto a 
drying rack and placed in a 30 °C oven overnight. Following the drying period, they were 
wrapped and stored at room temperature.
2.6.4 -  Obtaining vibratome sections
This was used to obtain sections from embryos in whole-mount in situ hybridisation 
experiments, which had been embedded in vibratome mix as described in section 2.4.5. 
The embryo blocks were trimmed so that their base was larger than their height to 
optimise sectioning, then positioned in the mounting tray using superglue and the 
mounting tray was filled with sterile PBS. Thirty to fifty pm sections were then cut, 
transferred onto glass slides and mounted with 50% glycerol/PBT. The slides were 
subsequently stored in flat slide holders at 4 °C and were regularly assessed for evidence 
of drying up and the glycerol/PBT solution was replenished.
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2.7  -  St a in in g  t e c h n iq u e s
2.7.1 -  Haematoxylin & eosin staining
Haematoxylin & eosin (H&E), which stains both the nucleus and the cytoplasm, was used 
for general histology. Paraffin sections were dewaxed in Histoclear for 10 minutes and 
then rehydrated through a series of 30 second washes with IMS solutions (100%, 95%, 
and 70%) and a rinse in MilliRo water. They were then immersed in Ehrlich’s 
haematoxylin (DPH) for 2.5 minutes and rinsed again in MilliRo water until the sections 
appeared blue. After rinsing under running tap water for five minutes, excess 
haematoxylin was removed by quickly dipping in acid alcohol solution (1% HC1 in 70% 
ethanol) before immersion in tap water until the sections turned blue again and then 
staining in 1% eosin (Raymond Lamb) for two minutes. The slides were finally rinsed 
under running tap water until the water ran clear and then were dehydrated through a 
series of 30 second IMS washes (70%, 95%, and 100%). After being placed in Histoclear 
for another ten minutes, sections were mounted using dextropropoxyphene (DPX, Fisher 
Scientific) medium and air dried.
2.7.2 -  Methyl Green staining
This is a nuclear stain and was used to counterstain sections from immunohistochemistry 
experiments. Following completion of staining with 3,3-diaminobenzidine 
tetrahydrochloride (DAB), sections were washed twice in water and placed in methyl 
green for ten minutes. They were then taken through three water washes (10, 10 and 30 
seconds respectively) and taken through three rinses of butanol (BDH) (10, 10 and 30 
seconds respectively) before finally being taken through two changes of Histoclear (30
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seconds and 5 minutes respectively). They were then mounted using DPX mounting 
medium and allowed to air dry in an extraction hood.
2.7.3 -  Periodic Acid Schiff (PAS) staining
This histochemical stain stains mucopolysaccharides a deep magenta colour. Sections 
were dewaxed in Histoclear for five minutes and then rehydrated through a series of IMS 
solutions (100%, 95% and 70%) for 30 seconds each. They were then rinsed with water 
and placed in the Periodic Acid solution for 10 minutes. They were then rinsed with 
MilliRo water, placed under tap water for one minute and then rinsed once again with 
MilliRo water. They were then placed in Schiff s reagent (pararosaniline HC1 1%, sodium 
bisulfite 4% in HC1) for twenty minutes, rinsed in MilliRo water and washed under tap 
water for another five minutes. They were then counterstained with Mayer’s 
haematoxylin for one minute, washed under tap water for five minutes and then 
dehydrated through an IMS series (70%, 95% and 100%) for 30 seconds each. They were 
then placed in Histoclear for five minutes and mounted as described above
2.8 -  iMMUNOfflSTOCHEMISTRY
2.8.1 -  General principles
Paraffin sections were pre-treated with Declere (Cell Marque Corp, USA) in order to 
enhance the exposure of epitope sites as well as for the purpose of dewaxing. The slides 
were immersed in Declere, diluted 1 to 20 with distilled water, and placed in the 
microwave {at medium) for 20 minutes. At the halfway point, the slides were checked to 
ensure that they were still well covered by the Declere solution. At that point, fresh 
diluted Declere solution was placed separately in the microwave and allowed to boil. At
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the end of the 20 minutes, the slides were transferred to the fresh Declere solution and 
allowed to cool down to room temperature for 15 minutes. They were then taken through 
two quick water washes and three washes in Tris-buffered-saline-Triton X-100 buffer 
(TBS-TX: 50 mM Tris HC1 pH 7.5, 150 mM NaCl, 0.5% Triton X-100 in water; the first 
two for ten seconds, third for five minutes) and then treated with 0.6% H2O2 (in 0.05 M 
Tris-HCl) for 7.5 minutes. Following three more TBS-TX washes, the slides were 
incubated for an hour in 10% fetal calf serum (in TBS-TX) at room temperature before 
overnight exposure to the primary antibody at 4°C. The primary antibody was diluted 
appropriately (Table 2.2) using 1% FCS (in TBS-TX) and 80 pi of the diluted antibody 
was applied to each slide. Parafilm was used to ensure adequate spread of the antibody 
and to prevent drying of the slides. The slides were then placed in a humid container. The 
following day the slides were taken through three TBS-TX washes, the diluted secondary 
antibody was applied in an identical manner as for the primary antibody and a two hour 
incubation was performed at room temperature. They were then washed with TBS-TX 
and developed using ABComplex and DAB. The ABComplex was prepared 30 minutes 
before the intended use and 6 drops were applied to each slide which were then placed in 
a moist environment without parafilm for 30 minutes. DAB was prepared, filtered with a 
0.45 pm millipore filter and applied to the slides. In order to optimise staining, the 
development of one of the slides was monitored under the microscope. The duration of 
DAB staining ranged from 15 to 30 minutes according to the antibody and no further 
specific staining could be achieved after that because of enzyme kinetics. Non-specific 
staining appeared beyond that time point and this was avoided. Sections were 
counterstained with methyl green, dehydrated and mounted in DPX mounting medium, as 
described in section 2.7.2.
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2.8.2 -  Antibodies used
The antibodies used and their dilutions are shown in Table 2.2.
Table 2.2 Antibody details
Primary
antibody
Source Immunogen
type
Dilution Secondary
antibody
Source Dilution
Nkx2.1 NeoMarkers
MS-699-P1
Mouse
monoclonal
IgG,
1:100 Biotinylated 
Rabbit Anti- 
Mouse
DAKO
E0354
1:400
Hnf3p DSHB*
4C7
Mouse
monoclonal
IgG,
1:100 Biotinylated 
Rabbit Anti- 
Mouse
DAKO
E0354
1:400
Shh Santa Cruz 
N19
Goat
polyclonal
IgG
1:200 Biotinylated 
Rabbit Anti­
goat
DAKO 1:250
Caspase 3 Cell
Signaling 
966 IS
Rabbit
polyclonal
IgG
1:1000 Biotinylated 
Goat Anti- 
Rabbit
DAKO
E0432
1:250
Phospho- 
histone H3
Upstate 06- 
570
Rabbit
polyclonal
IgG
1:200 Biotinylated 
Goat Anti- 
Rabbit
DAKO
E0432
1:400
*- Developmental Studies Hybridoma Bank
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2 .9  -  In  sit u  h y b r id isa t io n
2.9.1 -  Preparation of gene probes
2.9.1.1 - Transformation o f bacteria
Competent Escherichia coli (E. Coli) cells were used for transformation with circular 
plasmids containing a cDNA of interest. Competent cells were taken from -80 °C and 
thawed on ice. For each plasmid, 50 pi aliquots of competent cells were gently pipetted 
into premarked plastic tubes and kept on ice for 45 minutes. The tubes were then placed 
in a water bath at 42 °C for 45 seconds and then chilled on ice for two minutes. LB broth 
(500 pi) was added to each tube and they were placed on a shaker for 90 minutes. At the 
end of this period, 200 pi of cells were placed on LB agar plates and spread with a loop. 
The plates were placed in a 37 °C oven overnight.
2.9.1.2 - Isolation o f plasmid DNA/ DNA purification
Agar plates containing bacterial colonies were removed from the 37 °C oven, wrapped in 
clingfilm and placed at 4 °C until use. Fresh LB broth was prepared to which 1 pl/ml of 
ampicillin was added. Universal containers were marked (three for each plasmid) and 5 
ml of the LB broth/ ampicillin mix was added to each container. The agar plates were 
then inspected and isolated colonies were identified on the plate. The colonies were 
touched using an autoclaved pipette tip and the tip was then placed into the LB broth mix. 
The containers were then placed in a shaker, at 37 °C overnight. The next morning, 1.5 
ml of LB-broth was taken from each universal and placed into separate Eppendorf tubes. 
Cells were pelleted by centrifugation for two minutes at 10000 g. Plasmid was then 
isolated using the Promega Wizard plasmid isolation kit according to the manufacturer’s
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instructions. Briefly, excess fluid was discarded and the Eppendorfs were refilled with 1.5 
ml of LB-broth and centrifuged again. All excess fluid was pipetted off to leave the pellet 
at the bottom of the tube. The pellets were resuspended using 200 pi of cell resuspension 
solution and cells were then lysed using 200 pi of cell lysis solution. The tubes were 
gently inverted four times to mix cells and solution. Neutralisation solution (200 pi) was 
added and the tubes were again inverted several times to achieve adequate mixing. The 
purpose of this step is to denature the bacterial chromosomal DNA and proteins, 
producing a white precipitate. The lysate was then centrifuged for five minutes at 10000 g 
in order to pellet the bacterial chromosomal DNA and leave the plasmid DNA in solution. 
In order to purify plasmid DNA, the plunger was removed from a 2.5-ml syringe (one 
syringe per lysate) and the syringe attached to a microcolumn. One millilitre of DNA 
purification resin, together with the clear lysate from the previous step, were added to 
each syringe. The plunger was then reintroduced onto the syringe and the resin/lysate mix 
was pushed through the microcolumn. The syringe was removed from the microcolumn 
and the plunger was removed from the syringe. Two ml of column wash solution 
(containing ethanol) was introduced into the syringe, the plunger was reintroduced, the 
syringe was reattached to the microcolumn and the wash solution was pushed through the 
microcolumn. The microcolumn was then removed from the syringe, attached to an 
Eppendorf microcentrifuge tube and centrifuged at 10000 g for two minutes. The 
microcolumn was then transferred to a new microcentrifuge tube and the DNA was eluted 
from the column by adding 50 pi of sterile water to it, waiting for one minute and then 
centrifuging the tube at 10000 g for twenty seconds. The microcolumn was then removed 
and discarded and the Eppendorf tubes containing the eluted plasmid DNA were stored at 
-20 °C until use.
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2.9.1.3 - Digestion o f plasmid DNA
Once plasmid DNA had been isolated, it was checked for the presence of the required 
DNA insert using restriction endonucleases that cleave the DNA at specific sites. Two 
microlitres of plasmid were mixed with 1 pi of endonuclease, 2 pi of buffer and 15 pi of 
sterile water and kept at 37 °C for 90 minutes. The solution was then electrophoresed 
through a 1% agarose gel to confirm the presence of the appropriate DNA fragment. Once 
the presence of the expected insert site was confirmed, a large scale digestion was carried 
out in order to prepare enough linearised plasmid to allow preparation of labelled probes 
for in situ hybridisation. Twenty microlitres of plasmid, 5 pi of the appropriate 
endonuclease, 20 pi of the appropriate buffer and 155 pi of sterile water were incubated 
in a 37 °C waterbath for three hours, purified by precipitating with 400 pi of ethanol and 
10 pi of sodium acetate and stored at -  20 °C overnight. Before precipitation, the success 
of linearisation was checked by gel electrophoresis. Before proceeding to synthesis of the 
probe, the DNA was resuspended and tested again for integrity of the DNA. It should be 
noted that from this point onwards, only DEPC-treated solutions and pre-packed pipette 
tips were used to avoid contamination by RNA-ases. The samples were centrifuged at 
13000 g for 15 minutes (4 °C), the pellet was washed with 200 pi of freshly made 70% 
ethanol and centrifuged again at 13000 g for 5 minutes. The excess fluid was removed 
with a pipette and the pellet was air dried for 10 minutes, resuspended in 20 pi of DEPC- 
water and stored at -20 °C until use. Before freezing, 2 pi of each sample was run on a 
1% agarose gel.
2.9.1.4 - Synthesis o f digoxigenin(DIG)-labelled RNA probes
Synthesis of the labeled RNA probe was carried out using a Boehringer-Mannheim DIG- 
labeling kit. One microlitre of linearised plasmid DNA was mixed with 2 pi of DIG RNA
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labeling mix, 2 pi of lOx transcription buffer, 1 pi of RNAase inhibitor, 2 pi of the 
appropriate RNA polymerase and 12 pi of DEPC-water and incubated at 37 °C for two 
hours. The result was checked by running 1 pi of the DIG-labeled RNA transcript on a 
1% agarose gel. The amount of probe synthesised was estimated by comparing the 
brightness of the RNA and DNA bands on the electrophoresis gel. The transcription 
reaction was stopped using 2 pi of EDTA solution (pH 8.0) and precipitated using 2.5 pi 
of 4 M LiCl and 75 pi of ethanol, pre-chilled at -  20 °C. The probe was then stored at -  
20 °C overnight. The labelled probe was then resuspended by centrifuging at 13000 g (4 
°C) for 15 minutes, washing with 200 pi of 70% ethanol and recentrifuging for 5 minutes 
at 13000 (4 °C). The pellet was air dried for 5 minutes before dissolving in 100 pi of 
DEPC-water. The probe was either used straight away in the in situ hybridisation 
experiment or kept at -  20 °C for further use.
2.9.2 -  Whole-mount in situ hybridisation
In situ hybridisation on whole embryos was performed as already described (Copp et al, 
1999) with minor modifications.
2.9.2.1 - Embryo pre-treatment and hybridisation
The embryos to be used in this experiment had been stored in 100% methanol at -  20 °C. 
Storage in methanol is essential for the prevention of gas bubble formation during the 
subsequent use of hydrogen peroxide. The embryos were rehydrated by taking them 
through a series of washes in 75%, 50% and 25% methanol in PBT (0.1% Tween-20 in 
PBS) followed by two washes with PBT. The rehydration process was carried out with 
the embryos on ice on a slow rocker. The embryos were then bleached with 6% hydrogen 
peroxide in PBT for one hour. This was followed by three washes with PBT. Embryos
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were then treated with proteinase K (5 pg/ml in PBT) in order to digest protein and 
unmask RNA sites. Exposure to proteinase K was for 10 minutes for the El 1.5 embryos 
and for 7 minutes for the E l0.5 embryos. The embryos were then washed in glycine (2 
mg/ml in PBT) to inactivate proteinase K followed by two quick PBT washes. They were 
then refixed in glutaraldehyde (0.2% in PFA) for 20 minutes followed by two PBT 
washes. The embryos were then transferred to 2 ml microtubes and 0.5 ml of 
prehybridisation mix (50% formamide, 5x SSC pH 4.5, 1% SDS, 50 pg/ml yeast RNA,
50 pg/ml heparin) was added to each tube. The embryos were incubated in the 
prehybridisation mix for two hours at 70 °C. After the prehybridisation stage, the 
embryos were stored at -20 °C until further use or used immediately for the in situ 
hybridisation procedure. Otherwise, the prehybridisation mix was removed and replaced 
with 0.5 ml of hybridisation mix which was made by adding 10 pi of digoxygenin- 
labelled RNA probe to 0.5 ml of freshly made prehybridisation mix (1 pg/ml 
concentration of probe). The embryos were incubated in a 70 °C water bath overnight.
2.9.2.2 - Post-hybridisation
The embryos were transferred to bigger polystyrene tubes and most of the hybridisation 
mix was pipetted off. The embryos were washed twice (20 minutes each) at 70 °C with 
wash solution I (50% formamide, 5x SSC, 1% SDS) and twice (20 minutes each) at 65 °C 
with wash solution II (50% formamide, 2x SSC pH 4.5). This was followed by three five 
minute washes at room temperature with TBST working solution. The TBST solution was 
prepared as follows: 40 g of NaCl, 1 g of KC1, 125 ml of 1M Tris pH 7.5 were added to 
500 ml of water and then autoclaved to make lOx TBST solution. Then 50 ml of lOx 
TBST, 5 ml of Tween-20, 0.2 g of Levamisol were mixed and made up to 500 ml with 
water to make the TBST working solution. The embryos were preblocked with 10%
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sheep serum in TBST for 90 minutes at room temperature. The antibody solution was 
prepared concurrently. A tube of embryo powder was thawed. This had been previously 
prepared as follows: Ten litters of E12.5 CD1 mouse embryos were homogenised in PBS, 
diluted by 20% in ice-cold acetone and incubated on ice for 30 minutes. The solution was 
then centrifuged at 10000 g for two hours, the supernatant was removed, the pellet was 
washed with ice-cold acetone and centrifuged again. The pellet was then spread and 
ground into a very fine powder on a sheet of filter paper and allowed to air dry. The 
powder was then stored in an air-tight tube at -  20 °C. TBST solution was added to the 
thawed embryo powder. The amount of TBST solution required was 5 ml per tube of 
embryos used in the experiment The solution was heated at 70 °C for 30 minutes and 25 
pi of sheep serum and 1.5 pi of anti-digoxygenin antibody per embryo tube were added to 
it. The solution was kept on ice and shaken gently for 60 minutes to allow for adequate 
preabsorption of the antibody. The solution was centrifuged at 3000 g for 10 minutes and 
the supernatant was filtered using a 0.45 pm filter. The antibody was added to the embryo 
tubes (3 ml per tube) and the tubes were placed on a slow rocker at 4 °C for one to three 
days.
2.9.2.3 - Post-antibody development
The embryos were taken through three five-minute TBST washes followed by five one- 
hour TBST washes and left rocking overnight at room temperature. The next day the 
embryos were taken through four ten-minute NTMT (0.1M NaCl, 0.1M Tris HC1 pH 9.5, 
0.05M MgCl2,0.1% Tween-20, 0.02 g/ 50 ml of Levamisol) washes. They were then 
transferred to glass tubes and 18 pi of NBT solution was added per ml of NTMT. The 
tubes were wrapped in foil, placed in a light box and left to rock gently at room 
temperature. The embryos were checked for colour development initially every half an
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hour. When colour development was considered adequate (staining of areas of established 
gene expression and before background staining appeared), the reaction was stopped by 
washing the embryos twice with PBT. The embryos were stored in PBT solution with 
the addition of thimerizole (0.02%) to prevent fungal growth at 4 °C in the dark. The 
embryos could then be embedded in albumin/gelatin mixture (section 2.4.5) and sectioned 
on a vibratome for further analysis (section 2.6.4).
2.9.3 -  In situ hybridisation on sections
In situ hybridisation on paraffin embedded sections was performed using digoxygenin- 
labelled riboprobes for Shh and Ptch, as previously described (Breitschopf et al., 1992) 
with minor modifications.
2.9.3.1 - Pre-hybridisation treatment
Slides bearing wax-embedded embryo sections were de-waxed by immersion in two ten- 
minute Histoclear washes followed by two three-minute washes with ethanol. The 
sections were then rehydrated by taking them through two-minute washes with 90%, 70% 
and 50% IMS and then through one two-minute wash with freshly prepared PBS. The 
slides were then placed in freshly prepared 4% PFA in a fume hood for 20 minutes and 
then taken through two two-minute PBS washes. The slides were then exposed to 20 
pg/ml proteinase K for eight minutes and then taken through two two-minute PBS 
washes. They were then placed back in the 4% PFA solution in the fume hood for a 
further five minutes, followed by two more PBS washes. The slides were then placed in 
0.1M triethanolamine solution in the presence of a stirrer in a fume hood and acetic 
anhydride (0.25%) was drizzled over the sections. The purpose of this step is twofold: 
first to stop proteinase K activity and second to prevent non-specific electrostatic binding
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of the probe to the sections by masking positive charges on the sections. This step was 
followed by two more PBS washes and the sections were dehydrated through the same 
alcohol series and allowed to air dry.
Hybridisation mix was prepared as for the whole-mount experiment (section 2.9.2.1) with 
the addition of 1 pl/ml of RNAguard and 0.5 mg/ml of tRNA. The complete hybridisation 
mix was applied to the slides (80 pi per slide) and the slides were covered with fresh 
coverslips. The rack was then placed in a light tight box in the presence of tissue paper 
soaked in 50% formamide in 2x SSC. The boxes were sealed with tape and nescofilm and 
double bagged to preserve moisture before being placed in a 65 °C oven overnight. At all 
times, the slides were kept horizontal.
2.93.2 - Post-hybridisation
The coverslips were gently washed off the slides by placing the rack in 2x SSC solution at 
65 °C. The slides were then washed twice (20 minutes each) in 50% formamide in 
2xSSC, twice (30 minutes each) in 2x SSC and twice (30 minute each) in 0.2x SSC at 65 
°C. The purpose of these steps was to remove non-specific RNA binding. At the end of 
this series of washes, the slides were allowed to cool down to room temperature.
2.93.3 - Antibody detection
The slides were then put in a buffer (Bl) solution (0.1M Tris HC1, 0.15M NaCl pH 7.6) 
for two minutes and then blocked with 10% FCS in Bl in a humid chamber for 60 
minutes. The blocking solution was then drained and 300 pi of anti-digoxygenin antibody 
was applied to each slide. The sections were then covered with nescofilm coverslips. The 
antibody dilution was 1:1000 in 2% FCS in Bl buffer. The slides were left in a humid
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chamber at 4 °C overnight. The next day, the slides were taken through three three-minute 
Bl washes and then two equilibrating ten-minute B2 (0.1M tris HC1 pH 9.5, 0.1M NaCl, 
0.05M MgCh) washes. The developing reagent was then prepared in a light-protected 
container: 18 pi of NBT/BCIP (Boehringer-Mannheim) was added per ml of B2 buffer, 
and then 0.5 ml of this solution applied to each slide. The reaction was stopped with tap 
water when the characteristic bluish staining appeared. The sections were then dehydrated 
through an IMS series, taken through two ten-minute Histoclear washes and mounted 
using Vectra mount. This mounting medium was used instead of DPX because it caused 
minimal fading of the staining.
2 .10  -  Ph o t o g r a p h y  a n d  im a g e  pr o c e ssin g
2.10.1 -  Photography of whole embryos
Embryos were photographed using a camera attached to the stereo-microscope (Zeiss 
SV11). The negatives were scanned (Filmscan 1800, Microtec scanner) and the images 
stored as JPEG files.
2.10.2 -  Digital photography and image analysis
A Zeiss Progres digital camera, attached to a Zeiss Axiophot II microscope was used to 
capture digital images which were imported and processed using Adobe Photoshop 5.2 
software. Image parameters, such as brightness, contrast and colour balance were adjusted 
in order to achieve optimal visualisation of the image, without altering its nature or 
content.
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2.11 -  D a t a  a n a l y sis  a n d  st a t ist ic s
2.11.1 -  Graph creation
All data were represented by vertical box plots prepared using Sigmaplot (version 4.01) 
software. Vertical boxes with error bars define the median, 10th, 25th, 75th and 90th 
percentile values and all outlying values are represented by dots. This type of graph was 
used throughout the thesis unless specified, and was chosen in preference to mean +/- 
standard error plots because of the lack of normality in some of the data.
2.11.2 -  Statistical analysis
Statistical analysis was performed using Sigmastat (version 1.0) software. The tests used 
were the unpaired t test (where data were normal) or the Mann-Whitney test (if normality 
failed) when comparing two groups of data. The chi square analysis of contingency tables 
was used to determine significant association between two different parameters. 
Alternatively, if there were fewer than five expected observations in any cell of a 2x2 
contingency table, the Fisher exact test was used. A p  value smaller than 0.05 was 
considered significant. Allowance for multiple comparisons using the same set of data 
(protection of a  level) was made by requiring the value of the test statistic (e.g. student’s 
t) corresponding to 0.05/No. tests to be excluded in order to achieve significance at 
/?=0.05.
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CHAPTER 3 -  M o u s e  m o d e l s  o f  t r a c h e o - o e s o p h a g e a l
MALFORMATIONS
3.1 -  In t r o d u c t io n
The close phenotypic similarity between the tracheo-oesophageal malformations in the 
Adriamycin-rat model and the human malformations, have made the model a useful tool 
in the study of the abnormal embryogenesis that underlies these defects.
Despite its obvious advantages, however, the Adriamycin rat model has an inherent 
problem. Although the laboratory rat has, for many years, played a significant role in 
efforts to improve our understanding of human biology, the study of the rat genome is 
only at its preliminary stages (Hancock, 2004). The relative paucity of molecular probes 
and markers available for the rat compared to the mouse has meant that, despite extensive 
morphological analysis of the model, little progress has been made in deciphering the 
complex molecular mechanisms that underlie tracheo-oesophageal malformations. This 
problem has been compounded by the fact that all genetic models of foregut 
malformations have been described in the mouse. On the other hand, the global loss of 
function of a gene, as seen in the genetic models, leads to extensive foregut defects and is 
unlikely to be a very good representation of the embryological events that lead to specific 
tracheo-oesophageal malformations in humans. In that respect, the rat model is a much 
better research tool.
These considerations suggested the need to adapt the Adriamycin model to the mouse.
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Moreover, the value of such an adaptation would be greatly increased if the abnormal 
organogenesis in the Adriamycin model could be studied in close conjunction with that in 
the genetic models of tracheo-oesophageal malformations. The Shh null mutant mouse 
embryo would be a good candidate for such a parallel study. It has been described as 
having foregut malformations, including OA/TOF and the role of Shh in mouse biology 
has been extensively studied in a number of organ systems. However, the review of the 
published literature does not lead to a clear understanding of the foregut morphology in 
the Shh null embryos. For this reason, further clarification and detailed description of the 
tracheo-oesophageal morphology in the mutant embryos would be desirable.
This chapter describes the development of an Adriamycin mouse model of tracheo- 
oesophageal malformations based on the work on the rat model as well as preliminary 
work on the effect of Adriamycin on mouse embryos. Aspects of normal tracheo- 
oesophageal development that are still a matter of debate are also addressed. Furthermore, 
the tracheo-oesophageal morphology in the Shh null embryos is described and 
comparisons are made with the Adriamycin-treated mouse embryos.
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3.2  -  R e su l t s
3.2.1 — The Adriamycin mouse model of tracheo-oesophageal malformations
3.2.1.1 - Normal tracheo-oesophageal development in the mouse 
Stages of tracheo-oesophageal separation
In the CBA/Ca strain (a commonly used inbred strain of mouse), there is no evidence of 
the respiratory primordium at E9.5 (15-20 somite stage) (Fig. 3.1a&c insets). In the 
pharyngeal foregut, an epithelial thickening in the ventral midline denotes the position of 
the thyroid primordium and the epithelium of the laterally placed pharyngeal pouches is 
also prominent (Fig. 3.1a inset). The foregut maintains a wide configuration. Further 
caudally, the ventral hepatic diverticulum denotes the junction between the foregut and 
midgut (Fig. 3.1c inset). By about E10 (20-25 somite stage), a ventral evagination has 
appeared in the floor of the post-pharyngeal foregut and is known as the laryngotracheal 
groove. The groove is the primordium of the inffaglottic larynx and trachea. At the caudal 
end of this groove, the primitive lung buds are seen growing in a ventrolateral direction 
and will form the future bronchi and lungs. By E l0.5 (25-30 somite stage), during a 
period of rapid longitudinal growth, the prospective trachea has gained significant length 
but is still part of an undivided foregut (Fig. 3.1a,b). At its cranial end, the 
laryngotracheal groove persists (Fig. 3.1a). At its caudal end, the primitive lung buds 
continue to grow and have started to separate from the main foregut tube (Fig. 3.1c). By 
E ll (30-35 somite stage), the ventral trachea has started to separate from the dorsal 
oesophagus. This separation starts at the level of the lung buds. In the meantime, the
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Fig. 3.1 Tracheo-oesophageal development in the CBA/Ca mouse (E9.5 -  E12.5)
Diagrams of early tracheo-oesophageal development (cranial to top, caudal to bottom; 
dorsal to right, ventral to left) and transverse sections stained with haematoxylin and 
eosin, through E l0.5 (a, b, c), El 1.5 (d, e,J) and E l2.5 (g, h, i) saline treated embryos. 
Sections correspond to the levels indicated in the schematic representations of the foregut. 
Insets in (a) and (c) are from corresponding levels from an E9.5 embryo, (a ,b, c) At E9.5, 
in the pharyngeal foregut, epithelial thickening denotes the position of the thyroid 
primordium in the ventral midline (black arrowhead, inset in a) and the primordia of the 
pharyngeal pouches (blue arrowhead, inset in a). The foregut maintains the wide 
configuration of the pharynx as far caudal as the junction with the midgut, where a 
ventral evagination (black arrowhead, inset in c) denotes the hepatic diverticulum (level 
of pericardio-peritoneal canals, blue arrowhead in c). At E10.5, the laryngotracheal 
groove (Lt) is a ventral evagination of the foregut (Fo) appearing at the caudal limit of the 
pharynx. It represents the primordium of the subglottic larynx and trachea. At the caudal 
end of the groove the primitive lung buds (Lb) are seen growing in a ventrolateral 
direction. At this stage, the respiratory foregut remains undivided, (d, e ,f) By El 1.5, the 
laryngotracheal groove can still be identified at the cranial end whilst at the caudal end 
the foregut has started to separate into a ventral trachea (Tr) and a dorsal oesophagus 
(Oe). The separation process (arrows in e) starts at the level of the lung buds and 
proceeds in a cranial direction. At its caudal end, the trachea is seen to bifurcate into the 
two bronchi (Br) that have developed from the lung buds, (g, h, i) By E12.5, only the 
cranial-most part of the laryngotracheal groove can be seen to be continuous with the 
lumen of the pharyngeal foregut (Ph) and has yet to separate from it. Just caudal to that 
level, the separation process has reached the larynx (La). Ao, aorta; At, atrium; s, atrial 
septum. Scale bars, 100 pm.
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respiratory foregut continues to gain in length. By El 1.5 (35-40 somite stage), the 
separation process has progressed in a cranial direction but the process is not yet 
complete. The undivided part of the foregut still features the laryngotracheal groove (Fig. 
3. Id) but its morphology appears to change just cranial to the level of separation with the 
appearance of lateral epithelial folds or ridges (Fig. 3.1e). The appearance of these ridges 
is also propagated in a caudal to cranial direction ahead of the process of separation. At 
its caudal end, the trachea ends in a bifurcation of two primary bronchi (Fig. 3. If). By 
E12.5 (45-50 somite stage), tracheo-oesophageal separation is all but complete, with the 
last part of the foregut to separate being the cranial end of the infraglottic larynx (Fig. 
3.1g,h). The morphology of the tracheal bifurcation remains unchanged (Fig. 3.1i).
Development of the larynx
At the cranial limit of the laryngotrachea, the entry into the airway is via the laryngeal 
vestibule which itself has to be separated from the pharynx and oesophagus. This process 
is a separate one from that of tracheo-oesophageal separation. The development of the 
larynx at the cranial limit of the airway provides an insight into the completion of the 
process of separation from the oesophagus. The development of the larynx can be 
considered in two stages: the development of the laryngeal vestibule (Fig. 3.2f), which 
provides the entry into the airway, and supraglottic larynx on the one hand and that of the 
infraglottic larynx, which is continuous with the trachea, on the other. Both parts of the 
larynx undergo a process of separation from the dorsally placed pharynx and oesophagus 
and during development their lumens become continuous to complete laryngeal 
development. The infraglottic larynx is derived from the cranial-most part of the 
laryngotracheal groove and its separation from the oesophagus forms part of tracheo-
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Fig. 3.2 Stages of normal laryngeal development
Sagittal section (a) of an El 5.5 embryo and transverse sections (b-f) from the level of the 
larynx in E12.5 (b, c, d), E13.5 (e) and E15.5 (/) embryos. All sections stained with 
Haematoxylin & Eosin. Approximate level of the transverse sections is shown by the 
dotted line in (a). At E l2.5 (b, c, d), the sections are taken from progressively more 
caudal levels, (a) The process of separation of the trachea (Tr) from the oesophagus (Oe) 
has been completed. As a result of this process, the infraglottic larynx, which is found at 
the cranial limit of the trachea, also separates from the oesophagus (arrow in a). (A) 
Between E12 and E12.5, the entrance into the airway is defined by the development of 
the epiglottic (E) and two arytenoid (A) swellings in the pharyngeal mesoderm, (c) The 
fusion of the two arytenoid cartilages in the midline defines a triangular space between 
the three swellings known as the cecum (C) and a midline mesodermal prominence, the 
laryngeal lamina (L). {d) Just caudal to that level, the laryngeal lamina transiently 
obliterates the foregut lumen, (e) By E l3.5, the fused epithelial surfaces forming the 
laryngeal lamina have started to separate from each other revealing the laryngeal lumen 
(arrow) in order to bring the larynx into continuity with the trachea. (/) The process of 
laminar separation is completed by E l5.5 with the laryngeal vestibule (Lv) being 
continuous with the trachea, m, manubrium; h, heart; Ph, pharyngeal foregut. Scale bar, 
100 pm
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oesophageal separation (Fig. 3.2a). The laryngeal vestibule is defined by the development 
of three swellings in the pharyngeal mesoderm: the midline epiglottic swelling, which 
will form the epiglottis and guard the entrance into the airway, and the two arytenoid 
swellings, which will form the arytenoid cartilages (Fig. 3.2a,b). The arytenoid swellings 
grow towards the midline and fuse to form an epithelial lamina and by doing so define a 
triangular space called the cecum (Fig. 3.2c). The development of these swellings starts at 
about E12 (40-45 somite stage) and fusion occurs about 12 hours later (E12.5, 45-50 
somite stage). The lumen of the cecum will become continuous with that of the 
infraglottic larynx and trachea as the laryngeal epithelial lamina, which transiently 
obliterates the lumen of the foregut, starts to separate, thereby forming the laryngeal 
vestibule (Fig. 3.2d-f). This process begins at about the E l3.5 stage and is completed by 
about E l5.5.
Length analysis of foregut components
Despite in depth analysis of the molecular aspects of respiratory development 
(bronchopulmonary morphogenesis in particular) the mechanisms by which the trachea 
becomes a separate organ from the oesophagus after originating from the foregut, have 
not been fully established either in the human or in any other organism. My aim was 
initially to use morphological data in order to try and resolve the controversy of whether 
the trachea develops by rapid outgrowth from the foregut or grows initially as part of an 
undivided foregut and then separates from it. To do this, the length of the trachea was 
measured during progressive stages of development between El 0.5 and El 2.5 and the 
length of the tracheal portion that remained undivided, and that which was separated, 
were recorded. In order to standardize the measurements, the cranial and caudal limits of
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the trachea were identified and used when counting the number of sections of known 
thickness (Fig. 3.3).
The limits were identified as follows: the cranial limit was the cranial-most region of the 
laryngotracheal groove, which ultimately forms the subglottic part of the larynx. By 
definition, this segment includes a small portion that is not strictly trachea, but the 
subglottic larynx shares its origin with the trachea from the laryngotracheal groove and 
separates from the foregut together with the trachea. Therefore, it was included in the 
length measurements. At early stages of development (E10.5 and El 1.5), this cranial 
point is clearly identifiable as the ventral outgrowth of the laryngotracheal groove 
whereas at El 2.5, this point was taken as the caudal limit of the laryngeal epithelial 
lamina (Fig 3.1a,d,g). The caudal limit of the trachea was easily identified as the point at 
which the trachea bifurcates into the two bronchi or bronchopulmonary buds (Fig 3.1f,i). 
In the case of El 0.5 embryos, where the trachea is not yet a separate structure, the two 
lung buds emerge from the caudal end of the prospective trachea and this level was used 
as the caudal limit of the measurements. In addition to the cranial and caudal limits, the 
point of separation of the trachea from the foregut (point where the undivided trachea 
becomes divided) is very easily identifiable (Fig 3.1e,h).
Analysis of these data reveals that at El 0.5, in CBA/Ca mice, the whole trachea is 
undivided (Fig. 3.3). By El 1.5, tracheo-oesophageal separation has started at the caudal 
end of the oesophagotrachea and is proceeding but has not yet been completed. The total 
length of the trachea has increased significantly (p<0.0001) but the length of the 
undivided segment is significantly shorter than the length of the El 0.5 undivided 
trachea/foregut (p<0.0001). This decrease supports the hypothesis that the trachea
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Fig. 3.3 Analysis of foregut lengths: undivided versus divided segments of the foregut 
during normal development
Box plots summarise length data according to gestation. The numbers above the vertical 
boxes denote the number of embryos examined for each gestation. The lengths were 
calculated by counting the number of sections of known thickness between the levels 
indicated by the dotted lines on the schematic representations (not to scale) below the 
graph. Representative transverse sections for each level and each gestation are shown in 
Fig.l. The plot demonstrates the shift from the predominance of the undivided segment at 
El 0.5, when the entire respiratory foregut is undivided, towards predominance of the 
divided segment at E12.5. By El 1.5, the length of the undivided segment has 
significantly decreased (compared to E10.5,/?<0.0001) and is significantly shorter than 
that of the divided segment (p<0.0001). The total foregut length (sum of the undivided 
and divided values) increases significantly with gestational age (p<0.0001).
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becomes a separate structure by a process of separation of the prospective trachea from 
the foregut rather than simply by a process of outgrowth and increase in length. It is also 
evident that at El 1.5, the divided segment (at the caudal end of the respiratory foregut) is 
significantly longer than the undivided segment (p<0.0001). Looking at the E l2.5 data, 
there is a significant increase in the total tracheal length (p<0.0001). This is contributed 
to, almost exclusively, by the separated trachea, as the separation process is all but 
complete. The last part to divide is the cranial end of the infraglottic larynx, which is 
separated by El 3. In summary, the trachea initially grows in length as part of the 
undivided foregut whilst subsequent growth accompanies the process of tracheo- 
oesophageal separation
3.2.1.2 - Establishing the Adriamycin mouse model 
Optimising the dose of Adriamvcin
Preliminary work was done in this laboratory by Bill Chaudhry on the effect of 
Adriamycin on CD1 and mutant curly tail (ct) mice. Embryos were exposed to the drug 
on E7.5 and E8.5 and a dose of 4 mg/kg was shown to cause tracheo-oesophageal 
malformations in the ct mice. In order to develop an Adriamycin mouse model of 
tracheo-oesophageal malformations, it was preferable to use a non-mutant strain rather 
than a mutant such as ct. The CBA/Ca strain was chosen and the effect of exposure of the 
embryos to different doses of Adriamycin on E7.5 and E8.5 was studied. Based on the 
dose of Adriamycin used in the rat experiments (1.75 mg/kg) and that used by Bill 
Chaudhry in the mouse experiments (4 mg/kg), doses between 2 and 6 mg/ kg were 
assessed in terms of the number of dead or resorbed embryos, the development of 
tracheo-oesophageal malformations and the association of these malformations with
105
Table 3.1 Adriamycin dose-response experiment, with dosing at E7.5 and E8.5
Adriamycin 
dose, mg/kg
Embryos
(litters)
Resorbed 
embryos (%)
T racheo-oesophageal 
defects (%) *
Lung defects 
(%)*
2 33 (3) 0(0) 0(0) 0(0)
3 102 (12) 4(4) 0(0) 0(0)
3.5 27 (3) 1(4) 0(0) 0(0)
4 95 (14) 3(3) 37 (40) 0(0)
4.5 66 (9) 2(3) 27 (42) 6(9)
5 63 (9) 13 (21) 25 (50) 15(30)
6 22(4) 13 (59) 5(56) 5(56)
* percentage of live embryos
maldevelopment of the lungs. The results of the dose-response experiment are shown in 
Table 3.1. None of the embryos treated with 2, 3 or 3.5 mg/kg of Adriamycin had 
tracheo-oesophageal or lung malformations. Malformations of the tracheo-oesophagus 
were common at doses of 4 mg/kg and above, while malformations of the lungs were 
observed in embryos exposed to 4.5, 5 and 6 mg/kg of Adriamycin. The frequency of 
resorption rose markedly from 5 mg/kg upwards. Since 4 mg/kg was associated with 
tracheo-oesophageal defects but not lung defects, this dose was chosen as the optimal 
level for all subsequent analyses.
Mice treated with 4 mg/kg of Adriamycin on E7.5 and E8.5 were next examined in more 
detail with respect to litter size, and the growth characteristics and spectrum of 
abnormalities found in embryos at different gestational ages. The numbers of live 
embryos in saline-treated and Adriamycin-treated litters showed no statistically
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Table 3.2 Mean numbers of live embryos in saline-treated and Adriamycin-treated (4 
mg/kg) pregnancies analysed on different days of gestation u=
Mean number of live embryos per litter (number of litters)
E10.5 E ll .5 E12.5 E13.5 E15.5 E17.5/ Overall
E18.5 Mean
Saline 6.9(11) 7.3(6) 6.6(7) 8(4) 7 (3) 7.3 (3) 7.29 (34)
Adriamycin 6.8(13) 6.8(19) 5.4 (8) 5.8 (9) 8.5 (4) 7.3 (6) 6.86 (59)*
u All mice dosed at E7.5 and E8.5
= Includes litters that were harvested but not subjected to sectioning and phenotypical analysis 
• The difference between the two groups is not statistically significant (unpaired t test, p=0.345)
significant difference between the two groups (Table 3.2) and the figures for individual 
gestations do not suggest progressive loss of Adriamycin-treated embryos as pregnancy 
progresses. The crown-rump (CR) length and somite number data of embryos treated with 
the 4 mg/kg dose compared to control embryos are summarised in Figure 3.4. Crown- 
rump lengths were similar between the two groups at E9.5, E l0.5 and El 1.5 whereas 
Adriamycin-treated embryos were significantly smaller at E12.5, E13.5 and E15.5 
(p<0.01). Saline-treated embryos were significantly more advanced in terms of somite 
number at E l0.5 (median 28 versus 27,p< 0.01) but there was no significant difference 
between the two groups at El 1.5 (median 39). Overall, these results suggest that 
Adriamycin at 4 mg/kg does not inhibit the progression of embryonic development but 
has a delaying effect on embryonic growth. Table 3.3 summarises the results of 
morphological and histological examination of 170 Adriamycin-treated and 85 saline- 
treated control mouse embryos and fetuses at various gestational ages. Overall, foregut
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Fig. 3.4 Crown-rump (CR) length and somite number in saline- and Adriamycin-treated 
embryos (4 mg/kg)
Box plots summarising crown-rump (CR) lengths (a) and somite numbers (b) according 
to gestational age at which embryos analysed (all dosing on E7.5 and E8.5). The numbers 
above the vertical boxes denote the number of embryos examined for each gestation. 
Asterisks (*) indicate statistically significant difference between saline and Adriamycin- 
treated groups using the unpaired t-test and the Mann-Whitney Rank Sum test. The 
numbers above the vertical boxes denote the number of embryos in each group, (a) 
Adriamycin-treated embryos have a closely similar crown-rump length to saline-treated 
controls at E9.5, E10.5 and El 1.5 whereas they are significantly smaller at E12.5, E13.5 
and E l5.5 (p< 0.01). (A) There is a statistically significant difference (P< 0.01) in the 
number of somites between saline-treated (median= 28) and Adriamycin-treated embryos 
(median= 27) at E l0.5, whereas there is no difference at El 1.5, when both groups have a 
median somite number of 39.
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malformations were observed in 39 % of Adriamycin-exposed embryos and fetuses older 
than E l0.5, whereas all saline-treated controls were normal. There was no progressive 
statistical trend in the percentage of OA/TOF embryos with increasing gestation with no 
difference between El 1.5 and El 7.5/18.5 (p=0.58). This supports a model of a defect 
early on that persists throughout further development.
Table 3.3. Prevalence of OA/TOF in Adriamycin-treated litters
Adriamycin-treated (4 mg/kg)
Embryonic day of 
analysis
Saline-treated* (litters)
Total No. of live 
embryos/fetuses (litters)
No. With 
OA/TOF 
(%)
10.5 22 (3) 39 (5) 0U
11.5 23 (3) 45 (7) 13* (29)
12.5 7(1) 20 (3) 12 (60)
13.5 10(1) 21 (5) 7(33)
14.5 8(1) 5 (1) 2(40)
15.5 7 (1) 11 (2) 6(55)
17.5/18.5= 8(1) 29 (4) 11* (38)
Total 85 (11) 170 (27) 51 (39) °
* All saline-treated embryos/fetuses were normal
= Fetuses from E l7.5/18.5 were grouped together because they represent near term foetuses 
u At E l0.5 it is not possible to identify embryos that will develop malformations. Hence the 39 
El 0.5 embryos are not included in the calculation of the percentage malformed
* There is no significant association between the percentage of embryos with OA/TOF between 
El 1.5 and E l7.5/18.5 (chi square test,/?=0.58)
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Aberrations of tracheo-oesophageal development
At E l0.5, foregut anatomy is comparable between Adriamycin-treated and control 
embryos. The laryngo-tracheal groove arises as an outpouching from the ventral aspect of 
the pharyngeal foregut, at the level where its luminal diameter narrows significantly (Fig 
3.5a,b). At this point in development, the trachea is not a separate structure from the 
oesophagus. Indeed, the bronchial buds can be seen arising from the main foregut tube at 
the caudal end of the laryngo-tracheal groove (Fig. 3.5c,d). Tracheo-oesophageal 
development diverges from normal by El 1.5 in a proportion of Adriamycin-treated 
embryos. Separation of trachea and oesophagus is under way by this stage in control 
embryos and proceeds in a cranial direction, starting at the level of the lung buds (Fig. 
3.6c,d). In contrast, 13 out of 45 Adriamycin-treated embryos at El 1.5 exhibited an 
undivided foregut (Fig. 3.6g,h). In 12 of these embryos, the oesophago-trachea gives rise 
to a fistula to the stomach, which either originates from a rostral position relative to the 
emergence of the bronchi or else arises as part of a trifurcation, at the level of origin of 
the bronchi. Tracheo-oesophageal malformations in embryos of all gestations conformed 
to one of these basic phenotypes (Figs. 3.7&8) with the exception of a single E12.5 
embryo in which the fistula originated from one of the main bronchi and became atretic 
before connecting to the gastrointestinal tract (Table 3.4). Adriamycin-treated near term 
fetuses, at E l7.5 and E l8.5, exhibited a small globular stomach connected to the TOF (11 
out of 29 studied, Fig. 3.8f).
The classic OA/TOF malformation was seen in two embryos, which exhibited an upper 
oesophagus as a dorsal outpouching from the undivided foregut. In these embryos, the 
pattern of separation of the proximal oesophagus from the ventral trachea was distinctly 
abnormal compared to saline-control embryos (Fig. 3.9d). The atretic upper oesophagus
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Fig. 3.5 Saline and Adriamycin-treated embryos are morphologically indistinguishable at 
E10.5
Transverse sections stained with haematoxylin & eosin, through E l0.5 saline-treated (a, 
c) and Adriamycin-treated (b, d) embryos. Sections a and b are at the level of the 
laryngotracheal groove (Lt) just caudal to the pharyngeal foregut. Sections c and d are 
from the caudal end of the groove at the level of emergence of the lung buds (Lb), (a, b) 
The development of the ventral evagination, that forms the laryngotracheal primordium, 
from the post pharyngeal foregut is morphologically comparable between saline controls 
and Adriamycin-treated experimental embryos, (c, d) The development of the lung (or 
bronchopulmonary) buds from the caudal end of the laryngotracheal groove does not 
appear to be disturbed in Adriamycin-treated embryos with the two groups being 
morphologically indistinguishable. Scale bar, 100 pm
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Fig. 3.6 Failure of separation of oesophagus and trachea during development of OA/TOF 
in Adriamycin-treated embryos.
Transverse sections, stained with haematoxylin and eosin, through El 1.5 saline-treated 
(a,b,c,d) and Adriamycin-treated (e,f,g,h) embryos. Sections a to d and e to h are from 
increasingly caudal levels. Sections d and h are taken from the level of the atrial septum. 
(a,b,ej) Appearance of the laryngo-tracheal groove (Lt) is comparable between saline 
and Adriamycin-treated embryos. (c,d,g,h) Further caudally, saline-treated embryos 
undergo separation of the ventral trachea (Tr) from the dorsal oesophagus (Oe) whereas, 
in Adriamycin treated embryos, a common oesophago-trachea (Oet) persists. In c, 
tracheo-oesophageal separation is associated with the appearance of lateral epithelial 
ridges (arrows). Ao, aorta; h, heart. Scale bars, 100 pm.
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Fig. 3.7 Variable level of origin of the tracheo-oesophageal fistula in Adriamycin-treated 
embryos.
Transverse sections, stained with haematoxylin and eosin, from an E l5.5 saline 
treated embryo (a,c) and from two E l5.5 Adriamycin-treated embryos (b and d).
Sections are at the level of the manubrium stemi and clavicles {a, b) and at the level of the 
cardiac outflow tract (c,d). The Adriamycin-treated embryo in (A) demonstrates a high 
origin of the fistula (arrow) from the undivided oesophago-trachea (Oet). At a similar 
level, a saline-treated embryo (a) exhibits a separate trachea (Tr) and oesophagus (Oe). In 
a second Adriamycin-treated embryo exhibits a lower level fistula originating at the 
level of emergence of the main bronchi (arrowheads), thereby forming a bifurcation 
(arrow). At the same level, the saline-treated embryo (c) shows an undivided trachea 
distinct from the oesophagus. In sections slightly caudal to this level, the trachea of the 
control embryo bifurcates to form the main bronchi (inset). Ao- aorta. Scale bar, 200 pm.
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Fig. 3.8 The oesophagotrachea in late gestation and near-term embryos/fetuses.
Sagittal (a,b) and transverse (c,d) sections stained with haematoxylin & eosin through 
El 5.5 saline- (a,c) and Adriamycin-treated {b,d) embryos. The level of the transverse 
sections in c and d approximately corresponds to the level of the dotted lines in a and b 
(level of clavicular heads and thoracic inlet). Dissected anterior foregut structures from 
E l8.5 saline- (e) and Adriamycin-treated (/) embryos. In the saline-treated embryos (a,c), 
the oesophagus (Oe) and trachea (Tr) are separate structures in contrast to the 
Adriamycin-treated embryos (b,d) that have an undivided oesophagotrachea (Oet) at the 
same level. The fistula comes off the oesophagotrachea at about the level of the cardiac 
outflow tract (arrow in b). (ej)  The fistula (Fi) forms a trifurcation with the main bronchi 
(arrow in f)  and connects to a small, globular stomach (St), h - heart, Th- thyroid gland,
Cl - clavicle, Sal - salivary glands, Lu - lungs. Scale bar, 200pm.
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Fig.3.9 A rare case of oesophageal atresia in an Adriamycin-treated embryo.
Transverse sections, stained with haematoxylin and eosin, through E12.5 saline-treated 
(a,c,e) and Adriamycin-treated (b,d,J) embryos. Sections are from the level of the thyroid 
in a and b and the atrial septum in c t o /  (a,b) Development of the laryngotracheal groove 
(Lt) is comparable between the saline- and Adriamycin-treated embryo. (ctd) Normal 
tracheo-oesophageal separation in (c) contrasts with sin undivided foregut in the 
Adriamycin treated embryo (arrow in d). At a slightly more caudal level, the oesophagus 
becomes a separate structure for a short distance (inset in d). In (e) the normally separated 
oesophagus (Oe) is patent whereas the oesophagus in the Adriamycin-treated embryo has 
become atretic (asterisk in f). Tr - trachea. Scale bar, 100 pm.
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Table 3.4. Types of tracheo-oesophageal malformations in Adriamycin-treated 
embryos/fetuses (all gestations)
Type of malformation Number of embryos/fetuses (%)
Oesophagotrachea with trifurcation 36 (70)
Oesophagotrachea with proximal fistula 11 (22)
Proximal oesophageal atresia with fistula 2 (4)
Other (absent or atretic fistula) 2 (4)
Total 51
lacked a lumen and ended blindly in the dorsal mesenchyme (Fig 3.9f). This proximal 
oesophageal atresia phenotype would appear to be a modification of the initial 
malformation (oesophagotrachea with trifurcation or proximal fistula) and its presence 
can only be determined in embryos at El 2.5 or older. The types of tracheo-oesophageal 
malformations are summarised in Table 3.4. Adriamycin-treated embryos/foetuses that 
had separated their trachea and oesophagus had normal tracheo-oesophageal morphology. 
It should be noted that in all Adriamycin-treated embryos, including those with tracheo- 
oesophageal malformations, the fusion of the arytenoid swellings and the formation of the 
laryngeal epithelial lamina proceeded normally. Lung development and segmentation was 
also normal.
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Foregut length analysis was used to supplement the observations described above. At 
El 1.5, about 60% of Adriamycin-treated embryos were morphologically comparable to 
controls, hi contrast, affected Adriamycin-treated embryos had significantly different 
ratios of divided/ undivided foregut length. Within this group, there were two types of 
embryos. In one type, the respiratory foregut remained undivided along its entire length. 
In the second type, there was a divided segment but this was significantly shorter than in 
control embryos, whereas the undivided segment was significantly longer compared to 
controls (data for both types combined are shown in Fig. 3.10). The total length of the 
respiratory foregut in affected Adriamycin-treated embryos (both types) was comparable 
to control embryos (Fig. 3.11). At E12.5, the foregut at this gestation in control embryos 
is almost entirely divided. In contrast, a proportion of Adriamycin-treated embryos had a 
foregut that was entirely undivided or had a short divided segment (Fig. 3.10). Again, the 
total length of the foregut was comparable to control embryos (Fig. 3.11). These 
observations suggest that the growth in length of the respiratory foregut in affected 
Adriamycin-treated embryos is not disturbed, and supports the idea that there is 
interference with the separation process itself.
Effect of Adriamvcin on other organ systems
Malformations observed in other systems are summarised in Table 3.5. Embryos were 
examined for abnormalities of the notochord, thymus and cardiovascular system. 
Malformations of the notochord were found in 20 out of 104 embryos at E10.5-E12.5. Of 
25 embryos with demonstrable foregut malformations (El 1.5/12.5), 10 had notochord 
defects. Conversely, out of 13 embryos with abnormal notochords, 10 had tracheo- 
oesophageal malformations. The association between tracheo-oesophageal malformations 
and notochordal defects was statistically significant (chi square test; /?=O.0041). The
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Fig. 3.10 Disturbance in the length of undivided versus divided foregut segments in 
affected Adriamycin-treated embryos
Box plots summarise length data. The numbers above the vertical boxes denote the 
number of embryos examined for each gestation. The lengths were calculated by counting 
the number of sections of known thickness between defined levels as indicated by the 
dotted lines on the schematic representations in Fig. 3. The saline-treated control data is 
shown in this figure for purposes of comparison (already shown in Fig. 3). The pattern in 
affected Adriamycin-treated embryos sharply contrasts with the arrangement in saline- 
treated control embryos. At both gestations (El 1.5 and E l2.5), the foregut remains 
largely undivided. It should be noted that Adriamycin-treated embryos with disturbed 
tracheo-oesophageal separation conform to two main patterns; the majority fail 
completely to separate the trachea from the oesophagus whilst in a small number a limited 
degree of separation takes place, with the tracheo-oesophageal fistula originating from a 
rostral position relative to the lung buds. This variation between embryos accounts for the 
outlying values seen in box plot representing the E l2.5 divided segment.
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Fig. 3.11 Comparing foregut growth in control and affected Adriamycin-treated embryos: 
total length of the respiratory foregut does not differ between saline controls and affected 
Adriamycin-treated embryos
Box plots summarise length data. The numbers above the vertical boxes denote the 
number of embryos examined for each gestation. The lengths were calculated by counting 
the number of sections of known thickness between defined levels as indicated by the 
dotted lines on the schematic representations in Fig. 3. Total lengths are the sums of 
undivided and divided segments. For each gestation, the total length of foregut in control 
and Adriamycin-treated embryos did not differ significantly (unpaired t-test; p> 0.05). 
The overall growth in length of the respiratory foregut appears to be unaffected by the 
administration of Adriamycin.
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notochord appeared either abnormally thickened or duplicated with the ventral branch 
either in close proximity to the foregut or actually tethered to it (Fig. 3.12a-d). The ventral 
branch disappeared in the mesenchyme when followed caudally in some embryos (Fig 
3.12d).Interestingly, the notochord appeared normal in all embryos older than E l2.5 
suggesting possible regression of the ventral branch.
Cardiac defects were also observed, involving both the outflow tract and the ventricular 
myocardium (Fig. 3.12f). These defects could be recognised in embryos at E l3.5 or 
older. In the outflow tract and great arteries the commonest defects were common arterial 
trunk and double outlet right ventricle. Many of the exposed mouse embryos also had 
defects of the compact myocardium, while anomalies of the inter- ventricular septum 
resembled muscular ventricular septal defects (VSDs; data not shown). A breakdown of 
the various defects is shown in Table 3.5. It should also be noted that only a fraction of 
the 66 embryos at E l3.5 or older could be examined for cardiac defects because many 
were dissected rather than sectioned, or appropriate sections to illustrate cardiac or great 
vessel anatomy were not available.
Bilateral or unilateral absence of the thymic rudiments was the commonest associated 
malformation (Fig. 3.12h). It could only be detected in embryos at E l3.5 or older, as this 
is the gestation at which the thymic primordium’s origin from the ventral aspect of the 
third pharyngeal pouch can be readily detected. Thymic agenesis affected 49 of 57 
examined embryos including all embryos with tracheo-oesophageal malformations. It 
should be noted that not all 66 embryos of the relevant gestations could be examined for 
the presence of thymic malformations as some of the embryos at later gestations were 
dissected rather than sectioned.
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Fig. 3.12 Malformations in other organ systems of Adriamycin-treated embryos.
(a-d) Transverse sections at the level of the pharynx, through an E12.5 Adriamycin- 
treated embryo; stained with H&E. (e,f) Transverse sections at the level of the cardiac 
outflow tract through an E l5.5 saline-treated (e) and Adriamycin-treated embryo (/); 
stained with H& E. (g,h) Transverse sections at the level of the manubrium stemi (m) 
through an E l4.5 saline-treated (g) and Adriamycin-treated (h) embryo; stained with 
H&E. (a-d) The ventral branch of the divided notochord appears to regress in the 
mesenchyme in the most caudal section (arrow in d )\e j)  The normal septation of the 
outflow tract into aorta (Ao) and pulmonary trunk (Pu) (e) contrasts with the undivided 
common arterial trunk in the Adriamycin-treated embryo (arrow in f). (g,h) The left 
thymic rudiment (Th) has not developed in this Adriamycin-treated E l4.5 embryo (h) in 
contrast to the saline-treated embryo (g) in which the thymic rudiments appear on either 
side of the trachea (Tr). At, atria; Oe, oesophagus. Scale bar, 200 pm.
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Table 3.5. Associated malformations in Adriamycin-treated (4 mg/kg) embryos and 
fetuses
Organ/ System affected Ratio of abnormal embryos (%)
Notochord* 20/104(19)
Thymus0 49/57 (87)
Cardiovascular2 26/35 (74)n
S  Ventricular septal defects 24/35
S  Common arterial trunk 15/35
S  Double outlet right ventricle 6/35
S  Overriding aorta 3/35
* This ratio includes embryos only between E10.5 and E12.5. The breakdown according to 
gestation is 7/39 for El0.5, 8/45 for El 1.5 and 5/20 for El2.5. Considering only gestations at 
which the tracheo-oesophageal malformations are morphologically demonstrable (El 1.5 and 
E12.5) then 10/13 embryos (77%) with abnormal notochords had tracheo-oesophageal 
malformations and 10/25 embryos (40%) with tracheo-oesophageal malformations had abnormal 
notochords. The association between tracheo-oesophageal malformations and notochordal defects 
was statistically significant (chi square test; p=0.0041)
° This ratio includes only embryos at El 3.5 or older (not all embryos of these gestations were 
available for analysis as some embryos were dissected and not sectioned)
2 This ratio includes only embryos at El 3.5 or older (not all embryos of these gestations were 
suitable for cardiac analysis as they were either not sectioned or the specific cardiac sections were 
either unavailable or insufficient for analysis) 
n Some embryos had more than one cardiac defect present
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3.2.2 -  The S h h '1' model
3.2.2.1 - General growth patterns o f the Shh null embryo
Despite reports in the literature that homozygous mutant fetuses survive until term, Shh'A 
embryos / foetuses were found to be under-represented in litters from E l2.5 onwards, 
with none at all in the single litter obtained at E l5.5 (Table 3.6). The difference in the 
percentage of Shh'A embryos was significant between El 0.5/El 1.5 litters on the one hand 
and E12.5/E13.5 litters on the other. The homozygous null embryos, which have cardiac 
malformations, start exhibiting evidence of cardiac insufficiency at about day El 2.5, and 
by E l4.5 they are extremely oedematous. It is probable that the late embryonic lethality is 
associated with severe cardiac failure. The homozygous null embryos do not appear to be 
developmentally delayed, based on development of the somites (Fig. 3.13), whereas they 
are significantly growth retarded compared to both heterozygous and wild type embryos, 
a discrepancy that becomes evident from E l0.5 onwards (Fig. 13,/?<0.0001). It is worth 
noting that compared to CBA/Ca mice, Shh embryos of all genotypes are more 
developmentally advanced at the same point in gestation (i.e. at same chronological age) 
in terms of their somite numbers. The difference is about 6 somites, which correlates with 
roughly 12 hours of development. Heterozygous embryos are morphologically 
indistinguishable from wild type embryos throughout gestation whereas homozygous null 
embryos can be readily distinguished on the basis of their grossly abnormal morphology, 
in particular forebrain defects (holoprosencephaly) and short limbs (Fig. 3.14a).
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Fig. 3.13 Development and growth of embryos of different Shh genotypes
Box plots summarise data for somite numbers (a) and crown-rump length (b). (a) There 
is no statistically significant difference in somite numbers between Shh'1' embryos and 
their pooled heterozygous and wild type littermates in somite numbers at either E l0.5 or 
El 1.5. This suggests that general development in homozygous null embryos is 
comparable to the morphologically normal embryos, up to El 1.5. (A) The crown-rump 
length of Shh1' embryos is significantly shorter than that of their pooled heterozygous and 
wild type littermates (p<0.0001) at both E10.5 and El 1.5. This suggests that homozygous 
null embryos are growth retarded.
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Table 3.6. Number of Shh mutant embryos examined
Gestation Embryos (litters) Resorbed embryos Shh'1' embryos *
E10.5 21 (2) 1 (5 %) 6/20 (30 %)
E ll .5 18(3) 2(11 %) 5/16(31 %)
E12.5 32 (4) 2 (6 %) 1/30 (3 %)
E13.5 34(5) 2 (6 %) 2/32 (6 %)
E14.5 9(1) 0 (0 %) 1/9(11 %)
E15.5 6(1) 0 (0 %) 0/6 (0 %)
Total 120(16) 7 (6 %) 15/113(13%)
* as a percentage of live embryos
The Fisher exact test was used to test the association between the percentage of null mutant 
embryos and the embryonic on which the litters were harvested. There is significant difference 
between E10.5 and E12.5 (p=0.012), E10.5 and E13.5 (p=0.04), El 1.5 and E12.5 (p=0.015) and 
between El 1.5 and El3.5 (p=0.03).
3.2.2.2 - Stages o f tracheo-oesophageal development in the Shh null embryos
The pharyngeal foregut of Shh null embryos appears abnormally shaped at El 0.5 in that it 
is narrower, as if compressed from the sides, compared to the wild type structure (Fig. 
3.14c&g). This may, of course, reflect the severity of the forebrain malformation 
(holoprosencephaly/ failure of separation of the optic vesicles). The laterally placed 
pharyngeal pouches appear to develop normally (Fig. 3.14c). The thyroid primordium 
develops normally and originates from the apex of the foregut which is almost diamond 
shaped, rather than ventro-dorsally flat (Fig. 3.14c).
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Fig. 3.14 Foregut anatomy in the E l0.5 Shh null embryo
A Shh null embryo at El 0.5 (a), a schematic representation of the foregut (b) and 
transverse sections, stained with H&E, from an E l0.5 Shh'A embryo taken from the levels 
indicated in the diagram (c-f) and from corresponding levels from a control embryo 
(pooled Shh+/+ / Shh+/' embryos) (g-l). (a) Homozygous null embryos are readily 
distinguishable by the narrow, undivided forebrain (arrow in a), fused optic vesicle, short 
limbs (Li) and enlarged heart (h). (c-t) The pharyngeal foregut (Ph) in Shh A embryos is 
diamond shaped (c), in contrast to the flat shape of control embryos (g). Development of 
the thyroid primordium (Th) and the pharyngeal pouches (Pp & arrow in c) is comparable 
between null mutant and control embryos. In Shh'A embryos, the thyroid primordium 
develops from the ventral aspect of the foregut and the pharyngeal pouch derivatives 
(arrow in c) develop normally from the lateral aspects of the ‘diamond’. The post­
pharyngeal foregut (Fo) in Shh'A embryos remains undivided and its lumen narrows 
significantly (d) before widening again at the level of the lung buds (Lb) in (e). In sharp 
contrast, the foregut in control embryos exhibits the characteristic folds (arrowheads in h) 
and more caudally divides into an oesophagus (Oe) and a trachea (Tr) in (/). Further 
caudally in control embryos (A:), the trachea divides into two normal lung buds, (fl) The 
post-lung bud foregut in Shh'A embryos joins what appears to be a morphologically 
normal stomach (St) in a way comparable to control embryos. Scale bars, 1 mm for a and 
100 pm for c-l
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Shh+/+/Shh+/
In contrast to wild type embryos, the post pharyngeal foregut narrows significantly and 
there is no identifiable laryngotracheal groove. The foregut is very narrow without an 
obvious prospective trachea (Fig. 3.14d) whereas wild type embryos exhibit the 
characteristic lateral folds and a well demarcated prospective trachea (Fig. 3.14h). In 
Shh+I+ embryos at E l0.5, the foregut has already separated into a ventral trachea and a 
dorsal oesophagus at more caudal levels (Fig. 3.14i), unlike the CBA/Ca foregut which is 
undivided at this gestation owing to the relative developmental delay of the strain. In 
contrast to Shh wild type embryos, the Shh null foregut remains undivided (Fig. 3.14d). 
At the caudal end of the undivided foregut, the lung buds emerge ventrolaterally but 
appear fused (Fig. 3.14e). Another characteristic is the short length of post lung bud 
oesophagus (or fistula) that connects to what appears to be a normal stomach (Fig. 3.14f). 
In some embryos, the lung buds and stomach are so close that they appear to be directly 
connected.
The foregut morphology of Shh null embryos changes at El 1.5 and maintains its features 
at E l2.5 and E l3.5. The pharyngeal foregut remains abnormally shaped but assumes a 
more flat shape, similar to the normal pharynx. The pharyngeal pouch derivatives 
continue to appear to develop normally. More caudally, the foregut assumes a crescent 
shape (Fig. 3.15b). By E13.5, it becomes clear that the crescent shape of the pharyngeal 
foregut is caused by pressure from mesodermal thickening/swelling at the level of the 
thyroid gland (Fig. 3.15b). Caudal to that level, the foregut lumen narrows down 
significantly to almost pinpoint diameter (Fig. 3.15c). The foregut remains undivided 
along its entire length, and more caudally, starts to widen again until it ends in a 
trifurcation of two fused bronchopulmonary buds and a distal oesophagus/ fistula that 
leads to the stomach (Fig. 3.15d). The bronchopulmonary buds fail to separate and by
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Fig. 3.15 Foregut anatomy in the E l3.5 Shh null embryo
Schematic representation of the foregut in the El 3.5 Shh homozygous null embryo (a) 
and transverse sections, stained with H&E, through E l3.5 null embryos taken at the levels 
indicated on the diagram. (b-f) The pharyngeal foregut (Ph) has a crescent-like shape, 
which appears to be the result of a ventral mesodermal thickening (arrow in b). The post­
pharyngeal foregut (Fo) has a pinpoint diameter (arrow in c) and widens caudally just 
cranial to the level of the lung buds (Lb). The foregut remains undivided between the 
pharynx and the lung buds and ends in a trifurcation of two lung buds and a fistula (Fi) to 
the stomach (d). The lung buds are fused and the developing bronchopulmonary 
structures are very rudimentary consisting of unbranched spaces (d). The fistula arises 
dorsally and also narrows down as it lies adjacent to the liver (e) (Li). The fistula (arrow 
in J) connects to the stomach (St) which appears morphologically normal. Scale bar, 200 
pm
139

El 3.5 the lungs consist of a fused collection of dilated structures that lack the elaborate 
branching pattern seen in wild type embryos (Fig. 3.15d). The lung fusion and abnormal 
segmentation of null embryos is similar to the features of embryos treated with high doses 
of Adriamycin. The main difference is that the branching is much more rudimentary in 
the Shh null mutants. The fistula continues its course towards the stomach but continues 
to be in direct communication with the lungs (Fig. 3.15d). It eventually loses contact with 
the lung and continues as a narrow distal oesophagus towards the stomach (Fig. 3.15e,f). 
This phenotype is common to all Shh null embryos.
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3.3 -  D isc u ssio n
3.3.1 — Importance of the Adriamycin mouse model of OA/TOF
The Adriamycin rat model of oesophageal atresia and tracheo-oesophageal fistula has 
been extensively studied since it was first described in 1996 (Diez-Pardo et al., 1996).
The majority of the work on this model has focused on analysis of the morphology of the 
tracheo-oesophageal defects and the malformations observed in other organ systems. A 
number of theories have been put forward to explain the faulty organogenesis in the 
model but there has been little progress in understanding the cellular and molecular 
events that underlie these malformations. This lack of progress is understandable as the 
availability of molecular probes and genetically modified strains for the rat is 
significantly limited compared to the mouse. Yet, the Adriamycin rat model has provided 
a reproducible and reliable model of tracheo-oesophageal malformations, the phenotype 
of which closely parallels that of the human defects (Diez-Pardo et al., 1996; Crisera et 
al., 1999a; Merei et al., 1998c; Merei et al., 1997b). The adaptation of the Adriamycin 
model to the mouse provides extensive opportunities to study the molecular mechanisms 
that underlie these malformations and also allows direct comparison between 
developmental processes in the teratogenic and genetic models. Furthermore, this 
combined approach may contribute to our understanding of the cellular/molecular 
mechanisms that underlie normal development, which are not themselves well 
understood.
3.3.2 — Resolving the controversy of normal tracheo-oesophageal development
The controversy about the mechanisms that underlie normal tracheo-oeosphageal 
development is longstanding and one that has not yet been fully resolved. It is remarkable
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that we have significant knowledge of the transcriptional control of pulmonary 
development, yet there is still a debate about the basic concept of how the trachea 
develops and separates from the oesophagus. The present detailed analysis of the stages 
of normal tracheo-oesophageal development in the CBA/Ca mouse was an integral part of 
the characterisation of the mouse model. Moreover, it contributes towards a resolution of 
the controversy regarding the mechanisms of normal development.
Historically, the two most prominent theories have been the so-called “tap water” theory 
(Sasaki et al., 2001b) and the theory of the ascending septum (Gray & Scandalakis, 1972). 
The former supports the notion that the trachea, with the two lung buds at its caudal end, 
simply grows caudally away from the foregut, from which it originates and, as a result, 
becomes separated from the oesophagus. The “ascending septum” theory supports the 
notion that the foregut is divided into a ventral trachea and a dorsal oesophagus by a 
septum that grows in a cranial direction. A variation of the septum theory suggests that 
the lateral walls of the foregut collapse and fuse, resulting in separation without the actual 
formation of an epitheliomesenchymal septum (Qi & Beasley, 2000; Williams et al., 
2003). My data suggest that tracheo-oesophageal development involves elements of both 
theories. Following the appearance of the laryngotracheal groove in the narrowed, post­
pharyngeal foregut at about E10 in the mouse, the foregut grows in length for 
approximately another 24 hours with no evidence of separation. At about that time, the 
trachea starts appearing as a separate structure at its caudal end, at the level of the lung 
buds. From that point onwards, the separated trachea increases significantly in length and 
by El 1.5, the divided segment is longer than the undivided one. Tracheal growth is likely 
to contribute to the lengthening of the separated trachea, although it is important to bear 
in mind that during this period the entire foregut continues to grow in length. Yet, at the
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same time, the absolute length of the undivided segment decreases significantly between 
E10.5 and El 1.5 and virtually disappears by E12.5. These observations suggest that there 
is an active separation process that is responsible for separating the originally undivided 
foregut whilst active growth of the various foregut components continues. Even if we 
assume that the rate of longitudinal growth of the respiratory structures is far greater than 
that of the rest of the foregut, a specific separation process is still required to account for 
these changes in lengths.
3.3.3 — T h e  early d efect in th e  Adriamycin m od el
Analysis of the Adriamycin mouse model (4 mg/kg) suggests that the early events within 
the developing foregut are not overtly disturbed in embryos destined to develop OA/TOF. 
The development of the laryngotracheal groove, and the appearance of lung buds from its 
caudal end, appear to proceed normally in Adriamycin-treated embryos. Development in 
treated embryos first diverges morphologically from that in controls between E l0.5 and 
El 1.5 when the foregut fails to divide into a distinct dorsal oesophagus and ventral 
trachea. It should be noted that this onset of abnormalities occurs more than 48 hours after 
the second dose of the teratogenic agent, at E8.5. The findings suggest that this failure of 
foregut division, with persistence of an oesophagotrachea, is fundamental to the 
embryogenesis of OA/TOF in the Adriamycin-treated mouse. Failure of foregut division 
can be total, in which case the oesophagotrachea ends in a trifurcation, or it can be partial, 
with a more proximal emergence of the fistula; in such embryos, the fistula and trachea 
are separate structures for a short distance. With regards to the nature of this early 
anomaly, analysis of the foregut length data suggest that disturbance of overall foregut 
growth is not a factor in Adriamycin-treated embryos as the total foregut length is 
comparable between affected experimental and control embryos. It appears that what is
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disturbed is the process of separation, resulting in the undivided segment contributing the 
whole or the majority of the foregut length. It should of course be pointed out that an 
assessment of growth with the use of markers of mitosis or proliferation would be 
required to address this question more accurately.
Analysis of the early events in the Adriamycin mouse model appears to reject an 
alternative theory put forward by researchers working on the rat model. It has been 
suggested that the primary defect is atresia and loss of continuity of the oesophagus with 
the development of an abnormal communication (fistula) between the trachea and the 
distal oesophagus/ stomach (Crisera et al., 1999a). This theory assumes that tracheo- 
oesophageal separation has already taken place and that the separated oesophagus then 
becomes atretic. This notion is contradicted by my data which suggest that, at the earliest 
possible point, the foregut can be seen as having failed to separate. Recent evidence that 
the tracheo-oesophageal fistula can be shown to be discontinuous from the stomach in 
some embryos (in the rat model) (Spilde et al., 2002a), could perhaps be explained by my 
observation that the fistula in the mouse model can itself be atretic and not communicate 
with the stomach whilst the fundamental defect remains the failure of tracheo- 
oesophageal separation.
3.3.4 — Specificity of the Adriamycin-generated defects
A general problem with teratogenic models is that it is often difficult to identify the 
specific effect on cellular function that produces the resulting phenotype. Adriamycin 
interferes with a number of cellular processes including DNA synthesis and cell 
replication (Ross et al., 1978). Crown-rump length data suggest that Adriamycin does 
have a growth retarding effect, but that this is only significant after E12.5. Adriamycin-
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treated embryos appear to grow normally in the initial period after exposure, during the 
time of tracheo-oesophageal separation (E10.5-12). Analysis of somite numbers at El 0.5 
suggests that Adriamycin-treated embryos are slightly developmentally delayed (27 
versus 28 somites), but this effect disappears by El 1.5. It is difficult to draw firm 
conclusions from these data, but it appears that growth and development in Adriamycin- 
treated embryos are not grossly disturbed during the early period of foregut patterning.
On the other hand, even small developmental perturbations in critical time windows can 
have significant phenotypic consequences. On balance, however, the Adriamycin effect 
appears to be a specific one, affecting tracheo-oesophageal separation and other 
morphogenetic processes (e.g. heart development).
Adriamycin appears to be a useful tool for the study of abnormal tracheo-oesophageal 
separation. It interferes with the process, but at the dose used in this study (4 mg/kg) does 
not seem to interfere with other related developmental events at either end of the 
respiratory foregut, such as pulmonary and laryngeal development. At the caudal end of 
the trachea, lung development is undisturbed, as is the development of the entry into the 
larynx at the cranial end of the laryngotrachea. Adriamycin specifically disturbs the 
tracheo-oesophageal separation process. The effect of Adriamycin on other organ systems 
is likely to be related to the timing of exposure to the teratogenic insult. This could 
account for the multiple associated malformations, reported in the Adriamycin-treated rat, 
which largely conforms to the VACTERL association (Merei et al., 1999; Beasley et al., 
2000; Millar et al., 2001).
The association between OA/TOF and notochordal malformations in the Adriamycin- 
treated rat has been studied in detail (Possoegel et al., 1999; Qi & Beasley, 1999;
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Vleesch, V et al., 2002; Gillick et al., 2003; Merei, 2004). Abnormalites of the notochord 
have also been linked to the development of midgut and other intestinal atresias (Gillick 
et al., 2002a; Merei, 2004). The close association between defects of the notochord and 
tracheo-oesophageal malformations makes it possible that the abnormal notochord 
somehow disturbs foregut development. The actual tethering of the ventral branches of 
the notochord to the foregut provides a mechanistic interpretation of such disruption (Qi 
& Beasley, 1999; Williams et al., 2001; Vleesch, V et al., 2002). Conversely, it has been 
suggested that compensatory overgrowth of the foregut during embryogenesis of 
OA/TOF causes abnormal bending of the tethered notochord (Merei et al., 1998). Others 
have questioned the cause-effect association between the two malformations as either of 
them can be seen in isolation (Possoegel et al., 1999). The role of the notochord as a 
source of important developmental signals (Kim et al., 1997) provides an alternative, 
molecular explanation for the association between abnormalities of the notochord and 
foregut. The conservation of Shh expression in the abnormally positioned notochord 
could underlie the development of tracheo-oesophageal malformations (Gillick et al., 
2003; Mortell et al., 2004). The findings, in the present study of the Adriamycin-treated 
mouse, of abnormally divided and positioned notochords, sometimes tethered to the 
foregut, are consistent with the studies in the Adriamycin-treated rat. Furthermore, the 
association of notochordal defects and tracheo-oesophageal malformations is statistically 
significant (Table 5). The role of the abnormal notochord as an ectopic source of Shh is 
discussed in depth in Chapter 5.
3.3.5 — The late rearrangement of the tracheo-oesophageal phenotype
An atretic upper oesophagus is an infrequent finding in the Adriamycin mouse model. 
Considering that all abnormal El 1.5 embryos share the phenotype of an undivided
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foregut without a distinct oesophagus, one could hypothesise that a short, atretic 
oesophagus, seen at El 2.5 in two embryos, develops as a result of rearrangement of the 
proximal oesophagotrachea rather than by atresia of a normally separated oesophagus.
This is consistent with the finding that the proximal atretic oesophagus is also abnormal at 
its cranial end, where it separates from the pharynx. This hypothesis is supported by 
evidence from the Adriamycin rat model that has a higher prevalence of proximal OA. In 
one report (Possogel et al., 1998), 9 out of 10 Adriamycin-exposed embryos at E l2 had 
an undivided oesophagotrachea, which developed into proximal OA with distal TOF in 
all 9 by E l3. In another study in the rat, the proximal oesophageal pouch first appeared as 
a dorsal outpouching from the cranial foregut on E l5, well after the completion of 
tracheo-oesophageal separation (Beasley et al., 2004). This confirmed that the 
development of the proximal oesophagus in OA/TOF is a separate developmental 
process. The higher prevalence of proximal (OA) in the rat model could perhaps be 
explained by a species difference in the way the foregut adapts to failure of separation.
An alternative explanation is that the Adriamycin effect on foregut development in the rat 
differs from that in the mouse, as the requirement for a significantly higher dose in the 
mouse would suggest (4 mg/kg versus 1.75 mg/kg in the rat).
The majority of late gestation or near-term affected Adriamycin-treated mouse fetuses 
have a persistently undivided or partially undivided oesophagotrachea with no evidence 
of the so-called upper oesophageal pouch. In fact, the near term phenotype of the majority 
of Adriamycin-treated fetuses resembles a rare human malformation known as 
laryngotracheo-oesophageal cleft. According to the classification of these malformations 
(Holder, 1993), in type III cleft there is a communication between the laryngotrachea and 
the oesophagus that extends into the trachea whereas in type IV cleft the communication
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extends all the way to the tracheal bifurcation. Based on this classification, the mouse 
phenotype of the oesophagotrachea and trifurcation or proximal fistula could be 
characterised as type IV or type III clefts respectively (see General Introduction). This 
phenotypic analysis would suggest that OA/TOF and laryngotracheo-oesophageal clefts 
are closely related embryologically and indeed share the same fundamental anomaly. 
According to this theory, all OA/TOFs start as clefts that are subsequently modified by 
rearrangement of the proximal foregut.
If we compare the Adriamycin rat and mouse models, there is obviously a phenotypic 
difference. The rat malformations resemble closely the human anomalies. On the other 
hand, the mouse malformations resemble the rare forms of human tracheo-oesophageal 
defects. The key, however, is that the two models have almost identical early 
malformations. Based on this similarity, the mouse model can be used to study the 
fundamental defects that underlie the majority of tracheo-oesophageal malformations.
3.3.6 — Fundamental defect in the Shh mutant
The foregut malformations in the Shh mutant mouse embryos have been previously 
described (Litingtung et al., 1998), although a review of the relevant literature reveals a 
lack of clarity in the description of the phenotypic arrangements at the caudal end of the 
trachea. Authors state that the lumen of the trachea/oesophagus, or even the lungs, is in 
direct contact with that of the stomach and call this oesophageal atresia and tracheo- 
oesophageal fistula. Atresia of the oesophagus is certainly not demonstrated and the 
nature of the fistulous connection between the trachea and the stomach/ distal oesophagus 
is not well illustrated or explained. Furthermore, the description of the cranial foregut
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contradicts the present findings, by suggesting that the trachea and oesophagus have 
separate lumens but never completely separate, with their walls in close apposition. My 
analysis offers a more straightforward interpretation of the tracheo-oesophageal 
development in the Shh mutant. Contrary to previous reports, I found that the trachea and 
oesophagus failed to separate in all embryos examined. The undivided oesophagotrachea 
gave rise to the lungs, which are themselves grossly abnormal. The 
oesophagotrachea/lungs are themselves connected to the stomach by a short 'fistula' 
which probably corresponds to the previous description of the lungs being ‘continuous 
with the stomach’ (Litingtung et al., 1998).
Hence, the tracheo-oesophageal phenotype of both the Adriamycin-treated and Shh 
mutant embryos is similar and essentially comprises an undivided oesophagotrachea and 
an abnormal communication (fistula) of this undivided structure to the stomach. Further 
clarification and analysis of the proximal foregut (pharyngeal) anatomy in the Shh mutant 
is required, as this was not analysed in detail in the present study.
3.3.7 — Importance of a comparative analysis of the Adriamycin and Shh models
One of the reasons for adapting the Adriamycin model from the rat to the mouse was the 
availability of mouse genetic models of tracheo-oesophageal malformations. The 
advantage of this approach is as follows: first, the tracheo-oeosphageal phenotype 
produced by Adriamycin closely resembles human malformations. Second, the analysis of 
the molecular mechanisms that underlie the abnormal tracheo-oesophageal development 
in the Adriamycin-treated mouse will benefit from a direct, stage by stage, comparison 
with an equivalent mouse model in which the tracheo-oesophageal malformations can be 
attributed to a precise genetic perturbation (loss of function mutation). The close
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phenotypic similarity between the Adriamycin and Shh models is a significant finding. It 
would suggest that both the action of the teratogenic agent and the loss of function 
mutation of Shh, lead to a similar failure in the physical separation of the trachea and 
oesophagus. This similarity does not, of course, mean that Adriamycin acts by directly (or 
indirectly) disturbing the function of Shh, although this is a possibility. More importantly, 
it focuses attention on the specific process of tracheo-oesophageal separation as 
fundamental to the pathogenesis of tracheo-oesophageal malformations. Furthermore, it 
allows us to create testable hypotheses for the possible mode of action of Adriamycin. 
Such hypotheses are elaborated and tested in subsequent chapters of this thesis.
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3.4 - Su m m a r y
The Adriamycin model of tracheo-oesophageal malformations was described in the rat 
whereas genetic models exist in the mouse. In order to study the molecular basis of these 
malformations, the Adriamycin model was adapted to the mouse. Analysis of the length 
of foregut segments suggests that during normal mouse development, the trachea grows 
initially as part of an undivided foregut and later becomes separated from the dorsal 
oesophagus with the separation process starting at the level of the lung buds and 
proceeding in a cranial direction. In the Adriamycin-treated mouse embryos, tracheo- 
oesophageal development is disturbed with the fundamental anomaly being a total or 
partial failure of the process of tracheo-oesophageal separation. Adriamycin, at the dose 
used for detailed analysis in this study, does not interfere with development at either end 
of the trachea (larynx and lungs) suggesting that its action specifically disturbs the 
tracheo-oesophageal separation process. The foregut of Shh null mutant embryos also 
fails to develop a separate trachea and oesophagus. These observations suggest that both 
the teratogen and the loss of gene function interfere with the same fundamental process 
during tracheo-oesophageal development.
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CHAPTER 4 -  D e v e l o p m e n t  o f  t h e  r e s p i r a t o r y  e n d o d e r m
4.1 - In t r o d u c t io n
The findings of the previous chapter suggested that normal
tracheo-oesophageal development involves an active process of separation between the 
ventral, respiratory and the dorsal, gastrointestinal parts of the anterior foregut. Failure of 
this process of separation seems certain to underlie the development of tracheo- 
oesophageal malformations in both Adriamycin-treated and the homozygous Shh null 
mutant mouse embryos. However, the findings of the previous chapter comprised entirely 
an analysis of morphological data. It is important to extend this analysis to ask whether 
the process of tracheo-oesophageal separation leads to segregation of molecularly defined 
cell populations (i.e. respiratory and gastrointestinal) within the developing foregut. It is 
moreover crucial to distinguish between models of abnormal morphogenesis in which 
either both cell fates are represented in the undivided foregut, or whether failure of 
separation results from the failure of either of the main cellular elements (respiratory or 
gastrointestinal) to develop. Theories attributing tracheo-oesophageal malformations to an 
imbalance of fates within the foregut have been formulated for the Adriamycin-rat model. 
On the one hand, it has been suggested that the respiratory element is deficient resulting 
in the lung buds arising directly from the primitive foregut in the absence of a normal 
trachea (Merei et al., 1998a; Merei et al., 1997b; Possogel et al., 1998a). The same theory 
postulates secondary trachealisation of the primitive foregut. On the other hand, it has 
been suggested that following normal development of the two elements, there is loss of 
the gastrointestinal element between the proximal oesophagus and the stomach (primary 
oesophageal atresia) (Crisera et al., 1999a).
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In order to resolve these conflicting theories, I reasoned that it would be important to 
study endodermal and respiratory development in both normal and abnormal tracheo- 
oesophageal development. In this chapter, therefore, I have studied expression of the 
endodermal marker Hnf3p and that of the respiratory marker Nkx2.1. The aim was to 
establish whether the effect of Adriamycin, or the loss of function of Shh, were mediated 
by, or associated with, interference with the molecular specification and development of 
the respiratory endoderm.
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4.2 -  R e s u lt s
4.2.1 -  Expression of the endodermal marker Hnfip
During normal mouse development, expression of the winged helix transcription factor 
Hnfip is detected at the onset of gastrulation (about E6.5) in the anterior portion of the 
primitive streak (Ang et al., 1993). Its expression persists in the developing neural tube 
and the definitive endoderm (Fig 4.1a), structures derived from the mouse equivalent of 
Hensen’s node. Endodermal expression is detected in both the foregut endoderm and the 
various foregut derivatives including the pharyngeal pouches, the hepatic diverticulum 
and the respiratory diverticulum . At E l0.5, Hnfip is detected in the postpharyngeal 
foregut and the endoderm of the ventral evagination representing the respiratory 
diverticulum and the primitive lung buds . As the trachea begins to separate from the 
oesophagus (El 1.5), both structures maintain strong Hnfip expression At E12.5, Hnf3p 
expression is maintained in the trachea, oesophagus, developing bronchopulmonary 
structures and other endoermally-derived organs, for example the liver, as shown by its 
detection in hepatocytes (Fig. 4.1a). In summary, Hnfip expression is consistent with that 
of a factor that is involved in both the establishment and the maintenance of the 
endodermal lineage.
Exposure to Adriamycin does not disturb the expression of Hnfip. Adriamycin-treated 
embryos had expression patterns closely similar to controls irrespective of whether they 
were morphologically normal or had tracheo-oesophageal malformations. At E l0.5, all 
Adriamycin-treated embryos have uniform Hnfip expression in the endoderm of the 
undivided foregut. From El 1.5 onwards, embryos that fail to separate the trachea from 
the oesophagus have an undivided foregut with Hnfip expression in both the ventral and
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Fig. 4.1 The transcription factor Hnf3p is uniformly expressed in the foregut endoderm.
Immunohistochemistry for Hnf3p on transverse sections from saline-treated (a) and 
Adriamycin-treated (b,c) E12.5 embryos, (a) At low magnification, Hnf3p is seen in the 
floor plate of the neural tube (Fp), the oesophagus (Oe), the lung buds (Lu) and the 
hepatocytes (hp - weak staining), {b) The common oesophagotrachea (Oet) of 
Adriamycin-treated embryos is uniformly stained in both dorsal and ventral parts, (c) At 
the level of the trifurcation, both the lung buds (arrowheads) and the prospective fistula 
(arrow) are positive for Hnf3p. Adr - Adriamycin. Scale bar, 120 pm.
156
aSaline
ok r -Fp
dorsal parts of the undivided tube (Fig 4.1b). This uniform expression persists all the way 
to the trifurcation of the two lung buds and the fistula with all three branches being 
positive (Fig 4.1c). Expression of Hnf3p in other endodermal derivatives and the floor 
plate of the neural tube is also undisturbed in Adriamycin-treated embryos (not shown).
4.2.2 -  The role of Nkx2.1 in respiratory development
4.2.2.1 - Expression patterns in normal development
In E9.5 CBA/Ca embryos, Nkx2.1 expression can be detected in ventral areas of the brain 
and in the thyroid primordium, which appears as a ventral midline thickening in the 
pharyngeal foregut (Fig 4.2a, inset). Strong Nkx2.1 expression in the thyroid primordium 
persists at 10.5 (Fig 4.2a). By E10.5, there is also strong Nkx2.1 expression in the ventral 
part of the post pharyngeal foregut (Fig 4.2c). The transcription factor is expressed in the 
endoderm of the laryngotracheal groove and the prospective trachea with a well-defined 
boundary between Nkx2.1 expressing and non-expressing endoderm (Fig 4.2c). At the 
caudal end of the prospective trachea, the two lung buds are also strongly positive for 
Nkx2.1 and have actually started to bud off the foregut (Fig 4.2e). This arrangement 
persists at El 1.5, with Nkx2.1 expression being restricted to the prospective respiratory 
epithelium (Fig 4.3a,d,e). by this stage, tracheo-oesophageal separation has started at the 
level of the lung buds and is progressing cranially. The separated trachea is strongly 
Nkx2.1-positive in contrast to the dorsal oesophagus that is entirely negative (Fig 4.3g,h). 
At more cranial levels, the still undivided foregut maintains the dorsoventral pattern seen 
in the E10.5 foregut (Fig 4.3d,e). At levels just cranial to the separation front, the foregut 
that is about to undergo separation appears to invaginate along the dorsoventral boundary 
demarcated by Nkx2.1 expression (Fig 4.3d,e). In order to demonstrate that dorsoventral
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Nkx2.1 expression corresponds to the pattern of respiratory differentiation of the foregut 
endoderm, I used a histochemical technique that stains proteoglycans produced by 
respiratory cells at this stage (Periodic Acid Schiff, PAS). The results show that Nkx2.1 
expression corresponds well with functional cellular differentiation within the developing 
foregut (Fig 4.3b,e,h,l). Strong Nkx2.1 expression is maintained at E12.5, during the 
period of completion of tracheo-oesophageal separation (Fig 4.4). Branching 
morphogenesis of the lungs is progressing and the bronchopulmonary tissues are strongly 
Nkx2.1- positive (Fig 4.4g). The trachea remains strongly Nkx2.1-positive in sharp 
contrast to the oesophagus that is negative (Fig. 4.4c,e). At this stage, laryngeal 
development is in progress and Nkx2.1 expression is seen in parts of the developing 
larynx. Specifically, it is expressed in the rostral-most part of the laryngotracheal groove, 
the precursor of the subglottic larynx (Fig. 4.4a). From E l4.5 onwards, the pattern 
described above has started to change; Nkx2.1 expression in the proximal respiratory 
structures (larynx and trachea) has started to be downregulated whilst strong expression is 
maintained in the developing lungs (Fig 4.5). Interestingly, in the anterior foregut, the 
thyroid adjacent to the trachea maintains a strong Nkx2.1 signal (Fig 4.5). This pattern 
persists towards term with expression becoming virtually restricted to the lungs.
4.2.2.2 - Expression patterns in the Adriamycin mouse model 
As seen from the analysis of the morphological data, the early developmental events 
within the anterior foregut are not overtly disturbed by Adriamycin treatment. 
Examination of Nkx2.1 expression confirms this finding. At E9.5, Nkx2.1 expression in 
the thyroid primordium is comparable to saline controls. At E l0.5, the laryngotracheal 
groove develops normally and the expression pattern of Nkx2.1 in the groove and in the 
ventral prospective trachea is comparable to controls in all Adriamycin-treated embryos
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Fig. 4.2 The expression pattern of the respiratory marker Nkx2.1 is not disturbed in
Adriamycin-treated embryos at E l0.5
Immunohistochemistry for Nkx2.1 on transverse sections from E l0.5 saline-treated 
(a,c,e) and Adriamycin -treated embryos (b,d,f). {a,b) Expression of Nkx2.1 in the thyroid 
primordium (Th), in the floor of the pharyngeal foregut (Ph), is undisturbed in 
Adriamycin-treated embryos. Nkx2.J expression in the primordium starts at E9.5 (inset).
(<c,d) Nkx2.1 marks the dorsoventral boundary within the anterior foregut (Fo) 
(arrowheads) and is expressed in the ventral, prospective tracheal epithelium, (e j)  At 
more caudal levels, Nkx2.1 is strongly expressed in the lung buds (Lb). Scale bar, 100 
pm.
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Fig. 4.3 Failure of foregut separation in Adriamycin-treated embryos is not associated with a 
disturbance in the dorsoventral pattern of Nkx2.1 expression
Immunohistochemistry for Nkx2.1 (except in b) on transverse sections from saline-treated 
(a,b, d,e,g,h,k,[) and Adriamycin-treated (cf,i,m) El 1.5 embryos. Sections in b,e,h and I were 
counterstained with PAS (Periodic Acid Schiff) which stains with magenta colour the 
proteoglycans produced selectively by cells of the respiratory lineage at this stage. Sections 
from top to bottom are from increasingly caudal levels and sections in each row are from 
corresponding levels. (a,b,c) Sections at the level of the laryngotracheal groove (Lt) show that 
Nkx2.1 expression is comparable in saline and Adriamycin-treated embryos. Note the strong 
PAS staining in the ventral-most part of the groove. (d,ej) At levels just cranial to the point 
of tracheo-oesophageal separation, the foregut (Fo) in saline-treated embryos develops 
epithelial folds that coincide with the dorsoventral boundary of Nkx2.1 expression 
(arrowheads in d) as well as the dorsoventral boundary of PAS staining (arrowheads in e). In 
Adriamycin-treated embryos, the dorsoventral pattern ofNkx2.1 expression is not disturbed 
(arrowhead in f)  although at this level there are no identifiable epithelial folds. (g,hti) At more 
caudal levels, the Nkx2.1-positive trachea (Tr) has separated from the Nkx2.1 -negative 
oesophagus (Oe) in saline-treated embryos (g) and the respiratory trachea stains strongly for 
PAS in contrast to the oesophagus (h). In the Adriamycin-treated embryo, the foregut has 
failed to separate and persists as an undivided oesophagotrachea (Oet) which, however, 
maintains the correct dorsoventral pattern of Nkx2.1 expression (arrowhead in /'). (k,l,m) The 
bronchi (Br) maintain both a strong Nkx2.1 and PAS signal (k.l). The oesophagotrachea in 
Adriamycin-treated embryos ends in a trifurcation of an Nkx2.1-negative fistula and two 
Nkx2.1-positive bronchi. Scale bar, 100 pm.
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Fig. 4.4 The dorsoventral pattern of N kx2.1 expression is maintained in both saline- and
Adriamycin-treated embryos at E l2.5.
Immunohistochemistry for Nkx2.1 on transverse sections from saline-treated (a.c.e.g) and 
Adriamycin-treated (b,d,fh) El 2.5 embryos. (<a-d) Sections at the level of the thyroid 
gland (Th) show comparable expression in the laryngotracheal groove (Lt) {a, b). At a 
slightly more caudal level, the Nkx2.1 positive trachea has become separated from the 
Nkx2.1 negative oesophagus in saline-treated embryos, in contrast to Adriamycin-treated 
embryos that have an undivided oesophagotrachea (Oet). The oesophagotrachea 
maintains the correct dorsoventral pattern of Nkx2.1 expression (arrowheads). (e j)  At the 
level of the heart (h), this pattern persists (arrowheads in f). (g,h) The branching bronchi 
maintain a strong Nkx2.1 signal in contrast to the oesophagus in saline-treated embryos.
In Adriamycin-treated embryos, the strong bronchial signal contrasts with the lack of 
Nkx2.1 expression in the fistula (Fi). Scale bar, 100 pm.
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Fig. 4.5 Following tracheo-oesophageal separation, at E14.5, the trachea loses most of its 
Nkx2.1 expression in contrast to the lungs
Immunohistochemistry for Nkx2.1 on transverse sections from a saline-treated (a) and an 
Adriamycin-treated (b) El 4.5 embryo taken at the level of the thyroid gland (Th). (a). In 
saline -treated embryos, the trachea (Tr) is weakly positive for Nkx2.1 in contrast to the 
thyroid gland which maintains a strong Nkx2.1 signal. The oesophagus (Oe) remains 
completely Nkx2./-negative. The inset shows that the branching bronchi (Br) also remain 
strongly Nkx2./-positive. (£) In Adriamycin-treated embryos that have failed to separate 
the trachea from the oesophagus, the undivided oesophagotrachea (Oet) also has a very 
weak Nkx2.1 signal in contrast to the adjacent thyroid gland. Although not immediately 
obvious from this section, the oesophagotrachea still maintains the dorsoventral boundary 
of Nkx2.1 expression at this level (arrowheads). This is confirmed by other sections (not 
shown). Scale bar, 200 pm
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Fig. 4.6 Changes in the dorsoventral balance of Nkx2.1 expression of the undivided 
foregut
Immunohistochemistry for Nkx2.1 on transverse sections from Adriamycin-treated E l3.5 
embryos. Section a is from the level of the thyroid gland and sections b and c are from 
progressively more caudal levels, (a) The undivided oesophagotrachea (Oet) has a clear 
dorsoventral boundary in Nkx2.1 expression at the level of the thyroid gland (Th) which 
also has a strong Nkx2.1 signal. Even at this level, the ventral Nkx2./-positive domain has 
started to extend onto the dorsal foregut (arrowheads in a). (b,c) This encroachment 
becomes more pronounced in more caudal sections but the dorsal-most part of the 
oesophagotrachea maintains its Nkx2.1-negative status (arrowheads in b and c). Scale 
bar, 200 pm
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(Fig 4.2c,d). The same applies to the lung buds at the caudal end of the prospective 
trachea (Fig 4.2e,f). At El 1.5 and beyond, those Adriamycin-treated embryos that are 
phenotypically normal, with successful tracheo-oesophageal separation, have an Nkx2.1 
expression pattern that is identical to saline controls. In El 1.5 Adriamycin-treated 
embryos with an undivided oesophagotrachea, expression of Nkx2.1 is not itself disturbed 
but rather reflects the failure of tracheo-oesophageal separation. In the El 1.5 undivided 
foregut, Nkx2.1 is expressed in the ventral, respiratory part of the structure and is absent 
from the dorsal part with a sharp boundary between the two domains (Fig 4.3c,f,i). This 
pattern extends caudally as far as the level of the lung buds where the foregut effectively 
ends in a trifurcation of two buds and a fistula connecting the oesophagotrachea to the 
stomach (Fig 4.3m). The lung buds clearly originate from the ventral, Nkx2.1 -positive 
half of the undivided foregut and are themselves strongly Nkx2.1-positive whereas the 
fistula arises from the dorsal, Nkx2.1- negative half and is itself entirely Nkx2.1-negative 
at this stage (El 1.5) (Fig 4.3m). This pattern of dorsoventral Nkx2.1 expression persists 
for both the oesophagotrachea and the fistula at E12.5 (Fig 4.4d,f,h). From E13.5 
onwards, this pattern changes gradually. The foregut remains undivided, but the balance 
of Nkx2.1 expression along the dorsoventral axis shifts dorsally (Fig 4.6). The Nkx2.1 
positive domain starts encroaching onto the dorsal foregut but does not take over the 
entire foregut. A small Nkx2.1 negative domain persists in the dorsal-most part of the 
undivided foregut. Interestingly, this encroachment becomes more evident more caudally 
(Fig 4.6). At later gestations (E l5.5 onwards), the gradual downregulation of Nkx2.1 
expression in the cranial respiratory structures makes it difficult to comment on this 
balance.
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4.2.2.3 - Tracheo-oesophageal fistula in the Adriamycin mouse model
As described above, the Nkx2.1 status of the trifurcation branches, with the ventral 
bronchi being positive and the dorsal fistula negative, reflects the dorsoventral 
distribution of the respiratory marker within the undivided foregut from which the 
trifurcation originates (Fig 4.7). As this balance changes gradually from E l3.5 onwards, 
so does the Nkx2.1 status of the fistula. The fistula now has a mixed status with its ventral 
part Nkx2.1-positive and the dorsal part Nkx2.1 -negative (Fig 4.7c). As the course of the 
fistula is followed from the trifurcation to the stomach, the fistula loses its Nkx2.1- 
positive domain and becomes entirely Nkx2.1-negative (Fig 4.7d). In fact, this loss of 
Nkx2.1-positive cells is seen within the first 40 micrometers of the length of the structure. 
In the case of embryos where the fistula originates from the main bronchi, rather than 
directly as a branch of the trifurcation, this arrangement is preserved (Fig 4.7e,f). The 
small residual Nkx2.1-negative domain is initially carried with the one of the two bronchi 
and subsequently buds off as the fistula, carrying the negative, as well as some positive, 
cells. As described above, these Nkx2.1-positive cells are subsequently lost within a short 
distance from the origin of the fistula. In summary, the fistula originates as, and 
essentially remains, a dorsal, Nkx2.1-negative structure despite subsequent minor 
alterations in gene expression profile near its origin.
4.2.2.4 - Respiratory development in the Shh'A embryo
There are significant morphological differences between the foregut of CBA/Ca 
Adriamycin-treated embryos and that of homozygous Shh'1' embryos. In the Shh'1' 
embryos, the pharyngeal and post-pharyngeal foregut is abnormally shaped, there is no 
identifiable laryngotracheal groove and pulmonary development is grossly abnormal. 
Despite these differences, the Nkx2.1 expression in the foregut of Shh mutant embryos is
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Fig. 4.7 The origin and Nkx2.1 status of the tracheo-oesophageal fistula
Immunohistochemistry for Nkx2.1 on transverse sections from saline-treated control {a) 
and Adriamycin-treated (b-j) embryos. In the E l2.5 control (a), the ventral bronchi (Br) 
stain strongly for Nkx2.1 whereas the oesophagus is negative. In an El 1.5 Adriamycin 
treated embryo (A), the trifurcation of the oesophagotrachea produces an Nkx2.1 
negative fistula (Fi) whereas the bronchi express Nkx2.1 strongly. In an E l3.5 
Adriamycin-treated embryo, the ventral half of the fistula stains for Nkx2.1 close to its 
its origin (c), but this staining is transient and disappears as the fistula makes its way 
towards the stomach (</)• In the unusual arrangement of the fistula originating directly 
from the bronchi {ej)y the undivided foregut ends in a bifurcation of two bronchi with the 
Nkx2. / -negative domain of the oesophagotrachea being ‘carried’ with the right main 
bronchus (arrowheads in e and J). This Nkx2./-negative domain will give rise to the 
fistula in adjacent sections. Scale bar, 50 pm.
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similar to that of Adriamycin-treated CBA/Ca mice. At E l0.5, wildtype embryos from 
Shh litters have just started the process of tracheo-oesophageal separation at the level of 
the lung buds (approximately six somites, or 12 hours, more advanced than CBA/Ca 
embryos). In contrast, all Shh'1' embryos have failed to start the separation process 
without being developmentally delayed (Fig 3.13a). Their Nkx2.1 expression pattern, 
however, is similar to wildtype embryos. The expression in the thyroid primordium is 
undisturbed (Fig 4.8c,d). There is also expression in the ventral endoderm of the 
prospective trachea (Fig 4.8e,f). At the caudal end of the undivided foregut there is a 
trifurcation of two Nkx2.1-positive lung buds and an Nkx2.1-negative fistula (Fig 4.8h). 
This is a similar arrangement to the trifurcation in the El 1.5 Adriamycin-treated embryos.
At El 1.5, the pharyngeal foregut assumes the characteristic crescent shape described in 
Chapter 3 and its Nkx2.1-negative status contrasts with the strong staining of the 
developing thyroid (Fig 4.9b,c). The foregut remains undivided but the Nkx2.1 
expression pattern has changed compared to the E l0.5 undivided foregut. Interestingly, 
these changes are in line with the findings for the post-El3.5 Adriamycin-treated 
embryos. The Shh'A undivided foregut narrows significantly and there is no longer a well- 
defined prospective trachea (Fig 4.9d). Whilst Nkx2.1 is expressed in this narrow, 
undivided foregut, the expression signal is weaker than that in either the thyroid or the 
lung buds (Fig 4.9d). However, most of the endoderm of the narrow structure is Nkx2.1- 
positive with perhaps the exception of the dorsalmost part of the tube (Fig 4.9d). The 
lumen of the foregut widens and the signal becomes stronger as we move more caudally 
with the dorsoventral pattern of Nkx2.1 expression beginning to be re-established (Fig 
4.9e). At the level of the origin of the lung buds, the dorsal Nkx2.1-negative domain is 
clearly defined (Fig 4.9f,g). This domain will give rise to the negative fistula, which is
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Fig. 4.8 Expression of Nkx2.1 is not disturbed in E10.5 Shh'1' null mutant embryos.
Photographs of whole wild type (a) and mutant (b) embryos, and immunohistochemistry 
for Nkx2.1 on transverse sections from E10.5 Shh+/+ /Shh+I' embryos (c,e,g) and E10.5 
Shh1' embryos (d ,fh ). (a,b) Mutant embryos are growth restricted, cyclopic (arrow) and 
have major heart (h) and limb bud (Li) abnormalities. (c,d) Expression of Nkx2.1 in the 
thyroid primordium (Th) at the floor of the pharyngeal foregut (Ph) is undisturbed in 
mutant embryos. Note the abnormal shape of the mutant pharynx (d ) (e j)  The undivided 
foregut (Fo) displays a well-defined (arrowheads) ventral expression of Nkx2.1 in both 
types of embryos. (g,h) At more caudal levels, wild-type embryos have a separate 
oesophagus (Oe) and trachea (Tr) in contrast to mutants that have a completely undivided 
foregut which ends in a trifurcation of lung buds (Lb) and fistula (Fi). At that level, the 
original dorsoventral pattern of Nkx2.1 expression is maintained. Scale bars: a,b - 1mm 
and c-h - 100pm.
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Fig. 4.9 Expression of N kx2.1 in the El 1.5 Shh null mutant embryo
Immunohistochemistry for Nkx2.1 on transverse sections from Shh'1' El 1.5 embryos (6-0- 
Levels of sections correspond to the schematic representation of the null mutant foregut 
(a). (b,c) At the level of the pharynx (Ph), the strong signal of the thyroid gland (Th) is in 
sharp contrast to the lack of staining of the pharyngeal foregut which assumes the 
characteristic crescent shape (c). (d,e) As the lumen of the undivided foregut (Fo) narrows 
significantly, weak Nkx2.1 expression involves most of the structure with the exception 
of the dorsal-most endoderm (arrows in d). Further caudally (e), the lumen of the 
undivided foregut widens again and the dorsal, Nkx2.1-negative domain is better defined 
(arrowheads in e), although some Nkx2.1-positive cells are still found in the dorsal 
endoderm (arrows in e). (f,g) The lumen of the undivided foregut is continuous with the 
bronchopulmonary structures (Br) and the lungs (Lu) appear fused. The dorsal, Nkx2.l- 
negative part of the foregut is ‘carried’ with the bronchi (arrows in/ and g) as they 
undergo some degree of rudimentary branching. (h,i) Further caudally, the fistula (Fi) 
which connects the lungs to the stomach originates from the clearly defined Nkx2.1- 
negative endoderm (arrows in h and /). Scale bar, 100 pm
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Fig. 4.10 The trifurcation in E12.5 Shh'/m mutant embryos displays a distinct dorso-ventral 
pattern of Nkx2.1 expression in contrast to the undivided oesophagotrachea.
(a). Photograph of an El 2.5 mutant embryo displaying a severe forebrain malformation 
with a midline proboscis (Pr), abnormal limb (Lb) development and an enlarged, failing 
heart (h) with resulting liver (Li) congestion and severe oedema of the body wall (arrow). 
(b-d) Immunohistochemistry forNkx2.1 on transverse sections from an E l2.5 null mutant 
embryo. (A) At the level of the thyroid gland (Th), the undivided foregut (Fo) has the 
appearance of an oesophagus and is Nkx2.1 negative. The trachea appears not to have 
properly formed compared to wild-type embryos (inset), (c) Further caudally, the 
undivided oesophagotrachea (Oet) has uniform Nkx2.1 staining along the dorsoventral 
axis. (d) At the level of the trifurcation, the two lung buds (Lb) are positive for Nkx2.1 
and fused, in contrast to the fistula (arrow) which is completely negative. Scale bars: a -  1 
mm and b,c,d - 100 pm.
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seen to originate directly from the lungs (Fig 4.9h,i). As the fused bronchopulmonary 
structures undergo a rudimentary degree of branching, the dorsal Nkx2.1-negative 
endoderm is ‘carried’ with the branching structures and eventually emerges as the fistula 
(Fig 4.9h,i). The fistula continues towards the stomach as an Nkx2.1-negative structure. 
This arrangement is almost identical to some of the Adriamycin-treated CBA/Ca 
embryos. At E12.5 and E13.5, the arrangement described above persists both in the 
anterior foregut and at the level of the trifurcation of the Nkx2.1-negative fistula and 
Nkx2.1-positive bronchopulmonary buds (Fig 4.10d). One difference is that it is no 
longer possible to identify the Nkx2.1 -negative domain in the dorsal aspect of the 
undivided foregut (Fig 4.10c). In summary, there are very significant similarities between 
the Nkx2.1 expression pattern of the undivided foregut in the Adriamycin-treated 
CBA/Ca and Shh'1' homozygous embryos.
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4 .3 - D isc u ssio n
4.3.1 -  Respiratory field specification and development
One of the earliest genes expressed in the cells of the endoderm that commit to a 
respiratory lineage is the transcription factor Nkx2.1 (Lazzaro et al., 1991). The upstream 
regulation of this expression is not known. The role of Nkx2.1 is critical for both tracheal 
and pulmonary development. In my study, Nkx2.1 expression marks a ventral territory 
within the undivided foregut as well as marking the developing lung buds. As a result of 
longitudinal growth of the anterior foregut, the Nkx2.1- positive domain also lengthens 
before the process of tracheo-oesophageal separation has started. When it does begin, 
separation takes place along the dorsoventral boundary of Nkx2.1 expression. This 
boundary also corresponds to a cellular differentiation boundary as shown by the early 
distribution of proteoglycans (i.e. PAS staining) in cells of the respiratory endoderm. The 
role of Nkx2.1 appears to change later in gestation. With tracheo-oesophageal separation 
completed, its expression is largely restricted to the pulmonary epithelial cells where it is 
associated with the processes of branching morphogenesis and the specification of 
pulmonary epithelial cells.
The study of embryos that have lost Nkx2.1 expression as a result of targeted disruption of 
the Nkx2.1 locus supports the critical role of Nkx2.1 in respiratory development. These 
embryos have profoundly disturbed respiratory development with total failure of foregut 
separation and markedly hypoplastic lungs that cannot sustain life (Yuan et al., 2000; 
Minoo et al., 1999). The presence of a rudimentary respiratory system in Nkx2.1(-/~) 
embryos suggests that Nkx2.1 is not required for the specification of the respiratory 
primordium. It does however control the physical separation of the tracheal and
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oesophageal components of the foregut as well as the development of the phenotypic 
characteristics of the trachea as shown by the markedly abnormal tracheal rings found in 
these embryos. Since the rings are derived from the splachnic mesoderm through 
interactions with the developing respiratory endoderm, Nkx2.1 is likely to play an 
important role in epithelial-mesenchymal interactions. In the lungs, Nkx2.1 supports 
branching morphogenesis and the significantly reduced expression of Bmp4 in the lungs 
of Nkx2.1(-/-) embryos suggests a possible mechanism based on regulation of Bmp 
signalling by Nkx2.1 (Minoo et al., 1999). Finally, loss of Nkx2.1 function blocks 
pulmonary cell differentiation as shown by the absence of pulmonary surfactant protein 
gene expression (Minoo et al., 1999).
4.3.2 -  Does Adriamycin disturb endodermal and/or respiratory development?
Whatever the nature of the effect of Adriamycin on foregut development, it does not seem 
to involve interference with endodermal maintenance or specification of the respiratory 
lineage. The transcription factor Hnfifi is known to play a critical role in the formation 
and maintenance of the foregut endoderm and endodermally-derived organs, including 
the trachea, lungs, oesophagus and stomach (Ang et al., 1993). In Adriamycin-treated 
embryos from El 1.5 onwards, it is expressed uniformly in the oesophagotrachea and lung 
buds in a pattern comparable to saline-treated controls, where it is expressed in the 
endoderm of the separated respiratory and gastrointestinal organs. This suggests that the 
specification and maintenance of the foregut endoderm and its derivatives is not overtly 
disturbed during the development of OA/TOF in Adriamycin-treated embryos. The 
question of whether the development of the respiratory or gastrointestinal components of 
the foregut are specifically disturbed by Adriamycin has been addressed using the 
respiratory marker Nkx2.1. At E l0.5, when embryos destined to develop OA/TOF cannot
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be distinguished morphologically from controls, Adriamycin and saline-treated embryos 
are virtually identical in terms of Nkx2.1 expression. The conclusion is that the 
respiratory primordium is not only normally specified, but also grows in length 
appropriately.
A limitation of this study is that the conclusions are based on the study of a single 
respiratory marker, Nkx2.1. However, the respiratory expression of this transcription 
factor has been well documented (Lazzaro et al., 1991; Yuan et al., 2000; Minoo et al., 
1999; Pera & Kessel, 1998; Small et al., 2000) and its concordance with the respiratory 
phenotype (early production of proteoglycans) is also demonstrated in the present study 
using PAS staining. The effect of Adriamycin appears, therefore, not to disturb the 
specification of the respiratory versus gastrointestinal parts of the foregut, but rather to 
inhibit the physical separation of the two components. Respiratory development continues 
to be undisturbed in Adriamycin-treated embryos later in gestation (E l2.5 onwards), with 
normal levels of Nkx2.1 expression in the developing pulmonary epithelium. One 
potential source of confusion is the gradual expansion of the Nkx2.1 positive domain into 
the dorsal Nkx2.1-negative domain of the undivided foregut, which is observed from 
E l3.5 onwards. This could give the impression that the undivided foregut is almost an 
entirely respiratory structure and could perhaps explain the suggestion of Crisera et al. 
(1999) that a respiratory structure gives rise to a fistula of respiratory origin in the 
Adriamycin-treated rat embryo. It would appear though that this dorsal upregulation of 
Nkx2.7 is a secondary event, a response perhaps to the failure of separation. The temporal 
pattern of the expression shift supports this hypothesis. At El 1.5, all Adriamycin-treated 
embryos with an undivided foregut have an identical pattern of expression with the dorsal 
half of the undivided structure being Nkx2.7-negative. The encroachment of the Nkx2.1 -
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positive domain can only be detected beyond E l3.5. Another important observation is 
that the Nkx2.1-negative domain is never completely lost and persists, however small, in 
the dorsal-most part of the foregut. This late respiratory encroachment of the undivided 
oesophagotrachea is perhaps similar to what has been described previously as 
‘trachealisation’ of the foregut (Merei et al., 1997b; Merei et al., 1998; Possogel et al., 
1998).
4.3.3 -  Does the epithelial commitment of the tracheo-oesophageal fistula provide 
clues to a possible underlying imbalance in cell fates during the embryogenesis of 
Adriamycin -induced malformations?
The fistula that connects the dorsal, oesophageal, part of the undivided foregut to the 
stomach has been shown in previous studies in the Adriamycin-treated rat to stain 
positively for Nkx2.1 along its entire length (Crisera et al., 1999b) leading to suggestions 
that it is of respiratory origin. A recent study of human OA/TOF (Spilde et al., 2002b) has 
detected the presence of Nkx2.1 in tissues taken from the fistula at the time of surgical 
correction of the malformation. Furthermore, studies of human embryos and neonates 
with OA/TOF have identified histological evidence of cartilage formation, suggestive of 
respiratory differentiation in the fistula (Ibrahim & Sandry, 1981; Yeung et al., 1992; 
Dutta et al., 2000).
The evidence provided in the present study, from the Adriamycin mouse model, appears 
to contradict these findings. The TOF initially appears largely or completely negative for 
Nkx2.1 expression suggesting strongly that it is of gastrointestinal origin. Secondary 
down-regulation of Nkx2.1 expression in the fistula in the present study is unlikely, as it 
was observed to be completely negative at early stages (El 1.5). Furthermore, if Nkx2.1 is
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a reliable marker of the respiratory foregut component, then these results indicate that the 
fistula takes its origin from the dorsal part of the foregut, which is normally destined to be 
gastrointestinal. The observation that Nkx2.1-positve cells subsequently start to appear in 
the ventral half of the, originally Nkx2.1 -negative, fistula, is likely to represent late 
alterations in gene expression patterns rather than reflect the origin of the fistula.
This apparent contradiction in findings between mouse, rat and human could be attributed 
to species difference but there is no evidence for this and it is very unlikely. A much more 
plausible explanation is that the rat study (Crisera et al., 1999b) simply did not examine 
the fistula at the early stages of its development and consequently cannot argue about its 
origin. The human studies could also mislead as far as the origin of the fistula is 
concerned. Intraoperative specimens of the tracheo-oesophageal fistula can only be taken 
from its most proximal part, near its origin, and the presence of Nkx2.1-positive cells at 
that point would be consistent with the theories described above. Furthermore, the 
assessment of markers at term does not necessarily reflect the embryological origin of 
tissues. The use of other respiratory markers in the mouse, like Irxl and Irx2 (Becker et 
al., 2001), or markers for the oesophageal epithelium, like Hox-3 (Geada et al., 1992), 
would confirm the origin of the fistula in the experimental set up.
4.3.4 -  Does loss of function of Shh affect respiratory specification?
The precise relationship between the Shh and Nkx2.1 pathways is not well understood. 
What is clear from the examination of mutant (Shh'1') embryos is that the specification of 
the thyroid and respiratory primordia is not overtly disturbed as indicated by Nkx2.1 
expression at E l0.5. These findings suggest that Nkx2.1 is not directly regulated by Shh 
in the foregut, in keeping with recent work showing that Nkx2.1 expression in the
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neuroectoderm, but not in mesendodermally-derived structures, depends on Shh (Pabst et 
al., 2000). The tracheo-oesophageal malformations seen in homozygous Shh'1' mutants are 
likely to result from the failure of the already specified ventral Nkx2. /-positive element to 
separate from the foregut. The picture is complicated by the fact that the development of 
the lungs is grossly disturbed in these embryos. However, although the developing lungs 
appear fused with significantly reduced branching, they still strongly express epithelial 
Nkx2.1. These observations help to separate the issue of respiratory cell fate from that of 
the morphogenetic effects of loss of Shh function.
4.3.5 -  Suggested mechanisms of tracheo-oesophageal malformations
In Chapter 3 ,1 suggested that physical failure of tracheo-oesophageal separation underlies 
the development of tracheo-oesophageal malformations. The aim of the present chapter, 
was to extend this analysis by studying the pattern of cell fate specification and 
development in the foregut and determine whether the respiratory and gastrointestinal 
components, distinguished by gene expression properties, fail to separate. During the 
early critical stage of the embryogenesis of tracheo-oesophageal malformations, neither 
the action of Adriamycin nor the loss of function of Shh appear to overtly disturb the 
development of the respiratory primordium. During subsequent stages of development, 
the already specified foregut elements fail to physically separate. The evidence presented 
in this chapter strongly supports the hypothesis that the earliest recognisable 
malformation is a failure of separation. The various adaptive developmental events that 
follow this initial failure should not distract from the simplicity of the initial defect.
Another conclusion is that the well-demarcated boundary between prospective respiratory 
and non-respiratory epithelium (the Nkx2.1 expression boundary) is not by itself sufficient
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to effect the separation. Additional signals must be required and it is these signals that are 
the likely targets of Adriamycin. It is also plausible that these signals are related to the 
Shh pathway. Finally, it may be that Nkx2.1 (or its expression boundary) is necessary but 
not sufficient, as this study shows, for separation. This question has not been tackled in 
this chapter, but evidence from the Nkx2.1 homozygous mutant, which exhibits an 
undivided foregut, would suggest that the Nkx2.1 expression boundary is necessary for 
separation of the gastrointestinal and respiratory elements. It is likely that a combination 
of dorsoventral signals (both cell fate markers and other signalling molecules) are 
involved in the demarcation, initiation and execution of the separation process. The aim 
of the remainder of this thesis is to study these signals in greater detail.
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CHAPTER 5 -  R o l e  o f  s o n i c  h e d g e h o g  in  f o r e g u t
DEVELOPMENT
5.1 -  I n tr o d u c t io n
The molecular control of separation can be considered as having three components: the 
molecular factors themselves that provide the positional cues for dorsoventral division, 
the upstream signals that determine the expression of these factors and the downstream 
events that contribute to the separation process. This chapter deals with the molecular 
factors and their control whereas the downstream events are examined in Chapter 6. The 
requirements for the markers controlling separation are that they are expressed in the 
foregut endoderm and /or the adjacent mesoderm and they have a dorsoventral expression 
pattern which both precedes separation and coincides with the respiratory/ gastrointestinal 
boundary.
The respiratory marker Nkx2.1 satisfies these criteria. It has been shown to be necessary 
(Yuan et al., 2000; Minoo et al., 1999), but not sufficient (Chapter 4 data) for separation. 
Another candidate is the key developmental gene Sonic hedgehog (Shh). The secreted 
glycoprotein Shh and members of its signaling cascade are known to be involved in a 
wide range of morphogenetic processes in the developing embryo and have been shown 
to be expressed in the foregut (Riddle et al., 1993; Johnson et al., 1994; Roelink et al., 
1995; Marigo et al., 1996; Litingtung et al., 1998; Motoyama et al., 1998; Chuong et al., 
2000). Furthermore, tracheo-oesophageal malformations have been described in embryos 
with loss of function mutation for Shh (Litingtung et al., 1998; Pepicelli et al., 1998) and I
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have specifically shown in the first two chapters that these embryos exhibit failed 
tracheo-oesophageal separation. Mutations in other members of the Shh signaling cascade 
have also been shown to lead to tracheo-oesophageal malformations (Motoyama et al., 
1998; Mahlapuu et al., 2001). Based on these observations, I decided to study in detail the 
expression pattern of Shh and other members of its signaling cascade during tracheo- 
oesophageal development and in particular during the process of tracheo-oesophageal 
separation.
191
5.2 -  R e su l t s
5.2.1 — Expression patterns for Shh
5.2.1.1 - Expression o f Shh in control embryos
In E10.5 saline control embryos, Shh is expressed in the brain, floor plate of the neural 
tube, notochord, limb buds, foregut and hindgut (Fig. 5.1a). At E10.5, Shh is weakly 
expressed in both the dorsal and ventral endoderm of the pharynx and is absent from the 
lateral endoderm of the pharyngeal pouch derivatives (Fig. 5.1c). This expression pattern 
persists in the El 1.5 pharyngeal foregut (Fig. 5.2a). Just caudal to the pharynx, at E10.5, 
Shh is strongly expressed in the ventral endoderm of the prospective trachea with the 
dorsal, prospective-oesophageal endoderm lacking expression (Fig. 5.1d-g). There is a 
sharp boundary between expressing and non-expressing cells and this is maintained 
further caudally where Shh is strongly expressed in the lung buds but is still absent from 
the dorsal-most endoderm (Fig. 5.1h). At El 1.5, after tracheo-oesophageal separation has 
started, a striking switch in dorso-ventral expression occurs. Below the level of 
separation, Shh is now expressed in the oesophagus but not in the trachea (Fig. 5.2e). 
Sections taken just above the level of separation also show this ventro-dorsal switch (Fig. 
5.2d) whereas more cranial sections of the, as yet undivided, foregut persist in showing 
stronger ventral Shh expression, as seen in the E l0.5 embryos (Fig. 5.2b,c). Strong Shh 
expression is found in the developing lung buds at El 1.5 and later in gestation (Fig. 5.2f). 
At E l2.5, the oesophagus remains strongly positive and the trachea is completely 
negative for Shh (Fig. 5.3c,e). The lung buds remain positive for Shh throughout this 
period of development.
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Fig. 5.1 Expression of Shh and Ptcl in the E10.5 CBA/Ca embryo 
Patterns of Shh expression, and complementary Ptcl patterns, in saline-treated El 0.5 
embryos. In situ hybridisation for Shh (a,c-h) and Ptcl (b.ij.k): whole embryos and 
vibratome sections from whole-mount hybridisation experiments on E l0.5 saline-treated 
embryos (inset in k Adriamycin-treated). Sections (c) to (h) and (i) to (k) form two series of 
progressively more caudal sections, (a) Shh expression is seen in ventral areas of the brain, 
the floor plate (Fp), the notochord (arrowhead in a), the foregut (Fo) and hindgut (Hg) 
endoderm, including the lung buds (arrow in a) and the limb buds (Lb), (b) Ptcl expression is 
flanking the ventral neural tube (arrow in b) and ventral midline in the brain and is also found 
in the somites (S), the limb buds and the mesoderm surrounding the foregut and hindgut. (c-A:) 
Shh is strongly expressed in the floor plate of the neural tube (Fp) and the notochord (Nt) 
whereas Ptcl is expressed in the mesoderm adjacent to the ventral neural tube and around the 
notochord (arrowhead in i). (c,i) At the level of the pharyngeal foregut (Ph), Shh is expressed 
in both the dorsal and ventral endoderm (arrows in c) but is specifically absent from the 
endoderm of the pharyngeal pouches (arrowheads in c). Ptcl is expressed next to the Shh- 
expressing endoderm (arrows in i). (d,ej,k) Shh is expressed in the ventral endoderm of the 
laryngotracheal groove (Lt) with a sharp boundary between ventral expressing and dorsal 
non-expressing cells (arrowheads in d,e). Mesodermal expression of Ptcl is also restricted to 
the ventral foregut (arrowheads in j,k) although the boundary is not as distinct due to adjacent 
perinotochordal expression. Interpretation of dorsal Ptcl expression in Adriamycin-treated 
embryos is made difficult by the proximity of the foregut to the notochord and floor plate 
(arrow, inset in k) (f,g) Further caudally, Shh expression is restricted to the endoderm of the 
prospective trachea (Tr) (arrowheads). (h) At the level of the lung buds (Lb), the Shh dorso­
ventral boundary still exists (arrow) but appears less distinct. D -  diencephalon, T -  ventral 
telencephalon. Scale bar: a,b -  500 pm and c-k -100 pm.
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Fig. 5.2 Expression of Shh and P tc l  in the El 1.5 CBA/Ca embryo
Changing patterns of Shh expression (and complementary Ptcl patterns) in El 1.5 
embryos. In situ hybridisation for Shh (a-f) and Ptcl (g-l): vibratome sections from 
whole-mount hybridisation experiments on saline-treated embryos, a to/represent 
increasingly caudal levels and g  to / represent corresponding levels. (a,g) In the 
pharyngeal foregut (Ph), Shh is expressed ventrally and dorsally but is absent laterally 
from the endoderm of the pharyngeal pouch derivatives (arrowheads in a mark 
boundary). Ptch is expressed adjacent to Shh expressing endoderm (arrow in g). (b,h) At 
the level of the laryngotracheal groove (Lt), Shh is expressed in a well-defined ventral 
domain (arrows in b) and Ptch in the adjacent mesoderm (arrow in h). (c,i) At a slightly 
more caudal level, Shh is still ventrally expressed (arrow in c) but the expression appears 
to be shifting dorsally. This again is reflected in mesodermal Ptch expression (arrow in i). 
(id j) The pattern of Shh expression is now reversed with a well defined (arrowheads in d) 
dorsal Shh expression but weak expression ventrally. Ptch is expressed in the mesoderm 
adjacent to the dorsal foregut (Fo) (arrow in j). {e,k) Shh expression in the oesophagus 
(Oe) but only at low level in the trachea (Tr). Ptch expression is similarly confined to the 
peri-oesophageal mesoderm. (f,l) Shh is expressed in the oesophagus and lung buds (Lb). 
Ptch expression around the lung buds is stronger than the peri-oesophageal expression 
(asterisk in /). Fp - floor plate, Nt - notochord. Scale bar 100 pm.
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Fig. 5.3 Expression of Shh in El 2.5 saline-control and Adriamycin-treated CBA/Ca
embryos
Shh expression in the oesophagotrachea of E l2.5 Adriamycin-treated embryos is 
comparable with expression in saline-treated embryos. In situ hybridisation for Shh on 
transverse sections from saline- (a,c,e) and Adriamycin-treated (b,d,f) E l2.5 embryos. 
(a,b) At El 2.5, the cranial-most part of the laryngotracheal groove (Lt) has yet to separate 
from the oesophageal foregut. Both uniformly express Shh in saline- and Adriamycin- 
treated embryos. (c,d) At a slightly more caudal level in saline controls, the separated 
trachea (Tr) is completely negative for Shh whereas the oesophagus (Oe) retains a strong 
signal (c). In the Adriamycin-treated embryo (d), the undivided oesophagotrachea (Oet) 
reflects this dorso-ventral pattern in expression with a sharp boundary between expressing 
and non-expressing cells (arrows), (ej) This dorsal-positive, ventral-negative pattern 
persists further caudally and is unchanged as far as the level of the trifurcation. Scale 
bars, 100 pm.
197
Saline Adriamycin
a
/
Oe Oet
Tr
-ST
Oe Oet
Tr
Fig. 5.4 Ventro-dorsal Shh switch in saline-treated embryos and disturbance o f this
pattern in Adriamycin-treated embryos at E l0.5 and El 1.5
In situ hybridisation for Shh on saline-treated (a.d) and Adriamycin-treated (b,c,e) 
embryos. Vibratome sections from whole-mount experiments. (a,d) Shh expression shifts 
completely from the ventral, tracheal-prospective epithelium at E l0.5 (arrowheads in a 
mark boundary), to the oesophageal epithelium at El 1.5 (<d, after tracheo-oesophageal 
separation). (b,c) In these two E l0.5 Adriamycin-treated embryos, the undivided foregut 
(Fo) expresses Shh uniformly along the dorsoventral axis. Note Shh expression in part of 
the lung bud included in this section (arrow in b)(e) The undivided oesophagotrachea 
(Oet) in this El 1.5 Adriamycin-treated embryos shows diffuse staining along the dorso­
ventral axis. The signal appears stronger at the two poles and contrasts sharply with the 
pattern seen in saline-controls (d). (inset in e) The split notochord seen in some 
Adriamycin-treated embryos exhibits an asymmetrical Shh signal. The ventral branch 
(double arrowhead) has a much stronger signal than the more normally positioned dorsal 
branch (arrowhead). The ventral branch is abnormally close to the undivided foregut, 
which itself exhibits a uniform Shh signal. Scale bars, 100 pm.
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5.2.1.2 - Expression o f Shh in the Adriamycin-treated embryo
The expression pattern of Shh mRNA in Adriamycin-treated embryos is comparable to 
control embryos in the region of the pharyngeal foregut at both El 0.5 and El 1.5. There is 
low level expression of Shh mRNA in the pharyngeal endoderm in contrast to the laterally 
outgrowing derivatives of the pharyngeal pouches that specifically lack expression at both 
gestations (not shown). In the respiratory foregut, however, there is a disturbance in the 
precise pattern of Shh transcripts in Adriamycin-treated embryos compared to untreated 
embryos. At E l0.5, two out of five embryos examined lacked the dorso-ventral boundary 
of Shh mRNA seen in controls, and exhibited a more uniform expression of Shh 
transcripts along the dorso-ventral axis, in the caudal part of the undivided foregut (Fig. 
5.4b,c). Similar perturbations were seen in the undivided oesophagotrachea of 
Adriamycin-treated embryos at El 1.5. In these embryos, the dorso-ventral boundary was 
also absent, with a more uniform signal along the dorso-ventral axis of the undivided 
structure, in four out of four embryos examined (Fig. 5.4e). In contrast, all Adriamycin- 
treated embryos (n=4) that had a separate trachea and oesophagus displayed an identical 
Shh expression pattern to saline controls. Strikingly, at E l2.5, the undivided 
oesophagotrachea of Adriamycin-treated embryos re-established the dorso-ventral pattern 
of Shh expression seen in controls. The dorsal (oesophageal) part of the structure was 
strongly positive in contrast to the ventral (tracheal) part that was completely negative 
(Fig. 5.3d,f).
5 .2 .2  — S hh  p rote in  d istr ib u tio n  in th e  d ev e lo p in g  m o u se  em b ry o
The validity of using the anti-Shh antibody was confirmed by the presence of Shh protein 
in the notochord and the floorplate of the neural tube, which are established sites of Shh 
expression, at both E10.5 and El 1.5 (Fig. 5.5a,b). In the region of the notochord the
2 0 1
distribution of the peptide is quite distinctive, with the Shh protein found not only in the 
notochord itself, but also in the perinotochordal mesenchyme (Fig. 5.5a, inset). Shh 
protein was most abundant in the mesenchyme immediately surrounding the notochord, 
although Shh protein was also seen occasionally at some distance from the notochord, 
near the floor plate, and as far as the foregut.
At El 0.5, the pattern of Shh protein distribution matches closely the pattern of expression 
of the Shh mRNA in the respiratory foregut, as shown by the in situ hybridisation 
experiments. In the E l0.5 foregut, Shh protein is found in the ventral, tracheal- 
prospective epithelium and more caudally in the lung buds (Fig. 5.5a,b). There is a clear 
dorsoventral pattern of protein distribution, which matches the dorsoventral pattern of Shh 
mRNA expression (Fig. 5.5a,b). This pattern is also very similar to the Nkx2.1 expression 
pattern. In sharp contrast, the Shh protein pattern differs greatly from that of the Shh 
mRNA in the pharyngeal foregut rostral to the laryngotracheal groove. Shh protein is only 
occasionally detected in the pharyngeal epithelium, at the boundaries of the pouch 
derivatives.
At El 1.5, the significant discrepancy between Shh gene expression and protein 
distribution, seen in the E l0.5 pharyngeal foregut, persists. Shh protein is found only in 
the ventral midline, at a point corresponding to the origin of the thyroid diverticulum (Fig. 
5.5c) and laterally at the junction between the pharynx and the pharyngeal pouch 
epithelium (Fig. 5.5c, inset). This pattern was reproducible in all examined embryos 
(n=10) and might indicate a role for Shh in the budding of pharyngeal derivatives.
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Fig. 5.5 Distribution of Shh protein in the developing foregut
Immunohistochemistry for Shh protein on transverse sections from saline-treated E10.5 (a,b) 
and El 1.5 (c-h) embryos. Sections a to b and c to h are from increasingly caudal levels, (a,b) 
There is a strong protein signal at El 0.5 in both the floor plate of the neural tube (Fp) and the 
notochord (Nt), both areas with established Shh expression. The secreted nature of the Shh 
glycoprotein is demonstrated by the Shh signal in the mesenchyme that surrounds the 
notochord (inset in a). In the E l0.5 foregut (Fo), the ventral, tracheal-prospective, epithelium 
is Shh-positive, with clearly demarcated dorsoventral boundary (arrowheads in a). At the 
level of the lung buds (Lb), the ventral signal persists and the dorsoventral boundary lies 
dorsal to the lung bud boundary (arrowheads in b). (c) At El 1.5 at the level of the pharyngeal 
foregut (Ph), the midline thyroid diverticulum (Th) has a strong Shh signal. The foregut 
epithelium generally lacks Shh signal except at the boundaries of the pharyngeal pouches (Pp) 
(arrowhead, inset in c). (d) At the level of the ventral laryngotracheal groove (Lt), the 
epithelium of the groove is Shh-positive in contrast to the dorsal epithelium that is negative. 
(e) Just caudal to the laryngotracheal groove, the foregut is still undivided and the Shh signal 
is still restricted to the ventral epithelium. (/) As the level of tracheo-oesophageal separation 
is approached, the signal has largely shifted dorsally, although occasional ventral cells 
maintain their signal (arrow in f). Despite this dorsal shift, there is little signal in the 
dorsalmost epithelium, and in some embryos the Shh signal is found mostly in the folding 
epithelial ridges that mark the separation point (arrowheads, inset in f). (g) The separated 
oesophagus (Oe) also has Shh-positive cells, as does the dorsal part of the trachea (Tr) (arrow 
in g). (h) As the trachea changes shape, and the level of tracheal bifurcation is approached, 
tracheal Shh signal is mostly located in the middle third of the tracheal epithelium (arrowhead 
in h), at the point of tracheal separation. Scale bar, 50 pm
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In the El 1.5 respiratory foregut, the pattern of Shh protein distribution does not exactly 
match the mRNA expression pattern. In particular, the protein distribution pattern is 
patchy, unlike the uniform pattern of mRNA expression. In the cranial aspect of the 
respiratory foregut, Shh protein is present largely in the ventral epithelium of the 
laryngotracheal groove, with a clear boundary of dorsoventral staining (Fig. 5.5d). More 
caudally, Shh protein is found in the ventral half of the still undivided foregut with 
absence of protein from the dorsal half of the foregut (Fig. 5.5e). This agrees with the Shh 
mRNA expression pattern, but the signal in the ventral epithelium is restricted to a small 
number of cells and it is not easy to define a dorsoventral boundary. As more caudal 
sections are examined, a dorsalward shift of the protein distribution is observed, similar to 
the shift in mRNA distribution at the same stage (Fig. 5.5f). Shh protein is detected in the 
region of future tracheo-oesophageal separation and just dorsal to this dorsoventral 
boundary, in the ventral part of the oesophageal-prospective epithelium (Fig. 5.5f). In 
contrast to the mRNA expression pattern, occasionally small numbers of cells are positive 
for the Shh protein in the ventral epithelium (Fig, 5.5f). Another difference between the 
protein distribution and the Shh in situ hybridisation signal is that in the dorsal, 
prospective-oesophageal epithelium, the Shh protein is largely absent from the dorsal- 
most part of this epithelium (Fig. 5.5f).
At levels just caudal to tracheo-oesophageal separation, Shh protein is detected in both 
the dorsal oesophagus and ventral trachea but with much more intense staining in the 
oesophagus (Fig. 5.5g). At this level, tracheal Shh protein is patchy and largely found in 
the dorsal part of the divided structure (Fig. 5.5g). The pattern changes more caudally 
towards the level of the bifurcation of the trachea into the two lung buds. At this level, 
whereas Shh protein persists in the dorsal oesophagus, it becomes more abundant in the
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trachea and is present at the bifurcation (Fig- 5.5h). This pattern largely
conforms to the mRNA expression pattern, where transcripts are abundant in the lung 
buds but absent from the trachea just caudal to the level of tracheo-oesophageal 
separation.
5.2.3 -  Expression of mRNA for the Shh transmembrane receptor Ptcl
The transmembrane receptor Ptcl is a key downstream component of the Shh 
transduction pathway. As well as coding for the Shh receptor, Ptcl is a Shh target gene 
and is upregulated by Shh (Grindley et al., 1997). Hence, Ptcl serves as a useful 
functional ‘read-out’ of Shh activity. Whole mount in situ hybridisation in El 0.5 saline- 
treated embryos, shows Ptcl expression in various tissues throughout the embryo 
including the brain, neural tube, somites and limb buds and, as a general rule, in areas 
immediately adjacent to Shh expression (Fig. 5.1b). It is found flanking Shh expression in 
the floor plate and notochord, in cells flanking the ventral midline in the brain and in the 
posterior part of the limb bud (Fig. 5.1b,i-k).
In the early foregut, Ptcl mRNA is expressed in the mesoderm adjacent to Shh- 
expressing endoderm: at E l0.5, there is ventral Ptcl mRNA expression in the mesoderm 
adjacent to the ventral endoderm of the pharyngeal foregut (Fig. 5.2i). Some Ptcl 
expession is also seen in the dorsal pharyngeal mesoderm but this dorsal expression could 
be associated with the SM-positive floor plate and notochord (Fig. 5.1i). The close 
proximity of the pharyngeal foregut to the neural tube makes such distinction very 
difficult. There is also Ptcl expression in the mesoderm surrounding the ventral 
endoderm of the prospective trachea with no expression in the mesoderm adjacent to the 
dorsal, oesophageal- prospective endoderm (Fig. 5.1j,k).
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Expression of Ptcl continues to be complementary to that of Shh at El 1.5. In the 
pharyngeal foregut, it is expressed in the ventral mesoderm (Fig. 5.2g). At the level of the 
laryngotracheal groove, the ventral mesodermal expression of Ptcl mRNA mirrors the 
persistent ventral Shh expression at this level (Fig. 5.2h). Further caudally, there is a 
definite shift in mesodermal Ptcl mRNA expression. In sections just caudal to the 
laryngotracheal groove, the strongest expression is in the ‘middle’ mesoderm (Fig. 5.2i). 
Further caudally, just cranial to tracheo-oesophageal separation, the ventral-to-dorsal 
switch is completed with Ptcl expression exclusively in the dorsal mesoderm surrounding 
the oesophageal-prospective endoderm (Fig. 5.2j). Caudal to the level of tracheo- 
oesophageal separation, Ptcl expression is found in the dorsal peri-oesophageal 
mesoderm (Fig. 5.2k). At the level of the lung buds, Ptcl is strongly expressed in the 
mesoderm surrounding the lung buds, again reflecting the pattern of Shh expression at 
this level (Fig. 5.21).
Analysis of Ptcl expression in Adriamycin-treated embryos at El 0.5 (n=4), shows that 
this is not disturbed. However, as Ptcl is expressed in the perinotochordal mesoderm, and 
as the notochord is very close to the foregut, it is difficult to comment on expression in 
the mesoderm surrounding the dorsal foregut (Fig. 5.1k, inset). In the El 1.5 Adriamycin- 
treated embryo, failure of foregut separation was associated with a blurring of the 
mesenchymal ventral-to-dorsal shift in Ptcl expression, presumably reflecting the 
corresponding disturbance in the expression of Shh in Adriamycin-treated embryos.
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5.3 -  D isc u ss io n
5.3.1 -  Dynamic Shh expression and the separation process
The pattern of Shh expression gives important clues to the possible molecular 
mechanisms that underlie foregut development. Shh has important morphogenetic roles in 
various developmental processes. In the pharynx, Shh mRNA is weakly expressed in both 
the dorsal and ventral epithelium, but is absent from the epithelium of the pharyngeal 
pouch derivatives. This would be consistent with the Shh expression boundaries playing a 
role in organ budding from the epithelium of the gut tube. The evidence also suggests that 
boundaries between Shh expressing and non-expressing regions may play a role in 
respiratory system development. Shh expression is tightly regulated so that it shifts from 
the ventral, prospective-tracheal, epithelium (at E l0.5) to the dorsal oesophageal 
epithelium as tracheo-oesophageal separation proceeds in a caudal to cranial direction (at 
El 1.5). These changes in Shh expression are restricted to the foregut caudal to the 
pharynx and cranial to the lung buds. Strong ventral expression with a definite 
dorsoventral boundary starts at the level of the laryngo-tracheal groove. At the caudal end 
of the tracheal epithelium, the strong Shh expression in the lung buds is not 
downregulated even after tracheo-oesophageal separation is completed. These 
observations suggest that Shh is specifically upregulated in the ventral, prospective- 
tracheal epithelium and downregulated in the epithelium of the definitive trachea. 
Conversely, Shh expression appears to be downregulated in the dorsal, prospective- 
oesophageal epithelium and upregulated in the epithelium of the definitive oesophagus. 
This complete and specific ventral-to-dorsal switch that precedes tracheo-oesophageal 
separation suggests that Shh may have a role in the septation process itself. The 
maintenance of Shh in the lung buds suggests that their development is a separate process
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from that of tracheo-oesophageal separation and is consistent with the known role of Shh 
in lung proliferation and branching morphogenesis (Bellusci et al., 1997b).
5.3.2 -  The Shh mRNA/protein pattern difference
Whereas very little protein signal is detected in the E l0.5 pharynx, the overall patterns of 
mRNA and protein distribution in the foregut distal to the pharynx are similar, both 
exhibiting a distinct dorsoventral boundary. At El 1.5, the peptide and mRNA patterns 
remain largely concordant in parts of the foregut where the gene expression in the ventral 
endoderm is unchanged from E l0.5 (i.e. the rostral undivided foregut and the lung buds). 
Between these two levels, Shh mRNA expression shifts from ventral to dorsal ahead of 
tracheo-oesophageal separation. The protein pattern also appears to shift but lags behind 
the mRNA shift. Specifically, at the level of separation or just cranial to it, the highest 
concentration of protein is in the dorsal half of the foregut but more so around the site of 
separation rather than in the dorsalmost foregut epithelium. Furthermore, the ventral 
tracheal-prospective endoderm still has some Shh-positive cells. However, patchy and 
inconsistent immunostaining of other tissues positive for Shh mRNA (e.g. pharyngeal 
foregut) suggests that there may be considerable variability either in Shh mRNA 
translation/stability or in protein turnover from structure to structure. This, coupled with 
possible differences in experimental sensitivity, particularly in relation to the Shh 
antibody which may be variable in its detection of the diffusible, variably modified (by 
cholesterol, palmitoyl residues) Shh-N peptide, could account for the discrepancies 
between mRNA and protein distribution patterns.
The discrepancy raises the question of validity of the technique. However, analysis of 
mRNA expression has been used in virtually all studies of the developmental role of Shh
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and as my data closely agree with the findings of these other studies, the mRNA patterns 
described here are likely to be accurate. Shh protein was consistently detected in both the 
notochord and the floorplate, tissues of intense Shh transcription, suggesting that the 
immunohistochemical analysis of Shh distribution is also valid. Furthermore, the 
observed difference in the distribution of Shh protein and mRNA in the post-pharyngeal 
foregut could be attributed to the combination of shifting mRNA expression and the small 
temporal difference between gene transcription and protein synthesis, as well as a 
possible difference in mRNA and protein turnover. This explanation would be consistent 
with the lag observed in protein distribution. An alternative explanation for the mRNA/ 
protein discrepancy is that Shh is a signaling molecule and the protein may be found in 
cells in which it is not synthesised and lack an mRNA signal.
Overall, it could be argued that protein patterns are largely in agreement with gene 
expression patterns but may not be as reliable in depicting rapidly changing temporal and 
spatial shifts. When interpreting these patterns, however, one should bear in mind that the 
protein is what directs function and that the protein patterns may be more accurate from a 
functional point of view.
5.3.3 -  How does Shh act in the foregut?
The differences described above raise the question of how exactly does Shh act to shape 
the foregut? Whereas the mRNA expression of Shh has been studied and interpreted in a 
number of organ-systems, it is the protein that mediates its action. The Shh protein has 
been shown to act both via short and long-range signaling (Drossopoulou et al., 2000; 
Gritli-Linde et al., 2001; Briscoe et al., 2001). The signaling capacity is restricted to the 
N-terminal peptide (Roelink et al., 1995) which results from autoproteolytic processing of
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the Shh protein (Bumcrot et al., 1995; Ingham, 1998). As a result of this cleavage, the N- 
terminal peptide becomes covalently linked to cholesterol (Porter et al., 1996) and 
consequently the secreted protein becomes tethered to the cell surface of the Shh 
expressing cells. This mechanism provides a basis for the short-range signaling mediated 
by Shh (Tabin & McMahon, 1997). The Shh signal is the result of binding of Shh to its 
receptor complex, involving patched and smoothened protein (Marigo et al., 1996), on the 
cell membrane, which in turn activates an intracellular cascade which involves the Gli 
family of transcription factors. Another proposed mechanism for the short-range signaling 
of Shh is the role of its receptor Ptcl acting as a sink for the Shh protein, thereby limiting 
its rate of diffusion. As Ptcl expression is upregulated by Shh, this would serve as a 
feedback mechanism to limit the range of Shh action. The recent finding that the 
endocytic receptor megalin is expressed in Shh expressing cells and binds the N-terminal 
Shh peptide, leading to its endocytosis, has suggested other mechanisms for the 
modulation of the range of the Shh signal. Megalin-mediated endocytosis could limit the 
levels of extracellular Shh protein or even mediate direct transduction of the Shh signal 
(McCarthy et al., 2002; McCarthy & Argraves, 2003).
There is also increasing evidence for the long-range nature of the Shh signal. In the past, 
this was questioned because of difficulty in demonstrating the presence of Shh peptides at 
a distance from its source (Marti et al., 1995). Optimised immunohistochemical 
techniques have demonstrated Shh signaling peptides in target tissues, away from the Shh 
source (Gritli-Linde et al., 2001). These studies have identified a crucial role for 
proteoglycans in this long-range signaling and Shh diffusion. Long -range signaling 
could also be mediated by the association of Shh with endocytic vesicles and recent 
studies suggest a possible role for megalin in this mechanism (Incardona et al., 2000;
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McCarthy & Argraves, 2003; McCarthy et al., 2002). Evidence for long-range signaling 
exists in the limb (Drossopoulou et al., 2000), tooth (Gritli-Linde et al., 2001) and neural 
tube (Ericson et al., 1997; Ericson et al., 1996)morphogenetic systems.
In the foregut, Shh is likely to act via short-range signaling. Shh secreted by cells of the 
foregut endoderm is likely to influence gene transcription in cells of the adjacent 
mesoderm. The end result is the activation of transcription factors that regulate the 
transcription of target genes. This is clearly demonstrated by the expression of Ptcl, both 
a receptor and a target for Shh, in the mesoderm adjacent to -ST///-expressing endoderm 
(this study and (Platt et al., 1997)). A number of other factors, including members of the 
Gli family of transcription factors, are also upregulated by Shh (Platt et al., 1997). The 
complementary nature of expression of Shh and its target genes (like Ptcl) would suggest 
that the expression data for Shh accurately represent the spatial and temporal pattern of 
Shh activity. What remains unclear is how factors expressed in the mesoderm surrounding 
the respiratory endoderm affect morphogenesis of the respiratory foregut and in particular 
tracheo-oesophageal separation. One can only speculate that mesodermal factors modify 
transcription of key endodermal genes that ultimately lead to morphological changes in 
the foregut. An alternative explanation is that Shh acts directly on adjacent endodermal 
cells and controls gene expression and key cellular processes. These include cell 
proliferation and programmed cell death, which are studied in detail in Chapters 6 and 7.
5.3.4 -  Control of Shh expression
It is only possible to speculate as to the factors that control Shh expression in the foregut. 
Signals from the notochord could play a role in this regulation as is the case with the 
induction of the Shh producing cells of the floor plate (Ericson et al., 1996). There is
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evidence that Shh is the signal responsible for the induction of Shh in the floor plate and 
that the induction itself is modulated by chordin, a BMP antagonist (Patten & Placzek, 
2002). It is possible that Shh, produced by the notochord, regulates endodermal 
expression of Shh. Shh in the endoderm could, in turn, induce a feedback mechanism that 
limits the range of action of the diffusible notochordal signal. The negative feedback 
mechanism could be mediated by Ptcl, which is upregulated in the mesoderm adjacent to 
SM-expressing endoderm, as seen in my experiments and in other studies (Platt et al., 
1997). Ptcl has been shown to limit the range of action of Shh during cell patterning and 
specification in the ventral neural tube (Briscoe et al., 2001). Another model of 
differential modulation of a default endodermal Shh pattern has been described in detail 
in the case of the development of the pancreas, which is also derived from the foregut. In 
this system, default dorsal Shh expression is inhibited by signals from the notochord in 
order to allow development of the dorsal pancreas. Conversely, ventral mesodermal 
signals induce Shh expression in the ventral endoderm and by doing so bring about 
development of the hepatic bud (Hebrok et al., 1998; Kim et al., 2000; Deutsch et al., 
2001). Similar mechanisms could be involved in the regulation of Shh expression in the 
region of the prospective trachea and could account for the ventro-dorsal switch in its 
expression. According to such a model, induction of ventral Shh expression in the 
respiratory foregut could be involved in respiratory development whilst the return to a 
default dorsal expression could be associated with the process of tracheo-oesophageal 
separation.
Another potential regulator of endodermal Shh expression are factors originating in the 
foregut endoderm itself. These factors could be involved in cell specification in which 
case they would themselves have a dorsoventral pattern of expression. Tracheo-
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oesophageal separation occurs between respiratory-specified and gastrointestinal- 
specified epithelium. This specification depends on the precise dorsoventral expression 
pattern of respiratory markers such as Nkx2.J (Yuan et al., 2000; Minoo et al., 1999). If it 
is argued that the dorsoventral Shh pattern somehow controls separation along the 
respiratory-gastrointestinal boundary, it could be hypothesised that Nkx2.J, or another 
respiratory or gastrointestinal marker, controls the Shh pattern. This hypothesis has a 
number of potential weaknesses. First, I have demonstrated that the Shh and Nkx2.1 
expression domains are not identical but show significant differences from each other. 
Second, even if Nkx2.1 and Shh had identical patterns of dorsoventral expression, these 
could be controlled by another, as yet unidentified, factor.
5.3.5 -  The Shh expression pattern in the Adriamycin-treated embryo
The effect of Adriamycin on the pattern of Shh expression suggests a possible mechanism 
for abnormal organogenesis in Adriamycin-treated embryos. At E10.5, some embryos 
lack the well-defined ventral Shh expression and show a more uniform pattern of 
expression in the caudal part of the undivided foregut. The morphological data suggest 
that although all Adriamycin-treated embryos appear normal at E l0.5, about 40% are 
destined to have an undivided foregut. It seems likely that the El 0.5 embryos that exhibit 
diffuse expression of Shh (also 40% of El 0.5 embryos) are the ones that are destined to 
be abnormal. At El 1.5, all Adriamycin-treated embryos that have an undivided 
oesophagotrachea lack the sharp dorso-ventral boundary in Shh expression seen in 
controls, exhibiting a more diffuse signal along the dorso-ventral axis of the common 
tube. It is not possible at this stage to rule out the possibility that the disturbance in 
expression is secondary to another factor that causes failure of separation. However, 
given the proven role of Shh in the separation process (i.e. Shh'1' has an undivided foregut)
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it is reasonable to suggest that disturbance of the tightly regulated Shh expression 
expression may underlie the action of Adriamycin in disturbing foregut separation. This 
hypothesis is also consistent with the lack of lung malformations in Adriamycin-treated 
mouse embryos with OA/TOF. Whilst failure of ventral Shh downregulation interferes 
with tracheo-oesophageal separation, it should not affect branching morphogenesis as the 
tips of the lung buds are normally strongly Shh positive throughout pulmonary 
development (Pepicelli et al., 1998). It would also be consistent with the Shh'1' mice 
having both tracheo-oesophageal and lung malformations, as Shh is required in the lungs. 
Rather unexpectedly, the undivided oesophagotrachea in E l2.5 Adriamycin-treated 
embryos re-establishes a dorso-ventral pattern in Shh expression with the dorsal 
epithelium positive and the ventral epithelium negative. This could indicate that the 
action of Adriamycin is transient and interferes with foregut expression patterns only 
around the time of tracheo-oesophageal separation. Once the foregut has failed to divide, 
the gradual re-establishment of the dorsoventral gradient may be of little consequence. A 
study on the Adriamycin rat model of OA/TOF has also suggested that the Shh expression 
pattern may be disturbed but the described pattern differs from my experience. Rather 
than a ventral-to-dorsal switch in Shh expression, it reports uniform expression that 
becomes downregulated only at the point of tracheo-oesophageal separation (Orford et 
al., 2001b). This downregulation is absent in the Adriamycin-treated rat embryos in 
which separation fails. This discrepancy could, perhaps, be explained on the basis of 
species differences. In contrast, a more recent study of the Adriamycin-treated rat reports 
a dorsoventral pattern of foregut Shh expression similar to the pattern described in section
5.2.1 (Arsic et al., 2004). This study also reports that a proportion of Adriamycin-treated 
embryos exhibit a disturbance of this dorsoventral pattern. Further evidence of 
disturbance of Shh signaling in Adriamycin-treated rat embryos is provided by an organ
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culture study in which the tracheo-oesophageal fistula can be induced to branch in 
response to exogenous Shh in contrast to the normal oesophagus (Spilde et al., 2003b). 
Another study in the rat used an ELISA technique to assess the quantity of Shh protein in 
the foregut and found this to be reduced in Adriamycin-treated embryos lacking the 
temporal variation seen in controls (Arsic et al., 2003).
5.3.6 -  Factors underlying the disturbance of Shh expression in Adriamycin-treated 
embryos
Trying to explain the specific developmental effects of a teratogen like Adriamycin would 
be a speculative exercise. The actions of Adriamycin range from interference with the 
function of the cell membrane, mutagenic effects and interference with DNA transcription 
and replication to a general disturbance of cell proliferation (Ross et al., 1978). The effect 
on the Shh expression pattern could be either direct or indirect. A direct effect is unlikely 
as the Adriamycin-treated embryos with abnormal foreguts exhibit more diffuse Shh 
expression in the dorsoventral axis of the foregut. This would require a direct activation 
of the gene by Adriamycin which seems unlikely, although Adriamycin has been shown 
in another context to interfere with transcription in a gene-specific manner (Arai et al., 
2000). Moreover, in this particular case it would be difficult to explain the restriction of 
the effect to the foregut. It should be pointed out, however, that detailed analysis of the 
Shh expression pattern in other organ systems, in the Adriamycin-treated mouse, was not 
performed in the present study, so it is not possible to rule out multi-organ effects of 
Adriamycin on Shh gene expression.
An indirect effect of Adriamycin on Shh expression seems more likely. Adriamycin could 
interfere with the expression of genes that regulate Shh expression. Upregulation of
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activators or downregulation of inhibitors could have the effect of disrupting the fine 
regulation of Shh expression, resulting in a more diffuse pattern across the foregut 
endoderm. Currently, no evidence exists to support this theory. An alternative idea would 
be that the Adriamycin-mediated disruption of Shh expression is the result of a non­
specific effect on the structures adjacent to the developing foregut. One such structure is 
the notochord. As discussed above, it could regulate Shh expression by the secretion of 
proteins that control expression in cells of the foregut endoderm. Due to the proximity 
between the notochord and the foregut, and the fact that both are midline structures, a 
secreted notochordal signal might establish a gradient resulting in a differential effect on 
the endodermal cells along the dorsoventral axis of the foregut. Any disturbance in the 
signal gradient could result in loss of the precise positional information conferred to the 
foregut endoderm and could disturb the spatial pattern of endodermal gene expression. 
The notochordal malformations noted in Adriamycin-treated embryos, which include 
duplication and tethering to the foregut, could provide the basis for a disturbed gradient.
A split notochord can result in a ventral notochord branch that is much closer to the 
foregut than the notochord in control embryos. In one embryo, the Shh signal in the 
ventral branch of the notochord was much stronger than the signal from the dorsally- 
positioned original notochord (Fig. 5.4d inset). The resulting Shh (or other protein) 
gradient would be disturbed, perhaps resulting in failure of Shh downregulation in the 
ventral foregut, a blurring of the dorsoventral boundary and a failure in separation. Other 
studies have argued that Adriamycin disturbs mesenchymal proliferation resulting in 
fewer cells between the notochord and the foregut and consequently a more ventrally 
positioned notochord and a potentially disturbed signal gradient (Orford et al., 2001). The 
variability of the notochordal malformations described in Adriamycin-treated embryos 
would also be consistent with the variable extent of the disturbance in tracheo-
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oesophageal separation. A weakness of the notochord theory, however, is that not all 
Adriamycin-treated embryos with undivided foreguts had malformations of the 
notochord. A possible explanation for this is that the abnormal ventral branches might 
have regressed, as demonstrated in Chapter 3, becoming undetectable just after the 
tracheo-oesophageal malformation was established. A related but distinct explanation is 
that Adriamycin might affect the notochordal signals without disturbing the structure or 
the position of the notochord. These various hypotheses remain to be tested.
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5.4 -  Sum m ary
Given that tracheo-oesophageal separation is disturbed in embryos with a loss of function 
mutation for Shh, I aimed to study the role of Shh in tracheo-oesophageal development 
and the separation process in particular. Shh maintained a dorsoventral pattern of 
expression throughout the period of normal tracheo-oesophageal development. 
Interestingly, there was a complete ventral-to-dorsal switch in Shh expression, which 
started at the level of the lung buds at the caudal limit of the respiratory foregut and 
progressed in a cranial direction just ahead of the process of tracheo-oesophageal 
separation. The expression of genes that are known transcriptional targets of Shh, like the 
transmembrane receptor Ptcl, mirrored that of Shh with expression in the mesoderm also 
exhibiting a ventral-to-dorsal switch. The pattern of distribution of the Shh protein in the 
respiratory foregut broadly followed the ventral-to-dorsal shift pattern but with a slight 
temporal delay compared to the gene expression pattern, perhaps reflecting the fact that 
the Shh expression was changing. The temporal and spatial relationship between the 
process of tracheo-oesophageal separation and this dynamic Shh expression pattern 
suggests that Shh may play an important role in the separation process itself. This 
hypothesis is supported by the observation that disturbance of the precise Shh expression 
pattern is associated with, and may underlie, the failure of tracheo-oesophageal separation 
in Adriamycin-treated embryos.
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CHAPTER 6 -  M e c h a n is m s  o f  t r a c h e o - o e s o p h a g e a l
SEPARATION AND DEVELOPMENT
6.1 -  In t r o d u c t io n
6.1.1 -  Separation mechanisms in development
The reshaping of organs as a result of luminal separation is a common theme in many 
organ-systems during development. Traditionally, this has been associated with a process 
of septation in which the development of a septum completes the separation of the initial 
lumen. Such morphogenetic mechanisms are thought to play a role in the development of 
the hindgut. In this system, septation is thought to contribute to the separation of the 
anorectal and genitourinary tracts (de Vries & Friedland, 1974; O'Rahilly, 1983; Qi et al., 
2000a). The mesenchyme that separates the two tracts is known as the urorectal septum 
but little is known about the mechanisms of its development, although programmed cell 
death has been shown to play a role in separation (Qi et al., 2000a; Qi et al., 2000b). In 
fact, the long held view that growth of this septum actively separates the hindgut is now 
being challenged by studies suggesting that it is a passive structure, simply representing a 
mesenchymal interposition between the two separating tracts (Paidas et al., 1999; Rogers 
et al., 2002). In contrast, septation in cardiac development is widely accepted as 
contributing to the separation of the four chambers and two outflow tracts of the heart 
(Icardo, 1996; Anderson et al., 2003; Moorman et al., 2003). In this system, programmed 
cell death has been shown to play a role in septation, in particular contributing to the 
completion of the process (Cheng et al., 2002; Sharma et al., 2004).
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6.1.2 -  Mechanisms of tracheo-oesophageal separation
The view that the foregut separates as a result of the development of a tracheo- 
oesophageal septum has been long held (Arey, 1966; Gray & Skandalakis, 1972). 
According to this theory, this septum forms when two lateral, ingrowing epithelial ridges 
fuse in the midline and consequently separate the lumen into the ventral trachea and the 
dorsal oesophagus. This process has been described as starting at the level of the lung 
buds and continuing in a cranial direction at the same time as the foregut gains 
significantly in length. Until recently however, there has been no conclusive evidence that 
such a septum exists (Zaw-Tun, 1982; O'Rahilly & Muller, 1984; Kluth et al., 1987). 
Furthermore, the contribution of the epithelial and mesenchymal elements of the foregut 
in its formation, or the specific cellular and molecular mechanisms that might be involved 
in the separation process, have not been studied in any detail. In view of this lack of solid 
evidence, a number of other theories have emerged to account for the development of a 
separate ventral trachea. Separation has been attributed to collapse of the lateral foregut 
walls without the formation of a septum, Kluth has described the role of epithelial folds in 
separation whereas others have suggested that differential growth rather than separation 
accounts for tracheal development (see Chapter 3).
The development of the Adriamycin rat model of OA/TOF has provided the opportunity 
to study the role of cellular and molecular mechanisms in the embryogenesis of the 
malformations but has also prompted a more detailed look at the mechanisms that 
underlie normal tracheo-oesophageal development and separation. Recent studies have 
focused on the role of programmed cell death (PCD) or apoptosis in the separation 
process and tracheo-oesophageal development in general. These studies have shown that 
PCD is detected in large numbers in the approximating lateral epithelial ridges at the
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point of tracheo-oesophageal separation (Qi & Beasley, 1998; Zhou et al., 1999; Williams 
et al., 2000; Orford et al., 2001). They suggested that apoptosis plays a role in 
remodelling and reshaping the separating foregut. These studies have not described any 
PCD activity in the developing foregut at earlier stages of development, or at different 
levels within the developing foregut, suggesting a rather limited role for PCD in 
physically separating and reorganising the dividing foregut. In fact, only one of these 
studies (Williams et al., 2000) specifically comments about lack of PCD in the pre­
separation foregut and the various levels of the foregut during tracheo-oesophageal 
separation, although there was no explanation of how apoptosis was detected. These same 
studies have confirmed that following separation, PCD is rare within the foregut, 
suggesting that it plays a specific role in the process. Moreover, these authors reported 
that Adriamycin-treated rat embryos that develop tracheo-oesophageal malformations 
have a different pattern of foregut PCD. The undivided foregut in these embryos had 
significantly reduced PCD in the region of the lateral ridges and it was suggested that this 
reduction was associated with the development of the malformation (Zhou et al., 1999; 
Williams et al., 2000; Orford et al., 2001). These studies did not address the issue of 
whether the reduction in PCD was a consequence rather than a cause of the failure to 
separate. Analysing the later stages in the abnormal Adriamycin-treated embryos, the 
same studies detected increased PCD in the dorsal mesenchyme of the atretic oesophagus 
(Zhou et al., 1999; Williams et al., 2000; Beasley et al., 2004). It is not clear from these 
accounts what the association is, if any, between this PCD activity and the development 
of the upper oesophageal pouch. Another study has failed to detect significant apoptosis 
in Adriamycin-treated rat embryos in the period immediately after administration of 
Adriamycin, suggesting that its action is not mediated by induction of PCD (Gillick et al., 
2002b). In summary, existing studies have suggested a limited but specific role for PCD
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in tracheo-oesophageal separation, and that reduced levels of PCD are associated with 
failure of separation.
6.1.3 -  Questions about tracheo-oesophageal separation
In previous chapters, I have shown that tracheo-oesophageal development is likely to 
involve an active process of separation of two, already specified, foregut components. In 
this chapter, I aimed to study the mechanisms that contribute to this separation. In view of 
the mechanisms surrounding the notion of a tracheo-oesophageal septum, I have so far 
avoided mention of such a structure. My aim was to study the cellular mechanisms that 
effect this separation and understand its nature. In particular, I wanted to know whether 
programmed cell death was simply a clearing mechanism, finishing off luminal division, 
or whether it had an earlier, regulatory role in the separation process. Furthermore, I 
aimed to study the pattern of cell proliferation within the developing foregut. On one 
hand, this would supplement the PCD data and demonstrate whether apoptosis is simply a 
by-product of increased number of cells within a specific region. On the other hand, it is 
important to correlate morphological observations made in previous chapters with 
proliferation patterns. For example, I have described the development of ingrowing lateral 
epithelial ridges at the site of future tracheo-oesophageal separation. It is important to 
demonstrate whether these ridges are a result of epithelial proliferation or a consequence 
of proliferation of the adjacent mesenchyme. Finally, I wanted to test the hypothesis that 
tracheo-oesophageal separation results from differential growth of the two foregut 
components. Foregut length analysis in Chapter 3 suggested that this was not the case but 
studying levels of proliferation would address this issue directly.
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6.2 -  R e su l ts
6.2.1 -  Programmed cell death (PCD) in the developing foregut
6.2.1.1 - Patterns ofprogrammed cell death during normal foregut development
At El 0.5, the main morphogenetic event in the pharyngeal foregut is the budding of the 
various derivatives of the laterally-placed pharyngeal pouches. The distribution of 
epithelial cells undergoing PCD is precise; they are located at the junction of the 
epithelium of the budding organs and the pharyngeal epithelium (Fig.6.1b). At levels 
where these organs are separated from the pharynx, they are found in the organ 
epithelium. PCD is also associated with midline pharyngeal foregut derivatives. The 
ventral, midline-positioned, thyroid primordium is itself marked by epithelial cells 
undergoing PCD (Fig. 6.1b inset).
The pattern of PCD in the foregut epithelium caudal to the pharynx is dynamic and 
appears to be intimately linked to the process of respiratory development and tracheo- 
oesophageal separation. At E l0.5, the stage at which respiratory tracheal specification has 
already taken place but tracheo-oesophageal separation has not yet started, there are three 
identifiable epithelial PCD patterns at different levels of the foregut. At the cranial end, 
PCD is localised in the ventral epithelium of the laryngotracheal groove in 6 out of 7 
embryos examined (Fig. 6.Id). At more caudal levels, PCD cells are found at the 
dorsoventral junction of the undivided foregut in 5 out of 7 embryos examined (Fig. 6. If). 
When individual sections are studied, a clear pattern emerges with foci of PCD cells 
located at corresponding points of the lateral foregut walls even if in some embryos the 
connecting imaginary line is somewhat oblique. The third level is that of the lung buds at
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Fig. 6.1 PCD patterns in the E l0.5 respiratory foregut (CBA/Ca embryo)
Immunohistochemistry for the PCD effector cleaved Caspase-3 on transverse sections 
from saline-treated (b,d,f,h) and Adriamycin-treated (c,e,g,i) E l0.5 CBA/Ca embryos at 
levels indicated in the schematic representation of the El 0.5 foregut (Fo) in (a).(£,c) At 
the level of the pharynx (Ph), both saline and Adriamycin-treated embryos have apoptotic 
cells at the boundaries of the pharyngeal pouch (Pp) derivatives (arrowheads) and in the 
midline thyroid primordium (arrows, inset). (d,e) At the level of the laryngotracheal 
groove (Lt), both saline and Adriamycin-treated embryos have apoptotic cells almost 
exclusively in the ventral groove epithelium. (f,g) Further caudally, apoptotic cells mark 
the dorsoventral boundary in saline-treated embryos (arrowheads in f). This pattern is 
absent in most Adriamycin-treated embryos which exhibit apoptotic cells at various 
points along the dorsoventral axis of the foregut (arrowhead in g). (h,i) At the level of the 
lung buds (Lb), saline-treated embryos have apoptotic cells at the boundaries of the 
individual buds (arrowheads) with persistence of the cells at the dorsoventral boundary 
(arrow & inset). In Adriamycin-treated embryos, the marking of the lung buds by 
apoptosis is still seen but most embryos lack PCD at the dorsoventral boundary. Scale 
bar, 100 pm
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the caudal end of the respiratory foregut. At that level, PCD cells are organised in two 
different formations. Dorsally, the pattern seen in the more cranial foregut persists with 
foci of PCD cells marking a dorsoventral boundary (Fig. 6.1h). At this level, the pattern 
of PCD cells on opposing foregut walls is maintained. More ventrally, the development of 
the lung buds is associated with another distinct PCD pattern. The junction of the lung 
buds and the rest of the foregut is marked by PCD cells (Fig. 6.1h). Furthermore, a 
concentration of PCD cells are found on the ventral aspect of the foregut at a point 
marking the junction between the left and right lung buds (Fig. 6.1h). In fact there are two 
groups of PCD cells at this location, each one corresponding to the bud/ foregut junction 
of that side (Fig. 6.1h). When viewed in this way, PCD appears to mark the budding of 
the bronchopulmonary primordia on each side of the developing foregut. The pattern 
described above is seen at this level in 6 of the 7 embryos examined.
The El 1.5 timepoint is a key developmental stage for tracheo-oesophageal development. 
At this stage, tracheo-oesophageal separation is in progress, moving in a caudal-to-cranial 
direction from the level of the lung buds. The pattern of PCD has changed from that 
described at El 0.5, reflecting the ongoing separation process. At the cranial end of the, as 
yet, undivided foregut, the pattern is similar to that of El 0.5, with PCD located in the 
ventral epithelium of the laryngotracheal groove (Fig. 6.2b). At more caudal levels of the 
undivided foregut, PCD is now restricted to the dorsal epithelium with near-complete 
absence ventrally (Fig. 6.2c). At this level, cells undergoing PCD appear to be evenly 
distributed in the dorsal epithelium with no obvious convergence on the dorsoventral 
junction. Further caudally, at the point of tracheo-oesophageal separation, the pattern is 
somewhat different. There is still a clear dorsal distribution of PCD and an absence of 
PCD from the ventral epithelium, but there is an obvious increase of dying cells at and
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Fig. 6.2 PCD patterns in the El 1.5 respiratory foregut (CBA/Ca embryo)
Immunohistochemistry for the PCD effector cleaved Caspase-3 on transverse sections (b 
to f) from saline-treated El 1.5 CBA/Ca embryos at levels indicated on the schematic 
representation of the foregut (Fo) in (a), (b) At the level of the laryngotracheal groove 
(Lt), PCD is seen almost exclusively in the ventral epithelium of the groove, (c) Further 
caudally, there is a complete reversal of this pattern with PCD concentrating in the dorsal, 
oesophageal-prospective, epithelium, (d) At the level of tracheo-oesophageal separation, 
PCD persists in the dorsal epithelium but is mostly concentrated in the folding, 
approximating epithelium at the separation site (arrowheads). (e) Caudal to the 
separation, the oesophageal epithelium maintains apoptotic cells with some apoptotic 
cells seen in the dorsal-most part of the separated trachea (Tr) as well as in the 
intervening mesenchyme (arrow), (f) As the level of tracheal bifurcation is approached, 
oesophageal PCD is still detected but is reduced. In contrast, apoptotic cells are 
concentrated in the middle third of the trachea at the site of tracheal bifurcation 
(arrowhead). Oe - oesophagus, Br -  bronchus. Scale bar, 50 pm
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around the point of separation (Fig. 6.2d). Just caudal to the level of separation, PCD 
remains in the dorsal oesophageal epithelium whilst a small number of cells undergoing 
PCD are found in the dorsalmost part of the separated ventral trachea (Fig. 6.2e).
Tracheal PCD disappears, however, a few sections caudal to separation. At the level of 
separation, PCD is also detected in the mesenchyme between the separating structures 
although it is not clear whether these cells are epithelial in origin, representing those 
excluded from the trachea and the oesophagus (Fig. 6.2e).
The PCD pattern in the separated structures was studied in more detail. Oesophageal PCD 
is found consistently in sections immediately caudal to tracheo-oesophageal separation 
whereas it is more sporadic in more caudal sections. This initial persistence of 
oesophageal PCD probably reflects the clear dorsal PCD pattern seen in the undivided 
foregut at this gestation. Similarly, the apoptotic cells in the dorsal trachea seen in 
sections caudal to the separation probably represent PCD on the ventral side of the 
folding epithelial ridges. As the separated structures are followed caudally the pattern 
changes further. Whereas sporadic oesophageal PCD continues, the initial dorsal tracheal 
PCD has disappeared and is now replaced by a consistent pattern of apoptosis in the 
middle third of the trachea as we approach the tracheal bifurcation into the two bronchi 
(Fig.6.2f). This is consistent with PCD marking of the site of tracheal separation.
The fact that the PCD pattern is a dynamic one is underlined by the pattern seen at later 
gestations. By E12.5, the process of tracheo-oesophageal separation is all but completed. 
To emphasise the role of PCD in tracheo-oesophageal separation, the epithelium of the 
oesophagus shows a complete lack of PCD at this stage (Fig. 6.3c-f). In fact this is so 
marked that it gives the impression that the experimental technique may have not worked.
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Fig. 6.3 PCD patterns in the E l2.5/E 13.5 respiratory foregut (CBA/Ca embryo)
Immunohistochemistry for the PCD effector cleaved Caspase-3 on transverse sections 
from saline-treated E12.5 (b-f) and E l3.5 (inset e & f) CBA/Ca embryos at levels shown 
on the schematic representation of the foregut (Fo) in (a). (b) At this level, the 
cranialmost part of the subglottic larynx (La) is about to separate from the oesophagus 
(Oe) in order to complete tracheo-oesophageal separation. PCD cells (arrow) mark the 
point of separation, (c) The separated trachea (Tr) and oesophagus show complete lack of 
PCD in contrast to the high level of apoptosis in the dorsal root ganglia (Drg, inset), (</)
At more caudal levels, closer to the tracheal bifurcation, some tracheal epithelial cells are 
Caspase-3 positive and are mostly concentrated in the middle third of the trachea 
(arrowhead). In contrast, no PCD is seen in the oesophagus. («e) At the level of the 
tracheal bifurcation, PCD cells are found primarily at the separation site (arrowheads), as 
well throughout the tracheal epithelium whilst the oesophagus remains completely 
negative. In contrast, there is no PCD in either the tracheal or oesophageal epithelium at 
the same level in E l3.5 embryos (inset), if) The separated bronchi (Br) maintain Caspase- 
3 positive cells with the oesophagus remaining entirely Caspase-3 negative. At E l3.5, no 
PCD is found in either structure (inset). Scale bar, 50 pm
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However, in the same sections there is clearly high level PCD in the dorsal root ganglia 
validating the complete oesophageal downregulation of cell death (Fig. 6.3c inset). The 
trachea also shows a lack of PCD in its proximal part although PCD is seen in the tracheal 
epithelium just cranial to the tracheal bifurcation into the two bronchi (Fig. 6.3c,d). More 
caudally, at the level of the tracheal bifurcation, there is a marked increase in PCD levels 
(Fig. 6.3e). These cells are concentrated in the middle third of the bifurcating trachea, 
marking the point of separation into the two bronchi (Fig.6.3e). This arrangement is very 
similar to that seen in the El 1.5 foregut, just cranial to the point of tracheo-oesophageal 
separation. In both cases, PCD marks the site of approximating epithelial ridges; in the 
case of the El 1.5 foregut these ridges approximate in the sagittal plane (mediolateral) 
whereas in the case of the El 2.5 trachea they approximate in the coronal plane 
(ventrodorsal). Further caudally, PCD persists in the separated bronchi (Fig. 6.3f). At 
these levels, there is complete absence of PCD in the oesophagus in sharp contrast to the 
trachea and bronchi (Fig. 6.3c-f). Apoptosis is also found at the cranial limit of the 
respiratory foregut. PCD is found at the point of separation of the cranial-most part of the 
laryngotrachea from the oesophagus (Fig. 6.3b). Cranial to that level, the development of 
the supraglottic larynx is still ongoing with active growth of the arytenoid swellings, the 
fusion of which will define the entrance to the airway (laryngeal aditus). The epithelium 
of the arytenoid swellings exhibits PCD.
By E l3.5, PCD in the foregut has all but disappeared. Specifically, there is absence of 
PCD in the trachea and bronchi suggesting that the process of tracheal bifurcation and 
shaping of the carina has been completed (Fig. 6.3e,f insets). PCD continues to be totally 
absent from the oesophagus (Fig. 6.3e,f insets). The lack of PCD is validated by the fact 
that significant apoptosis persists in the dorsal root ganglia in the same sections making it
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unlikely that this is a result of experimental error. Overall, these observations indicate that 
if PCD does indeed play a role in the development of the respiratory foregut, this is 
completed by E l3.5.
6.2.1.2 - Quantitation o f PCD
The epithelial cells undergoing PCD at any given time are only a small proportion of the 
total epithelial population and are found at variable positions in the foregut. This 
introduces a degree of subjective interpretation when the PCD patterns are described. I 
reasoned that in order to substantiate and confirm the descriptive patterns of apoptosis in 
the developing foregut (described in the previous section) it would be important to 
quantify PCD in standardised segments of the foregut (dorsal or ventral) at various levels 
along its anteroposterior axis. This quantitation also supplements the patterns already 
described. It assesses the actual intensity of PCD and allows objective comparisons of 
PCD in different parts of the foregut, as well as with the corresponding mitotic activity in 
specific regions. In order to quantify PCD, the proportion of cells that stained positive for 
caspase-3 in a defined part of the foregut was calculated. This proportion represents the 
apoptotic index for that particular part of the foregut. I chose to calculate the apoptotic 
index at cranio-caudal levels that were relevant to the PCD patterns described above.
Defining the levels for the study of the apoptotic index
For the El 1.5 foregut, I chose to study PCD patterns at various levels cranial to the level 
of separation as well as at levels of the separated trachea and oesophagus (Fig. 6.4). For 
each embryo, the specific section that corresponded to the specified level was studied for 
apoptotic activity. Levels one and five corresponded to the cranial limit of the 
laryngotracheal groove and the tracheo-oesophageal separation, respectively, whereas
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Fig. 6.4 PCD patterns in the El 1.5 respiratory foregut (CBA/Ca embryo)
Immunohistochemistry for the PCD effector Caspase-3 on transverse sections from 
saline-treated El 1.5 CBA/Ca embryos. The level of PCD activity in the foregut 
epithelium was determined by calculating the PCD (or apoptotic) index for a specified 
region of the epithelium as defined below. The index was the proportion of epithelial cells 
that stained positive for the anti caspase-3 antibody. The schematic representation of the 
El 1.5 foregut (Fo) indicates the cranio-caudal levels studied for PCD. Level 1 is the level 
of the laryngotracheal groove (Lt), level 5 that of the tracheo-oesophageal separation and 
levels 2,3 and 4 are evenly spaced between 1 and 5. Level 7 is the level of the tracheal 
bifurcation and level 6 is at a quarter of the distance between 5 and 7. The foregut at level 
1 is divided into two equal parts (dorsal and ventral). The foregut at levels 2 to 5 is also 
divided in dorsal and ventral parts but the dorsal one is subdivided into middle and 
dorsalmost segments. Sections from level 7 show the widened trachea (Tr) at the level of 
its bifurcation into the bronchi (carina). The trachea is divided into three equal parts: two 
lateral and one middle segments. Oe - oesophagus, Br -  bronchus. Scale bar, 50 pm
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levels two to four were equally spaced out between them as shown in Fig.6.4. The 
examination of the foregut at levels 1 to 5 would therefore identify the intensity of PCD 
related to the process of tracheo-oesophageal separation in view of the caudocranial 
progression of this process. Studying PCD at more caudal levels might reveal whether 
such patterns persisted after separation and whether tracheal separation into the two 
bronchi also had associated apoptotic patterns. Level seven corresponded to the level of 
tracheal separation whereas level six was at a quarter of the distance from five to seven. 
Level six was chosen in order to pick up persistence of the pre-separation pattern in the 
proximal trachea and oesophagus.
Defining the dorsoventral segments for the study of the apoptotic index 
The selection of the foregut segments to be studied at the individual levels also reflected 
the patterns already described and the possible role of PCD in tracheo-oesophageal 
separation. The gastrointestinal/ respiratory boundary coincides with the dorsoventral 
boundary of expression of Nkx2.1 and Shh. This dorsoventral boundary is clearly 
identifiable morphologically by the presence of epithelial folds. In the majority of 
embryos, the dorsoventral boundary does not correspond to the midway point on the 
dorsoventral axis; it is closer to the dorsal limit of the foregut. For this reason, and at the 
levels most relevant to tracheo-oesophageal separation (2 to 5), I divided the foregut into 
a ventral half and two equal dorsal parts, with the middle dorsal one corresponding to the 
dorsoventral boundary (Fig. 6.4). This division also applied to the study of patterns of 
mitosis (see below). For level 1, the foregut was divided into equal dorsal and ventral 
components as PCD activity appears to be concentrated in the ventral laryngotracheal 
groove. For level 7, the separating trachea has a different shape being more flat 
ventrodorsally. It was divided into three equal segments: one medial segment flanked by
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two lateral segments, as shown in Fig.4. The middle part corresponds to the site of 
separation of the trachea into the two bronchi.
Data analysis
The variation in the values of the apoptotic index suggests that there is a clear shift in 
apoptosis from the ventral to the dorsal epithelium as the level of separation is 
approached (Table 6.1, Fig.5). The level of apoptosis in the ventral half of level 1, which 
corresponds with cell death in the laryngotracheal groove, is high with up to 25% of cells 
undergoing PCD (Fig. 6.5a). The ventral index for this level is significantly higher than 
the ventral index for levels 3, 4 and 5 (p values of 0.003, 0.004 and 0.003). This suggests 
that there is very little PCD in the ventral epithelium caudal to the laryngotracheal 
groove. Conversely, there is significant increase in apoptotic activity in the dorsal half of 
the foregut {please note that for this calculation the two dorsal segments were pooled 
together as the dorsal half o f the foregut) in levels 4 and 5 compared to levels 1 and 2 (p 
values of 0.003, 0.002, 0.004 and 0.004). At level 5, as many as 30% of dorsal epithelial 
cells are undergoing PCD. To emphasise the dorsoventral divide in PCD activity, the 
difference in the PCD index between the dorsal and ventral segments of the foregut at 
levels 1,4 and 5 also reaches statistical significance (p values of 0.01, 0.0001 and 0.002). 
In order to study PCD in the zone of tracheo-oesophageal separation, the middle section 
was studied separately. The index for the middle section remains low along the foregut, 
rising sharply at level 4 and peaking at level 5 at which up to 32% of epithelial cells are 
undergoing PCD (Fig.5c). This observation is consistent with a specific role of PCD at 
the level of tracheo-oesophageal separation. The difference is significant between levels 3 
to 4 and 4 to 5 (p values of 0.02 for both comparisons), confirming the trend as the 
separation point is approached. However, the overall rise in dorsal PCD as we move from
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cranial to caudal is not solely attributable to the gradual increase in middle segment cell 
death. A significant increase in PCD in the dorsal-most segment between levels 2 and 3 ip 
= 0.03) occurs before there is any demonstrable increase in the region of future separation 
(middle segment) (Fig. 6.5b). At level 3, the dorsal-most PCD index is significantly 
higher than both the middle and ventral indices (p values of 0.04 and 0.01). PCD in this 
dorsal segment remains high in levels 4 and 5. In summary, these observations suggest 
there are two main characteristics in the PCD pattern in the El 1.5 foregut. The first is the 
shift of apoptotic cells to the dorsal foregut and the second is the concentration of 
apoptotic cells at the point of separation.
At level 6, which is nearer the tracheo-oesophageal separation than the tracheal 
bifurcation, there is significantly more PCD in the oesophagus than the trachea (p=0.01) 
(Fig. 6.5a). This appears to represent a persistence of the pattern cranial to the separation 
with dorsal PCD persisting in the oesophagus and a low level of tracheal PCD being 
contributed to by the ventral portion of the pre-separation middle segment (Fig. 6.4L5). 
This pattern changes in more caudal sections of the trachea and oesophagus as these 
structures grow and as the level of tracheal separation is approached. Oesophageal PCD 
falls significantly between levels 6 and 7 (p=0.03) (Fig. 6.5a) whereas the tracheal PCD 
becomes redistributed and is found almost exclusively in the middle part of the separating 
trachea (Fig. 6.5c). At level 7, middle segment tracheal PCD is significantly higher than 
both lateral tracheal segment and oesophageal PCD (p values of 0.008 and 0.01) with 
20% (mean) of cells undergoing PCD in the middle segment. This observation would 
support a role for PCD in the development of the point of tracheal bifurcation.
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Table 6.1. PCD patterns in the E ll .5 respiratory foregut (CBA/Ca embryo)
PCD cells
Mean (Standard deviation)
Total cells PCD index (%)
Level 1 (n=5) Dorsal half 3.8 (2.2) 90.8(16.1) 4.2 (2)
Ventral half 12(12.1) 70.2 (40.8) 14.2 (6.5)
Level 2 (n=5) Dorsal half 3.2 (2.8) 94.6 (28.1) 3.4 (2.4)
Dorsal-most 1.8 (1.5) 47.4 (12.5) 3.9 (3.1)
Middle 1.4 (2.1) 47.2 (21.5) 2.5 (2.8)
Ventral half 2.6 (3.7) 48.2 (14.9) 4.9 (5.4)
Level 3 (n=6) Dorsal half 8.5 (6.8) 87.3 (19) 9.3 (5.5)
Dorsal-most 6.7 (5.5) 45.3 (7.4) 15.2 (9.5)
Middle 1.8 (2.3) 44.3(11.1) 3.7 (4.7)
Ventral half 3(4.1) 77.8 (42.2) 2.6 (3.1)
Level 4 (n=6) Dorsal half 13 (4.4) 116.2 (24.5) 11.4 (3.7)
Dorsal-most 6(3.2) 55.8 (13.4) 8.4 (6.2)
Middle 7 (3.4) 60.3(15.1) 11.5 (4.8)
Ventral half 1 (1.26) 109 (26.6) 0.8(1)
Level 5 (n=6) Dorsal half 17.7 (6.3) 101.8 (21) 18 (8.3)
Dorsal-most 5.5 (4.7) 45.2 (10.2) 12.9(11.7)
Middle 11.8(3.5) 56.7 (12.9) 21.6 (7.8)
Ventral half 3.7 (1.5) 105.8 (29.6) 3.5 (1.5)
Level 6 (n=6) Oesophagus 6.8 (3.6) 46.8 (8.7) 14.5 (7.4)
Trachea 4.3 (3.3) 93.3(18.5) 4.5 (3.1)
Level 7 (n=5) Oesophagus 0.8 (1.3) 17.8 (3.8) 3.8 (6)
Trachea 6.4 (2.5) 99.4(18.9) 6.6 (2.9)
Trachea middle 6(2.3) 32.6(12.1) 20 (9.8)
Trachea lateral 0.2 (0.3) 33.6 (3.8) 0.6 (0.9)
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Fig. 6.5 PCD quantitation in the El 1.5 foregut (CBA/Ca embryo)
Apoptotic index of the foregut epithelium at different levels of the El 1.5 foregut. Levels 
and segments are those defined in Fig. 4. (a,b,c) Vertical box plots with error bars 
defining the median, 10th, 25th, 75th and 90th percentile values. All outlying values are 
represented by individual dots, (a) In this analysis, the middle and dorsal segments in 
levels 2 to 5 are merged into one dorsal segment. This figure illustrates a ventral-to-dorsal 
shift in PCD activity as we move caudally towards the level of tracheo-oesophageal 
separation. Ventral PCD at level 1 is significantly higher than ventral PCD at levels 3,4 
and 5 (p values of 0.003, 0.004 and 0.003). Conversely, dorsal PCD at levels 4 and 5 is 
significantly higher than dorsal PCD at levels 1 and 2 (p values of 0.003, 0.002, 0.004 and 
0.004). Oesophageal PCD does, however, fall significantly between levels 6 and 7 
(p=0.03). At levels 1,4,5 and 6 there is a significant difference between ventral and dorsal 
PCD (p values of 0.01, 0.0001, 0.002 and 0.01). (A) Apoptosis at the level of the tracheal 
bifurcation (level 7) in different segments of the trachea as defined in Fig 4. The index 
for the middle tracheal portion (TR/Md) is significantly higher than that for the lateral 
tracheal segments (TR/Lt) or the oesophagus (p values of 0.008 and 0.01). (c) This plot 
illustrates the sharp rise in middle segment PCD as the level of tracheo-oesophageal 
separation is approached. The index at level 4 is significantly higher than that at level 3 
(p=0.02) and that for level 5 is significantly higher than that for level 4 (p=0.02). The 
index for the dorsalmost segment at level 3 is significantly higher than the middle and 
ventral indices for the same level {p values of 0.04 and 0.01) as well as significantly 
higher than the dorsalmost index for level 2 (p=0.03).
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6.2.1.3 - Patterns o f  PCD in models o f  abnormal tracheo-oesophageal development
PCD in the foregut of Adriamycin-treated embryos
The analysis of PCD patterns in Adriamycin-treated El 0.5 embryos is complicated by the 
fact that all treated embryos at this stage share the same morphology. As discussed in 
previous chapters, the foregut at this stage is still normally undivided in CBA/Ca 
embryos. A proportion of El 0.5 Adriamycin-treated embryos subsequently fail to divide 
their trachea and oesophagus whilst others undergo normal tracheo-oesophageal 
separation. Consequently, if PCD is related to tracheo-oesophageal separation, contrasting 
PCD patterns might be expected within a group of morphologically indistinguishable 
E l0.5 Adriamycin-treated embryos.
At the level of the pharynx, PCD marks the boundary between pharyngeal epithelium and 
the epithelium of pharyngeal pouch derivatives (Fig. 6.1c). In the same sections, PCD is 
seen at the site of the midline thyroid primordium (Fig. 6.1c inset). This pattern was seen 
in 6 out of 6 Adriamycin-treated embryos examined. Further caudally, PCD was seen in 
the ventral epithelium of the laryngotracheal groove (as also seen in saline-control 
embryos) in 4 out of 6 embryos examined (Fig. 6.1e). Caudal to the laryngotracheal 
groove, only one out of six Adriamycin-treated embryos exhibited the pattern of PCD 
clusters marking the dorsoventral boundary. In contrast, this PCD localisation was seen in 
5 out of 7 saline-control embryos. Embryos were judged to exhibit this pattern if 
apoptotic cells were found at equivalent points on opposite sides of the lateral foregut 
wall in consecutive sections. Instead, at this level, in Adriamycin-treated embryos, there 
were individual apoptotic cells at seemingly random points along the foregut dorsoventral 
axis (Fig. 6.1 g). At the level of the emergence of the lung buds, all six Adriamycin-
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Fig. 6.6 PCD patterns in affected Adriamycin-treated El 1.5 CBA/Ca embryos
PCD patterns are disturbed in Adriamycin-treated embryos in which tracheo-oesophageal 
separation has failed. Immunohistochemistry for the PCD effector cleaved Caspase-3 on 
transverse sections of Adriamycin-treated El 1.5 CBA/Ca embryos. Sections are from 
increasingly caudal levels with (a) at the level of the laryngotracheal groove (Lt) and (d) 
at the level of the lung buds (Lb), (a) At the level of the laryngotracheal groove, PCD 
distribution is comparable to saline control embryos (see Fig. 6.2b) with apoptosis in the 
ventral epithelium of the groove, (b) At more caudal levels, the dorsal PCD shift seen in 
normal development (Fig. 2c,d) is absent and clusters of apoptotic cells are found at 
various points along the dorsoventral axis of the foregut (arrowheads, inset -  separate 
embryo), (c) As the level of the lung buds is approached, apoptosis appears to be 
restricted to the dorsal-most part of the undivided oesophagotrachea (Oet). (d) At the 
level of the lung buds, the undivided foregut ends in a trifurcation of two buds and the 
fistula (Fi) to the stomach. At this level, epithelial PCD is found at the lung bud 
boundaries (arrow). A concentration of apoptotic cells is also found in the mesenchyme, 
dorsal to the undivided foregut and appears to be associated with an area of mesenchymal 
cell condensation (arrowhead). Scale bar, 50 pm
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treated embryos exhibited a ventral PCD pattern similar to that seen in saline-control 
embryos with the lung buds being marked out by apoptotic cells (Fig. 6.li). In contrast, 
only two out of six embryos examined had PCD in the dorsal foregut in a pattern similar 
to control embryos (Fig. 6.1h). As I have speculated above, these clusters may represent 
the caudal-most limit of the dorsoventral boundary. In summary, the aspect of PCD 
patterning affected by Adriamycin exposure appears to be the marking of the dorsoventral 
boundary, with the lung bud and pharyngeal patterns seemingly unaffected.
Adriamycin-treated embryos at El 1.5 broadly fall into two groups; those that are 
morphologically indistinguishable from saline-treated control embryos and those in which 
tracheo-oesophageal separation has failed. The PCD pattern in the former group (data not 
shown) is very similar to the pattern seen in saline-treated controls. In the anterior foregut, 
apoptotic cells are found ventrally, in the laryngotracheal groove. More caudally, they are 
found in the dorsal foregut and become concentrated in the approximating epithelial folds 
immediately cranial to the level of tracheo-oesophageal separation. At more caudal levels, 
some apoptotic cells persist in the separated oesophagus with the trachea showing 
increased levels of PCD in its medial third immediately cranial to the level of bifurcation 
of the trachea into the two main bronchi.
In contrast, the pattern in Adriamycin-treated embryos that have an undivided foregut is 
disturbed compared to saline-treated control embryos and to Adriamycin-treated embryos 
with normal tracheo-oesophageal separation. PCD is still visible in the foregut but its 
spatial distribution is different. At the cranial end of the respiratory foregut, PCD is seen 
in the ventral epithelium of the laryngotracheal groove in a pattern similar to controls 
(Fig. 6.6a). Further caudally, no clear dorsal shift of apoptotic cells is seen but rather 
occasional PCD clusters are found at various points along the dorsoventral foregut axis
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(Fig. 6.6b). Direct, level to level comparison is difficult between the undivided 
Adriamycin-treated foregut and the divided foregut of saline-treated controls due to the 
lack of a tracheo-oesophageal separation point to be used as a reference and this 
limitation has to be taken into account when interpreting the more caudal patterns. Further 
caudally, the most striking feature in the undivided foregut is the lack of PCD in the 
middle segment (as defined for quantitative analysis) (Fig. 6.6c). In contrast, there is a 
concentration of PCD clusters in the dorsal-most foregut epithelium that persists almost to 
the level of the trifurcation or proximal fistula formation (Fig. 6.6c). In embryos that have 
a proximal fistula originating from the foregut above the level of the lung buds, this 
cluster appears to be associated with the origin of the fistula. Another concentration of 
apoptotic cells is also seen in the mesenchyme dorsal to the undivided foregut (Fig. 6.6d). 
This cluster is associated with a distinct arrangement of mesenchymal cells I have already 
noted in Chapter 1. This arrangement consists of cells in concentric circles strongly 
resembling a structure whose lumen has become obliterated. The PCD clusters in the 
dorsal-most foregut epithelium and the dorsal mesenchyme do not appear to be related to 
one another. At the level of the trifurcation, PCD cells are found at the junction of the 
lung buds and the foregut. This pattern is very similar to the El 0.5 PCD pattern of control 
embryos at the level of the physiological trifurcation. In summary, the disturbance in 
PCD pattern in Adriamycin-treated embryos with defective tracheo-oesophageal 
separation mainly affects the ‘marking’ of the dorsoventral boundary within the foregut.
PCD in the foregut of Shh'1' embryos
Analysis of PCD patterns in all embryos with the Shh background is complicated by the 
discrepancy in developmental stages with the CBA/Ca mice as described in previous 
chapters. The key gestation for the Shh mice, in terms of tracheo-oesophageal
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Fig. 6.7 PCD patterns in the foregut of El 0.5 Shh null-mutant embryos
PCD patterns are disturbed in the foregut of Shh null mutant embryos. 
Immunohistochemistry for the PCD effector cleaved Caspase-3 on transverse sections of 
El 0.5 Shh null embryos taken at levels indicated in the schematic representation of the 
foregut (Fo) in (a). (A) The narrow, post-pharyngeal undivided foregut has no significant 
PCD in sharp contrast to the high levels of apoptosis in the ganglion-like structures in the 
dorsal mesenchyme, (c) At the level of emergence of the lung buds (Lb), the undivided 
foregut ends in a trifurcation of a fistula (Fi) and two, abnormally fused, buds. Apoptosis 
is absent from the foregut at this level in sharp contrast to the significant apoptotic 
activity seen in the neural tube (arrow, inset). Scale bar, 50 pm
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development, is E l0.5. This is roughly equivalent to El 1 for the CBA/Ca strain and at 
this stage tracheo-oesophageal separation has started and is proceeding in a cranial 
direction. The PCD pattern in the E l0.5 homozygous mutants was contrasted with that of 
E l0.5 wild type embryos from Shh litters {pooled Shh+/+ +/~ embryos). The PCD pattern 
of E10.5 wild type embryos is very similar to that seen in the El 1.5 CBA/Ca embryos. At 
the cranial level, PCD is seen ventrally in the epithelium of the laryngotracheal groove. 
More caudally there is a shift of apoptotic cells to the dorsal epithelium and the 
dorsoventral boundary and PCD persists in the separated oesophagus. As discussed in 
Chapter 3, the foregut in homozygous Shh mutant embryos fails to divide. In addition to 
this failure of separation, the mutant foregut is morphologically different from that of the 
wild type in that its lumen is significantly narrower, especially in its middle part.
In Shh'1' embryos, foregut PCD is not abolished but is represented by occasional apoptotic 
cells or PCD clusters appearing at seemingly random points along the dorsoventral 
foregut axis. This bears no resemblance to the specific pattern seen in wild type embryos. 
Furthermore, although not abolished, foregut PCD appears markedly reduced, especially 
in view of the excess apoptotic cell death seen in other parts of the ailing Shh'1' embryos 
(Fig. 6.7b). Further caudally, the undivided foregut in null mutant embryos ends in a 
trifurcation of two fused bronchopulmonary buds and a fistula to the stomach. At this 
level, there are no PCD clusters marking the boundary between the foregut and the 
bronchopulmonary buds, nor are there apoptotic cells marking the boundary between the 
two buds (Fig. 6.7c). This contrasts not only with the pattern seen in wild type embryos 
and CBA/Ca saline-treated controls (at E l0.5) but also with Adriamycin-treated CBA/Ca 
embryos. This probably reflects the extent of foregut malformations in the null mutant 
embryos; apart from the failure of tracheo-oesophageal separation, bronchopulmonary
250
development is also markedly abnormal with persistent lung fusion and persistent 
communication between the fused lung structures and the distal oesophagus/ fistula.
6.2.2 -  Cell proliferation in the developing foregut
6.2.2.1 - Patterns o f mitosis during normal foregut development 
Proliferation was studied by looking at the level of mitotic activity, both in the foregut 
epithelium and mesenchyme. I calculated the percentage of cells staining positive for the 
mitotic marker phosphohistone H3 (i.e. the mitotic index).
Defining the anatomical levels for the study of mitotic index
I collected data for calculation of mitotic index from one section at each of four levels of 
the E10.5 foregut (Fig. 6.8) and seven levels of the El 1.5 foregut (Fig. 6.9). At E10.5, the 
most cranial level was that of the laryngotracheal groove and the most caudal level was 
that of the lung buds. Two more intermediate levels were placed at regular intervals, 
according to number of sections and about 60 to 70 micrometres apart, along the 
anteroposterior axis of the foregut. . The inclusion of
an additional intermediate level, compared to the PCD study, aimed to enhance the 
comparison between ventral and dorsal mitosis at E l0.5. At El 1.5, mitotic index data 
were collected at seven levels along the anteroposterior axis of the respiratory foregut 
(Fig. 6.9). Five of the seven levels used in the mitotic index study were the same as those 
used for the study of the apoptotic index. This allowed for direct comparison between 
mitotic and apoptotic activity for those levels. The difference in two of the levels reflects 
the fact that the two experiments address somewhat different aspects of tracheo- 
oesophageal development. The levels for the mitotic study were more evenly spaced 
along the AP axis of the respiratory foregut whereas more levels were studied for
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apoptosis cranial to the point of separation, reflecting the dynamic nature of the PCD 
pattern in this part of the foregut.
Defining the dorsoventral segments for the study of mitotic index 
At El 0.5,1 aimed to test the hypothesis that the respiratory part of the foregut has a 
higher rate of proliferation than the gastrointestinal part. Such a difference could account 
for the development of the trachea as a separate structure from the oesophagus (as 
discussed in Chapter 3). At each level, the foregut epithelium was divided for analysis 
into dorsal and ventral parts. At levels 1,2 and 3, this distinction corresponded to the 
dorsal and ventral halves of the foregut whereas at level 4, the ventral part comprised the 
lung buds (Fig. 6.8). At E l0.5, the gastrointestinal/ respiratory boundary in the foregut 
roughly corresponded to the midway point along the dorsoventral axis. As there are no 
morphological pointers to this boundary at this gestation (no waist), the separate analysis 
of two dorsoventral halves of the foregut (for levels 1-3) appeared to be a satisfactory 
method of study.
At the El 1.5 stage, I wanted to investigate whether differential epithelial proliferation 
contributes to tracheo-oesophageal separation. Specifically, I wanted to test the 
hypothesis that epithelial proliferation contributes to the appearance of the ingrowing 
epithelial ridges seen at levels cranial to the separation. For this reason, the foregut was 
divided for analysis into equal ventral and dorsal parts and the dorsal part was subdivided 
into two equal parts (as for the study of PCD) (Fig. 6.9). The middle part corresponded to 
the site of tracheo-oesophageal separation in the vast majority of sections (see PCD 
section). At the same levels (2&3), I also wanted to study the role of the mesenchyme in 
tracheo-oesophageal separation. I wanted to test the hypothesis that extrinsic
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Fig. 6.8 Mitotic activity in the foregut of El 0.5 CBA/Ca embryos
Immunohistochemistry for the mitosis marker phosphohistone H3 on transverse sections 
of El 0.5 untreated CBA/Ca embryos. Note that epithelial cells that are H3-positive are 
easily identifiable in these sections. The mitotic index represents the proportion of cells in 
a specified part of the epithelium that are H3-positive. The schematic representation of 
the E l0.5 foregut (Fo) indicates the levels at which sections were studied in order to 
calculate the epithelial mitotic index. Level 1 is at the level of the laryngotracheal groove 
(Lt), level 4 at the level of the emerging lung buds (Lb) and levels 2 and 3 are evenly 
spaced between the two. For levels 1 to 3, the mitotic index was calculated for equal 
dorsal and ventral segments whereas at level 4, the ventral segment comprised the lung 
buds, (the oblique dividing line reflects the lung bud arrangement in this particular 
section) Scale bar, 100 pm
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Fig. 6.9 Mitotic activity in the foregut of El 1.5 CBA/Ca embryos
Immunohistochemistry for the mitosis marker phosphohistone H3 on transverse sections 
of El 1.5 untreated CBA/Ca embryos. Note that epithelial and mesenchymal cells that are 
H3-positive are easily identifiable in these sections. The mitotic index represents the 
proportion of cells in a specified part of the epithelium or mesenchyme that are Ex­
positive. Schematic representation of the El 1.5 foregut (Fo) indicates the levels at which 
sections were studied to calculate the epithelial and mesenchymal mitotic index. Level 1 
is at the laryngotracheal groove (Lt), level 3 at the tracheo-oesophageal separation and 
level 2 is intermediate. Level 6 is at the tracheal bifurcation, level 5 is intermediate 
between 3 and 6 and level 4 is intermediate between 3 and 5. Finally, level 7 corresponds 
to the level of the separated bronchi (Br) and oesophagus (Oe). For the, as yet, undivided 
foregut (levels 1-3), the sections were subdivided as for the study of PCD with ventral 
and dorsal halves for level 1 and one ventral segment and two dorsal (one middle and one 
dorsalmost) segments for levels 2 and 3. For the calculation of the mitotic index in the 
bronchopulmonary buds (level 7), the average of the two buds was used. The surrounding 
mesenchyme was subdivided accordingly, with the width of each mesenchymal area 
corresponding to the width of the foregut as indicated by the shaded areas at level 3 (same 
principle applied to level 2). The dorsoventral division of the mesenchyme corresponds 
exactly to that used for the epithelial calculation. Tr -  trachea. Scale bar, 50 pm
255
Fo
Oe'
L1
L2
L3
L4
L5
L6
L7
L4
h£
LI
Lt
L7
Oe /
^  * y
t
#• •  *  J j .  . I i1
■ •  *  £ l ♦
*
' Br~ 
D r  ?
**•
mesenchymal pressure, specifically at the dorsoventral boundary of the foregut, 
contributes to epithelial folding and separation. I studied the mitotic index in a defined 
area of the mesenchyme adjacent to the foregut. The width of this area on either side of 
the foregut corresponded to the width of the foregut itself and the mesenchymal area was 
subdivided for analysis into two dorsal and one ventral part, precisely corresponding to 
the epithelial division (Fig. 6.9). For levels 4 to 7 ,1 compared the mitotic index between 
the separated dorsal (gastrointestinal) and ventral (respiratory) structures (Fig. 6.9).
Data analysis
At E l0.5, the mean mitotic index ranged from 7% to 14 % with no statistically significant 
differences between the ventral and dorsal halves of the foregut at all levels studied 
(Table 6.2, Fig. 6.10). Furthermore, comparison between ventral mitosis at the level of 
the lung buds with ventral mitosis at the other levels does not reveal significant 
differences. This observation is inconsistent with the notion of the ventral foregut 
growing at a higher rate resulting in the trachea developing as a separate structure. The 
dorsal mitotic index is also comparable at the four levels with no significant difference 
detected.
At El 1.5, analysis of the levels of mitosis in the separated respiratory and gastrointestinal 
structures reveals that this is increased compared to the corresponding sections of the 
undivided foregut (Table 6.3, Fig. 6.1 la). The mitotic index at levels 6 and 7 is as high as 
42% for the oesophagus and as high as 36% and 38% for the trachea and bronchi. The 
respiratory mitotic index is significantly higher at levels 6 and 7 compared to level 2 (p 
values of 0.002 and 0.02 respectively) and significantly higher at level 6 compared to 
level 1 (p=0.02). The dorsal mitotic index at levels 6 and 7 is significantly higher than the 
index at both level 1 (p values of 0.002 and 0.007 respectively) and level 2 {p values of
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0.002 and 0.007 respectively). On the other hand, there is no significant difference in 
mitotic index between the trachea/ bronchi and the oesophagus, or between the ventral 
and dorsal halves of the undivided foregut, at any of the levels studied (Fig. 6.1 la). These 
observations suggest that following separation, increased proliferation could account for 
the rapid longitudinal growth of both the trachea and the oesophagus, although the two 
structures appear to grow at comparable rates. Mitosis in the middle foregut section at 
levels 2 and 3 (undivided) is not significantly different from either the dorsal-most or 
ventral sections (Table 6.3, Fig. 6.1 lb). This suggests that localised peaks of proliferation 
are unlikely to account for the infolding epithelium at the site of future tracheo- 
oesophageal separation. However, mitotic index in the middle section was significantly 
greater at the level of separation (level 3) compared to level 2 (p=0.049). This could 
reflect the general trend of increase in epithelial proliferation at increasingly posterior 
levels (Fig. 6.11a).
The study of mesenchymal proliferation revealed no significant differences between the 
index for the middle segment and either the dorsal-most or ventral parts at both levels 2 
and 3 (Table 6.3, Fig. 6.12). This observation does not support the notion that 
differential mesenchymal proliferation could account for the change in the configuration 
of the foregut (infolding/ waist formation) at the different levels. The mesenchymal 
mitotic index is, however, significantly increased in the middle segment at level 3 
compared to level 2 (p=0.045), mirroring the epithelial proliferation for that segment.
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Table 6.2. Numbers of mitotic (H3 positive cells), total cells and mitotic index in the 
normal E l0.5 CBA/Ca foregut
Mean (Standard deviation)
H3-positive cells Total cells Mitotic index (%)
Level 1 (n=9) Dorsal
Ventral
7.2 (4.5) 
9.1 (2.8)
58.7(13.9) 
74.7 (16.8)
13.7(11.9) 
13.0 (5.6)
Level 2 (n=9) Dorsal 5.9 (3.4) 65.8 (14.7) 9.5 (6.2)
Ventral 5.7 (3.4) 72.8 (20.6) 8.6 (6.8)
Level 3 (n=9) Dorsal 5.6 (2.9) 70.8(15.5) 7.2 (3.4)
Ventral 10.0 (4.6) 109.1 (20.1) 8.3 (2.3)
Level 4 (n=8) Dorsal 7.0 (3.2) 78.5 (29.2) 10.3 (5.1)
Ventral 11.1 (3.2) 122.5 (28.6) 10.2 (3.7)
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Table 6.3. Levels of mitosis (H3 positive cells) in the normal El 1.5 CBA/Ca foregut
Mean (Standard Deviation)
H3-positive cells Total cells Mitotic index (%)
Level 1 Epithelium Dorsal half 6.1 (3.3) 72.5 (26) 8.6 (4.1)
(n=10) Ventral half 7.3 (10) 68.2 (27.8) 9(7.5)
Level 2 Epithelium Dorsal half 5.6 (4) 92.5 (18.1) 6.6 95.8)
(n=10) Dorsal-most 3.1 (2.5) 45.7(11.8) 7.5 (7.1)
Middle 2.5 (1.6) 45.8 (8.1) 5.7 (4.8)
Ventral half 4.6 (3) 80.1 (21) 6.7 (5.8)
Mesenchyme Dorsal-most 5 (3.6) 82.2 (31.1) 7.2 (5.3)
Middle 5.9 (5.7) 110.1 (56) 5 94.2)
Ventral half 16.3 (12.2) 273.9 (129.4) 5.7 (2.3)
Level 3 Epithelium Dorsal half 13.1 (10.1) 102.2 (21.9) 12.9 (8.5)
(n=10) Dorsal-most 6.8 (5) 53 (16.6) 13.1 (9.5)
Middle 6.5 (5.4) 48.2 (9.1) 12.9 (9)
Ventral half 11.8(9.6) 97.3 (31.8) 11.5(6.7)
Mesenchyme Dorsal-most 5.8 (4.6) 104.9 (46.3) 6.3 (5.6)
Middle 9.2 (5.3) 104.6 (40.1) 9.7 (7.2)
Ventral half 18.2(13.3) 277.2 (103.3) 6.1(3)
Level 4 Epithelium Oesophagus 9.4(5) 55.6(15.6) 18.1 (9.3)
Trachea 9.8 (4.3) 83.3 (46.7) 13.8 (8.3)
Level 5 Epithelium Oesophagus 7.7 (3.5) 52.3 (14.6) 14.7 (5.4)
Trachea 8.5 (5.4) 70.8(18.1) 11.6 (6)
Level 6 Epithelium Oesophagus 4.4 (1.4) 21.5(8.3) 22.4(10.6)
Trachea 15.5(10.2) 78.2 (21.5) 20.4(11.7)
Level 7 Epithelium Oesophagus 3.9 (2) 18.8(5.9) 23.5 (13.6)
Buds, average 10.3 (7) 59.3 (19.5) 19(14.1)
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Fig. 6.10 Dorsoventral distribution of mitosis in El 0.5 control CBA/Ca embryos
Mitotic index for the dorsal and ventral segments of the El 0.5 foregut. Levels and 
segments are defined in Fig. 8. There is no significant difference between the index of the 
dorsal and ventral segments at any of the four levels. Furthermore, there is no significant 
difference between the ventral index at the level of the lung buds and that of the other 
three levels.
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Fig. 6.11 Dorsoventral distribution of epithelial mitosis in El 1.5 control CBA/Ca
embryos
Mitotic activity in the El 1.5 foregut with levels as defined in Figure 9. (a) In this graph, 
the mitotic index was calculated separately for the ventral and dorsal halves at all levels, 
not taking into account the subdivision of the dorsal segment. There is no significant 
difference between the ventral and dorsal mitosis at each of the seven levels. There is, 
however, a gradual increase in mitotic index in more caudal sections and the separated 
structures have significantly higher mitotic indices than the corresponding segments of 
the undivided foregut. The tracheal index (level 6) is significantly higher than the ventral 
index for both levels 1 and 2 (p values of 0.02 and 0.002) and the bronchial index (level 
7) is significantly higher than the ventral index for level 2 (p=0.02). The oesophageal 
index for levels 6 and 7 is higher than the dorsal index for levels 1 and 2 (p values of 
0.002, 0.002, 0.007 and 0.007). (ft) In this analysis, the dorsal half is represented by equal 
dorsalmost (L2Ds & L3Ds) and middle segments (L2M & L3M) as described in Figure 9. 
At each of the two levels, middle segment mitotic indices did not differ significantly from 
either dorsal or ventral ones. The middle segment index was higher at the level of 
separation (level 3) than at level 2 (p=0.049). The higher mitotic rate at this level is in 
keeping with the general trend of increase in mitotic index at more caudal levels as shown 
in (a).
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Fig. 6.12 Mesenchymal mitosis in El 1.5 control CBA/Ca embryos
Mitotic activity in the foregut mesenchyme at or above the level of tracheo-oesophageal 
separation. Levels as for figure 9 with the dorsal segments being represented here by both 
dorsalmost (L2Ds & L3Ds) and middle (L2M & L3M) subdivisions as shown in figure 9. 
At each of the two levels, the mitotic index of the middle segment is not significantly 
different from either the dorsalmost or ventral segments. The middle segment 
mesenchymal mitosis is, however, significantly higher at level 3 than at level 2 (p=0.045).
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6.3 -  D isc u ssio n
6.3.1 -  Programmed cell death and tracheo-oesophageal separation
The pattern of PCD described in this chapter makes it likely that apoptosis does play a 
role in tracheo-oesophageal separation even though it remains unclear precisely how it 
contributes to folding of the epithelium and division of the foregut lumen.
The pattern of caspase-3 activation should be an accurate reflection of the level and 
distribution of apoptosis within the developing foregut as it is one of the key effector 
caspases. Nevertheless, it would be desirable to study PCD patterns with a different 
technique, as not all PCD is caspase-dependent. Several studies of foregut PCD in the 
Adriamycin rat model of OA/TOF used the TUNEL assay or simply identified the 
morphology of apoptotic cells (Zhou et al., 1999; Williams et al., 2000; Orford et al., 
2001b). These studies identified only a limited role for PCD, finding apoptotic cells 
solely in the epithelial ridges of the separating foregut in saline-treated embryos. The fact 
that the caspase-3 assay has identified a more extensive pattern of PCD makes it very 
unlikely that it is missing any significant number of apoptotic cells. The difference 
between PCD detected by TUNEL and caspase-3 could be attributed to a species 
difference (all previous studies were of rat) in overall level of PCD. A difference in 
sensitivity between TUNEL and caspase-3 is an unlikely explanation as TUNEL detects 
DNA fragmentation and should show more PCD than caspase-3 immunohistochemistry. 
Another possible explanation is that the majority of rat studies investigate PCD only at 
the time of tracheo-oesophageal separation and at the site of separation. The only rat 
study that specifically comments on PCD patterns in pre-separation gestations and at 
anatomical levels other than that of the separation, does not even explain how apoptosis
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was detected making it difficult to assess the findings and compare the patterns (Williams 
et al., 2000).
6.3.1.1 -  PCD and tracheo-oesophageal separation in the E l 1.5 foregut 
According to the rat studies, the localisation of PCD in the approximating epithelial folds 
is an indication that it is contributing to the division and reshaping of the foregut. As 
these ridges come together at the point of separation, some of the apoptotic cells from the 
original undivided foregut would then become localised in the intervening mesenchyme. 
Such cells are also demonstrated in the present study and could correspond to apoptotic 
cells seen at the folding epithelial ridges, at levels cranial to the point of separation.
Whilst PCD is likely to contribute to the remodelling of the separated trachea and 
oesophagus, its role may be more complicated as suggested by the extensive PCD pattern 
in this study. An observation that is perhaps difficult to explain is the dorsal 
predominance of PCD in the foregut cranial and caudal to the separation point in the 
El 1.5 foregut. Apoptotic cells in the folding epithelial ridges at the point of separation are 
associated in the same sections with apoptotic cells in the dorsal, prospective-oesophageal 
foregut but not in the ventral, prospective-tracheal foregut. Dorsal PCD cannot be simply 
explained on the basis of cell loss leading to reorganisation and separation, as perhaps is 
the case for apoptosis at the dorsoventral boundary. This dorsal predominance appears to 
occur in an organised manner in the El 1.5 mouse foregut. Just caudal to the 
laryngotracheal groove, PCD in the dorsal epithelium clearly predominates with PCD in 
the ridge epithelium becoming more prominent as we approach the separation level. It 
appears that in this context, PCD is somehow marking the dorsal foregut components just 
as the separation process is progressing in a cranial direction. Much more than just 
finishing off separation, PCD would appear to correlate with the process and its progress.
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The persistence of PCD in the separated oesophagus for some distance caudal to 
separation, is consistent with this notion. Tracheo-oesophageal separation would seem to 
be a process of separating the PCD-marked dorsal foregut from the largely PCD-free 
ventral foregut. Such a notion would perhaps require PCD to be able to alter the shape of 
the foregut or to lead to epithelial folding, in preparation for separation. Folding would be 
equivalent to a change in the shape of a number of cells in a specific part of the epithelial 
layer of the foregut. These cells are likely to be those at, and adjacent to, the site of future 
separation. Shape change is likely to depend on a change in the ratio between the basal 
and luminal diameters of the cell and this in turn would require a rearrangement of the 
cytoskeleton. There has been a recent report linking cells in the early stages of PCD with 
signals to neighbouring cells that cause changes in the arrangement of actin 
microfilaments (Rosenblatt et al., 2001). If this was the case in the foregut, it would imply 
that PCD has, at least at the initial stages, a signaling role. This notion could help explain 
the paradox of accumulation of PCD in the dorsal, oesophageal-prospective endoderm 
well away from the site of separation. A change in the shape of cells in the shorter dorsal 
part might contribute more effectively to folding. I have yet to demonstrate such a change 
in epithelial cell shape; electron microscopy assessment would be useful in this aspect.
6.3.1.2 - PCD in the caudal foregut at E l 1.5
The role of PCD in foregut morphogenesis is further illustrated at more caudal 
levels of the El 1.5 foregut. The dorsal pattern described above gradually gives 
way to a specific tracheal pattern of apoptosis. The trachea changes shape as the 
tracheal bifurcation is approached, becoming narrow dorsoventrally and wider 
form side to side. There is increasing PCD in the mid-portion of the trachea at the 
point where the epithelium appears to fold leading to the eventual separation into 
the two bronchi. This arrangement is similar to that associated with tracheo-
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oesophageal separation and provides further evidence of the role of PCD in the 
processes of luminal separation in the respiratory tract. This pattern of PCD at the 
site of tracheal separation remains prominent at E12.5, but then becomes 
significantly downregulated with almost no PCD in the E l3.5 foregut. One 
important distinction should be made, however. The pattern seen in the caudal 
trachea is specific to the point of tracheal bifurcation into the bronchi in contrast 
to the undivided foregut where it involves the whole dorsal foregut cranial to the 
separation. Furthermore, there is no evidence that tracheal separation is 
progressing cranially in any way similar to tracheo-oesophageal separation. 
Besides, the two lung buds are distinct structures as early as E l0.5. In this case, 
PCD is likely to be involved in the process of shaping the area of the tracheal 
carina (tracheal bifurcation) as well as the separation of the cranial end of the 
bronchi. At the same time, longitudinal growth of the bronchopulmonary buds is 
likely to be the major contributor to bronchial lengthening.
6.3.1.3 - PCD in the pre-separation foregut (El 0.5)
A major difference between the present study and previous PCD studies in the rat 
is that the latter did not demonstrate an apoptotic pattern in the pre-tracheo- 
oesophageal separation foregut (Qi & Beasley, 1998; Zhou et al., 1999; Williams 
et al., 2000; Orford et al., 2001b). It should be noted that only one of these studies 
includes an assessment of the relevant pre-separation gestations (Williams et al., 
2000). The present study has identified a distinct pattern in the E l0.5 foregut. At 
that gestation, the ventral part of the foregut has already been specified as 
respiratory epithelium and is already expressing different markers (e.g. Nkx2.1) 
from the dorsal epithelium. The foregut has, however, not started to divide
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physically. At this stage, PCD becomes organised in clusters on the lateral walls 
of the foregut and on many occasions these clusters are found on corresponding 
positions on the opposing walls. It is likely these are marking the foregut 
dorsoventral boundary although more detailed double labelling studies are 
required to confirm this. It should be noted that at this gestation there is no 
demonstrable change in foregut shape, and no formation of a waist to indicate the 
precise dorsoventral or oesophageal-respiratory boundary. This concentration of 
apoptotic cells would suggest that PCD plays an early role in marking the site of 
tracheo-oesophageal separation, well before any morphological evidence of 
epithelial folding or separation.
This principle is clearly demonstrated in the sections from the level of the lung 
buds. At that level, there is a reproducible pattern of PCD, which marks the 
junction between the lung buds and the foregut as well as the junction between the 
two lung buds. This PCD pattern reflects the development of the lung buds. The 
lung bud level is also the level at which tracheo-oesophageal separation will start. 
The apoptotic cells that are involved in tracheo-oesophageal definition and 
separation are likely to fall into two categories. Firstly, in some embryos at the 
level of the lung buds, the respiratory epithelium (as judged by Nkx2.1 expression 
-  Chapter 4) does not extend more dorsally than the junction between the lung 
buds and the foregut itself. It would seem logical that tracheo-oesophageal 
separation would start at that point and the PCD activity at that junction could be 
involved in this process. Secondly, the foregut specification in some embryos is 
such that respiratory epithelium does extend more dorsally and consequently the 
respiratory/ gastrointestinal junction is shifted more dorsally due to natural 
variation. This could account for the dorsal PCD clusters seen in some embryos in
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addition to the ones related to the lung buds (Fig. 6.1h arrows). It could also be 
significant that the more consistent PCD pattern is seen at the lung bud level 
where the process of tracheo-oesophageal separation is starting. In summary, the 
El 0.5 PCD pattern in the foregut is consistent with the notion of the apoptotic 
cells defining the borders between developing foregut components and 
derivatives, well before these structures start the process of separating from each 
other. This argument raises the possibility of PCD being involved in the initiation 
of the separation process. This question will be addressed in the next chapter.
Cranial to the laryngotracheal groove, the pharynx is characterised by the 
development of the pharyngeal pouches and their derivatives. PCD is associated 
with these processes in the present study. Apoptotic cells mark the junction 
between pharyngeal epithelium and that of the pharyngeal pouches. One 
explanation is that it could represent the boundary between two epithelial 
populations that are growing at different rates. Another explanation is that these 
PCD clusters might be contributing to the separation of these derivatives from the 
pharyngeal lumen; organs like the thymus and the parathyroids become detached 
from the pharynx to assume their position in the neck. If that is the case then this 
would be another example of separation. Epithelial PCD in the third pharyngeal 
pouch has been shown to be regulated by thymic and parathyroid endodermal 
transcription factors (Hoxa3 & Paxl) and Hoxa3{+l-)Paxl{-l-) compound mutants 
exhibit delayed separation of the thymic and parathyroid primordia from the 
pharynx (Su et al., 2001). A similar mechanism is possibly involved in the 
development of the thyroid. The thyroid diverticulum is a ventral, midline 
outgrowth from the floor of the pharyngeal foregut. As the thyroid gland develops 
and descends to its final position in the neck, it initially remains attached to the
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pharyngeal floor by the thyroglossal duct that subsequently regresses. Apoptosis 
seen at the site of the thyroid primordium in the present study may be contributing 
to this separation. Apoptosis in the thyroid primordium during the period thyroid 
organogenesis has been previously described and is likely to be regulated by the 
Bax/Bcl-2 system (Sun et al., 2002). Ventral PCD is also detected more caudally 
in the laryngotracheal groove. It is not clear what morphogenetic process this 
apoptotic activity might be contributing to. It might reflect an initial burst of 
proliferation at the early stages of the development of the respiratory primordium 
(E9.5) even though no such difference in mitotic activity was detected at E l0.5.
6.3.1.4 - Defining the PCD pattern
I have already concluded from data in this chapter that the precise temporospatial pattern 
of PCD in the foregut between El 0.5 and El 2.5 could play a role in the marking, 
initiation and execution of tracheo-oesophageal separation, as well as other processes 
including tracheobronchial development and pharyngeal pouch development. Assuming 
this is so, we need to understand what cellular/ molecular mechanisms could regulate the 
PCD pattern and lie upstream to apoptosis in this complex developmental cascade. As 
apoptotic cells are found in significant numbers at the boundary between two distinct 
epithelial populations, it would be logical to examine the case for gene expression 
patterns to be involved in PCD regulation. I have already shown that Nkx2.1 and Shh, 
genes involved in fate specification and foregut morphogenesis, are both expressed in 
distinct dorsoventral patterns in the developing foregut. The expression boundary of such 
genes could provide positional cues to cells committing to the apoptotic process. PCD 
patterns are dynamic and it seems unlikely that its induction will be associated solely with 
an expression pattern that does not change during development (e.g. Nkx2.1). Sonic 
hedgehog, on the other hand, has a dynamic pattern of expression with a complete
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dorsoventral switch in expression between E l0.5 and El 1.5. Interestingly, the foregut 
maintains a Shh boundary despite the expression reversal. Interestingly, recent studies 
have linked the induction of PCD with disruptions in gene expression gradients and have 
called this morphogenetic apoptosis (Adachi-Yamada & O'Connor, 2002). It could also 
be argued that the PCD pattern broadly follows that of Shh expression in the El 1.5 
foregut. Cranially, the laryngotracheal groove PCD coincides with ventral Shh 
expression. Moving caudally, there is a gradual increase in both dorsal PCD and dorsal 
Shh expression. As discussed in Chapter 5, this reversal of the El 0.5 Shh pattern appears 
to be propagated ahead of tracheo-oesophageal separation in a cranial direction. In an 
analogous, but by no means identical pattern, the pattern of PCD is restricted to the dorsal 
foregut and the lateral epithelial folds at the dorsoventral junction. It could be argued that 
Shh expression provides positional cues for the activation of the PCD process. This notion 
would of course imply that Shh has a pro-apoptotic role in this particular developmental 
system. A review of the literature reveals that Shh is involved in PCD regulation in a 
number of systems having either a pro or anti-apoptotic role, depending on cellular 
context (Oppenheim et al., 1999; Sanz-Ezquerro & Tickle, 2000; Charrier et al., 2001; 
Yamamoto et al., 2004; Sacedon et al., 2005). Other genes could be involved in PCD 
regulation and Bax and Bcl-2 expression in the foregut has been shown to be associated 
with epithelial PCD (Sun et al., 2002).
An alternative explanation is that PCD is not under the precise control of pro-apoptotic 
signals but rather is the result of mechanical stresses developing at the junction between 
various parts of the developing foregut that may be growing at different rates. This 
mechanism could contribute to the separation of foregut components. This could explain 
the presence of apoptotic cells at the junction between the proliferating epithelium of the 
pharyngeal pouch derivatives and the epithelium of the pharynx. Whilst this concept
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could account for some of the PCD observed in the developing foregut, it cannot explain 
the presence of apoptosis in the dorsal foregut at El 1.5, nor does it explain the clusters of 
PCD marking the dorsoventral boundary at E10.5, a time when the two parts of the 
foregut do not differ as far as gross morphology and mitotic index are concerned.
6.3.1.5 - PCD in models o f abnormal tracheo-oesophageal separation 
The models of abnormal foregut development further highlight the important role of 
PCD. In both the Adriamycin-treated mouse and Shh homozygous mutant models, 
abnormal development, and failure of tracheo-oesophageal separation in particular, is 
associated with a disturbed pattern of PCD. Apoptosis still takes place in the abnormally 
developing foregut in both models but its precise temporospatial pattern is disturbed. At 
El 0.5, the aspect of PCD mostly affected is the marking of the dorsoventral boundary. In 
the affected El 1.5 Adriamycin-treated mouse, there appears to be a shift in the 
concentration of PCD in the caudal foregut. This results in apoptotic cells concentrating 
in the dorsalmost part of the foregut, as well as the dorsal mesenchyme, whereas at 
equivalent levels in the control embryo, PCD is concentrated at the tracheo-oesophageal 
junction, where separation is occurring. This raises the question whether the fundamental 
developmental disturbance in the Adriamycin-treated embryos is in the positional 
information for PCD induction. One previous suggestion is that PCD occurs more 
dorsally and the result of this is the formation of the atretic upper oesophageal segment 
(Qi & Beasley, 2000). Some theories suggest that the concentration of apoptotic cells in 
the mesoderm, dorsal to the undivided foregut in Adriamycin-treated embryos, actually 
represents the atretic oesophageal segment (Zhou et al., 1999). Other theories suggest that 
mesodermal apoptosis may be associated with degenerating ectopic notochord and that 
the fundamental tracheo-oesophageal defect is caused by generally reduced foregut 
apoptosis (Williams et al., 2000). The findings of my work confirm that the PCD pattern
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seen in the Adriamycin-treated mouse embryos undergoes a dorsalward shift but that this 
is unlikely to be related to the upper oesophageal pouch. This pattern is identified at 
El 1.5 in the mouse whereas the upper oesophageal segment starts developing at E l2.5 as 
a result of reshaping of the cranial foregut. This temporal relationship makes it unlikely 
that the dorsal mesenchymal apoptosis represents the atretic oesophagus. In the case of 
the Adriamycin-treated mouse, it is possible that the dorsal PCD shift results in failure of 
separation at the dorsoventral junction. The hypothesis is that a disturbance in the normal 
dorsoventral pattern of PCD along the entire length of the respiratory foregut would result 
in total failure of tracheo-oesophageal separation and the development of an undivided 
oesophagotrachea ending in a trifurcation of two bronchi and a fistula. On the other hand, 
a dorsalward shift of PCD activity affecting only part of the respiratory foregut would 
allow partial tracheo-oesophageal separation and result in the fistula originating from the 
foregut cranial to the point of origin of the bronchi.
In the case of Shh homozygous mutant embryos, there is again loss of the temporospatial 
PCD pattern seen in controls. The mutant foregut lacks a recognisable PCD pattern with a 
seemingly random distribution of PCD clusters in the foregut endoderm. The reduced 
PCD activity in the mutant foregut endoderm is in contrast with increased apoptosis in 
other areas of the embryo like the neural tube. This high level of neural tube apoptosis 
could be attributed to the fact that the homozygous mutant embryos do not fare very well 
and exhibit generalised oedema. However, clearly loss of Shh function does not interfere 
with the ability of cells to undergo PCD in these non-gut regions. By the same logic, the 
downgrading and loss of pattern of foregut PCD could be secondary to local molecular 
disturbances related to the specific disturbance of the Shh signaling in the foregut. 
Alternatively, Shh might be proapoptotic specifically in the context of foregut 
development so that Shh loss of function leads directly to reduced PCD. Shh is known to
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have different effects on PCD depending on the cell/tissue context (Oppenheim et al., 
1999; Sanz-Ezquerro & Tickle, 2000; Charrier et al., 2001; Yamamoto et al., 2004; 
Sacedon et al., 2005).
Therefore, the patterns of PCD are disturbed in both models of failed tracheo-oesophageal 
separation. Both models are characterised by loss of the precise temporospatial pattern of 
Shh expression. The disturbance in the gene expression is however very different between 
the two models. The Adriamycin model is characterised by a more diffuse expression 
whereas the null mutant by lack of expression of a functioning gene. The feature shared 
by the two models is the loss of the dorsoventral Shh boundary. If, as discussed above, 
induction of PCD is linked to this boundary, the loss of PCD at the dorsoventral boundary 
can be explained.
6.3.2 — Proliferation and separation
Cell proliferation undoubtedly plays an important role in the development of the foregut, 
as the embryo is growing rapidly at this stage of development. The question that this 
study attempted to answer was whether differential rates of mitosis in specific 
components of the foregut may contribute to foregut morphogenesis. The respiratory 
system develops as a ventral outgrowth from the foregut. The mesenchyme that surrounds 
the respiratory (ventral) component of the foregut is well organised and has a higher cell 
density than the dorsal mesenchyme. There is, however, no evidence that the rate of 
mitosis in the mesenchyme adjacent to the epithelial tracheo-oesophageal ridge 
contributes to epithelial folding or that it exerts some sort of external pressure on the 
foregut. Neither was the ridge epithelium found to proliferate more rapidly, which could 
have contributed to its fusion in the midline forming a separating septum. These
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observations do not support a specific role for differential cell proliferation in the process 
of tracheo-oesophageal separation. Neither do the proliferation patterns support the 
hypothesis, developed in Chapter 3, that the tracheal primordium outgrows the 
oesophageal foregut resulting in the trachea being a distinct structure from the outset. The 
oesophageal foregut is proliferating at least as rapidly as the tracheal component. 
Differential growth of the trachea could be primarily driven by the caudolaterally growing 
lung buds, as the most distal part of the respiratory system but, again, the mitotic activity 
in the lung buds is not higher than in the dorsal foregut at that level. There is, however, 
one significant difference in epithelial proliferation and that is between mitotic index of 
the separated structures (both respiratory and gastrointestinal) at El 1.5 and the undivided 
foregut at more cranial levels. The epithelia of the trachea and oesophagus have a higher 
rate of proliferation than the undivided foregut. This observation could suggest that, once 
separated, the foregut components gain in length by proliferating at a significantly higher 
rate. Even if separation itself may not require regional proliferation peaks, longitudinal 
growth of the individual respiratory and gastrointestinal structures is likely to involve 
increased mitotic activity. Finally, the temporospatial pattern of mitosis does not 
correspond to the PCD pattern making it very unlikely that PCD is simply a balancing of 
increased proliferation in specific parts of the foregut.
6.3.3 -  Mechanisms of separation
It seems likely that a number of mechanisms interact to bring about the successful 
separation of the ventral trachea from the dorsal oesophagus. I have already shown that 
the undivided foregut grows and gains in length between E10 and El l ,  with its ventral 
part already specified as trachea. The subsequent growth of the foregut structures is 
coupled with another process, that of separation of this ventral respiratory component 
from the dorsal oesophageal segment. The traditional view has been that this separation is
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the result of the medial growth of an intervening septum, the components of which fuse in 
the midline and divide the foregut into dorsal and ventral parts. However, the concept of 
septation, although a popular theme in developmental biology, is not always supported by 
convincing evidence. In the case of hindgut development, the idea of an actively growing 
urorectal septum that separates the urogenital from the gastrointestinal tubes is now 
disputed with an alternative mechanism based on passive mesenchymal interposition 
between the two proliferating tracts being suggested (Paidas et al., 1999; Rogers et al., 
2002). On the other hand, cardiac septation as an active infolding process is a much more 
established developmental concept (Anderson et al., 2003; Moorman et al., 2003). In the 
case of the foregut, PCD appears to play a role in this process from its early stages to its 
completion. In the early stages, PCD may bring about folding of the foregut epithelium as 
a precursor to fusion and separation. Folding is likely to involve changes in the shape of 
epithelial cells as a result of rearrangement of their cytoskeleton. Different mechanisms 
are likely to be involved in the later stages of separation. Whilst folding approximates 
opposing epithelial layers, the actual separation process would involve opposing cells of 
the same respiratory/gastrointestinal specification to come into contact with each other 
and eventually lead to the separation of the two structures. The mechanism that could be 
involved in this process is cell adhesion. In summary, tracheo-oesophageal separation is a 
complex process likely to involve a precise choreography of cellular processes including 
programmed cell death, cell proliferation, cell adhesion and changes in the cellular 
cytoskeleton. In the next chapter, I will test the hypothesis that PCD is a requirement, and 
not simply an association, of tracheo-oesophageal separation.
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6.4 -  Sum m ary
In previous chapters, a tentative conclusion was drawn that separation of the foregut 
lumen into a ventral trachea and a dorsal oesophagus is an active process. In this chapter,
I studied the nature of this separation and in particular the roles of programmed cell death 
(PCD) and cell proliferation in this process. PCD occurs in reproducible patterns in both 
the E l0.5 and the El 1.5 foregut. Significantly, it is present in the foregut at a stage when 
tracheo-oesophageal separation has not yet started, suggesting that it may play a role in 
the marking and initiation of this process. Furthermore, the PCD pattern at El 1.5 
suggests that it does not simply appear at the site of tracheo-oesophageal separation in 
order to complete luminal division but is distributed in the whole dorsal foregut. This 
raises the possibility that it is involved in the process that underlies the change of shape of 
the foregut, which precedes separation. The importance of PCD in the process of tracheo- 
oesophageal separation is highlighted by the disturbance of its pattern in both the 
Adriamycin-treated embryo and the Shh homozygous mutant which are two models of 
failed tracheo-oesophageal separation. The study of cell proliferation suggests that this 
process is likely to contribute to the lengthening of the foregut structures following 
separation but does not appear to contribute to separation itself. It is likely that tracheo- 
oesophageal separation is a complex process requiring the precise interplay of a number 
of morphogenetic events.
2 8 0
CHAPTER 7  -  In  v i t r o  m o d e l  o f  t r a c h e o - o e s o p h a g e a l
DEVELOPMENT
7.1 -  Introduction
7.1.1 — Testing the hypothesis
I have so far identified a key role for the morphogenetic process of tracheo-oesophageal 
separation in both normal development and the embryogenesis of tracheo-oesophageal 
malformations. I have also identified a close association between separation and the 
temporospatial pattern of expression of sonic hedgehog and the pattern of programmed 
cell death. It would clearly be desirable to study this morphogenetic process more directly 
and to further investigate the role of gene expression and cell death in its initiation and 
execution. Specifically, the aim of studies in the present chapter was to test hypotheses 
formulated on the basis of previous observations. One such hypothesis is that a 
disturbance in the pattern of programmed cell death would lead to tracheo-oesophageal 
defects. In order to test this hypothesis, I reasoned that I needed to develop an appropriate 
experimental system that would allow a close study of tracheo-oesophageal separation 
and also direct interference with programmed cell death. One such system would be 
embryo culture during an appropriate embryological window.
7.1.2 -  The use of whole-embryo culture
Whereas it is possible to expose embryos to a variety of agents in utero (as is the case 
with Adriamycin), the precise level of exposure of the embryos cannot be easily 
controlled. Furthermore, the effects of these agents on the mother has to be taken into 
account and are difficult to quantify. Another problem with experimental analysis of
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embryos in utero is a relative lack of access and the difficulty of performing surgical 
manipulations of the embryos. For these reasons, the technique of in vitro embryo culture 
has been established as an invaluable experimental technique. Embryos have been shown 
to grow apparently normally in vitro for a period of up to 48 hours and the system allows 
precise control of the culture conditions, composition of the culture medium and 
concentration of additives and readily allows surgical manipulation (New et al., 1976). It 
should be noted that culture of embryos during this relatively ‘late’ period of 
embryogenesis involves exteriorisation from the yolk sac, a modification of the standard 
whole-embryo culture procedure (Cockcroft, 1990). Details of the procedure are 
described in Chapter 2 (section 2.5).
7.1.3 — Interfering with programmed cell death
The embryo culture system allows the possibility of interfering with programmed cell 
death by the addition of specific inhibitors to the culture medium. One such widely used 
PCD inhibitor is z-vad-FMK, a protease inhibitor which inhibits the cleavage and 
activation of several key components of the caspase pathway (Slee et al., 1996; Susin et 
al., 1996; Marchetti et al., 1996). Although not all PCD is caspase-dependant, caspase 
inhibition significantly reduces levels of apoptosis and z-vad-FMK has proved to be an 
invaluable scientific tool when studying the complex mechanisms of PCD activation 
(Susin et al., 1997; Coin et al., 2000; Fauvel et al., 2001). Several studies have shown that 
the agent could provide a novel therapeutic approach to diseases characterised by 
apoptosis-mediated tissue damage (Cook et al., 1996; Cheng et al., 1998; Li et al., 2000b; 
DeBiasi et al., 2004).
2 8 2
7.2 -  R e s u lt s
7.2.1 — Establishing the in vitro model
7.2.1.1 - The design o f the culture period
The time parameters of the culture experiment targeted the process of tracheo- 
oesophageal separation. It has already been shown in Chapter 3 that at E l0.5 the foregut 
is still undivided and that the separation process starts at about E ll and is still in progress 
at El 1.5. For this reason, the embryos were incubated from E10.5 for a period of 18 
hours, in order to focus on the separation process. During this time window, it is possible 
to directly interfere with the cellular/molecular processes involved in tracheo-oesophageal 
division. The size of embryos at this developmental stage makes them easy to manipulate, 
thus increasing the options for intervention.
7.2.1.2 - Choice o f culture medium
Embryos that developed in utero for the same period as the duration of the culture (18 
hours) served as controls, both with regard to embryo growth and development as well as 
tracheo-oesophageal development. The first aim was to establish an in vitro model of 
tracheo-oesophageal development. In order to optimise conditions to allow foregut 
development to proceed as normally as possible, an established culture medium was used. 
As described by Cockroft (1999), and previously used in our lab by P. Sharma and V. 
Reed, 25% rat serum in culture solution was used. Another aim of this chapter was to test 
the hypothesis that PCD is required for tracheo-oesophageal separation and development. 
In order to test the hypothesis, a specific PCD inhibitor (Z-vad FMK), dissolved in the 
chemical DMSO, was added to the culture serum in concentrations successfully used in
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this laboratory by P.Sharma (200 pM). In order to assess the effect of DMSO on the 
development of the embryos, this was added to the culture medium alone as a control. 
Previous studies have identified potential toxic effects of DMSO on embryo growth and 
development (Noel et al., 1975).
7.2.1.3 - Assessment o f cultured embryos and embryo survival
Cultured embryos were judged to be alive and were included in the study if they satisfied 
certain criteria at the 18-hour assessment. These were: the presence of a regular and 
vigorous heartbeat with a minimum rate of 60 beats per minute and the presence of blood 
flow in the umbilical, the head and neck vessels. Embryos that showed some early signs 
of ill health, for example a mild degree of oedema, but satisfied the criteria described 
above, were judged to be alive and were included in the study. The overall survival rate 
was 87.7 % and the rates were comparable between the different groups of cultured 
embryos (Tab. 1).
T a b le  7.1 Summary of cultured embryos and their treatment
Total cultured Alive at 18hrs % survival
Serum only* 16 14 87.5
DMSO in serum 18 15 83.3
z-vad (in DMSO) in 23 21 91.2
serum, 200 pM
Total 57 50 87.7
* Serum was diluted 1:4 with culture solution in all groups
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7.2.1.4 - Growth and development o f  cultured embryos
The development and growth characteristics of cultured embryos are summarised in Fig. 
7.1. It appears that development as judged by somite number, and growth as judged by 
crown-rump length of cultured embryos are comparable to control embryos growing in 
utero for an equivalent time period. The in utero embryos used in this comparison were 
harvested at the same time as the termination of culture of the experimental embryos 
(about 9.00 AM on El 1.5). For somite numbers, there is no statistically significant 
difference between the groups. The crown-rump lengths appear shorter in the in utero 
embryos and there is a significant difference between the in utero and z-vad-treated 
groups. This greater crown-rump length in cultured embryos is difficult to explain. It may 
reflect the slight loss of fetal curvature that is seen in culture, perhaps owing to removal 
of the amnion. This yields a larger crown -rump length without reflecting an increased 
embryonic body mass. Nevertheless, the fact that embryos develop normally in culture 
from E l0.5 for 18 hours suggests that the various developmental processes are unlikely to 
be non-specifically influenced by growth restriction, and hence increasing the usefulness 
of the in vitro model for studying mechanisms of organogenesis.
7.2.2 — Foregut development in cultured embryos
7.2.2.1 - Tracheo-oesophageal development in cultured embryos 
Tracheo-oesophageal morphology
Tracheo-oesophageal development proceeds normally in embryos cultured both in serum 
only and those cultured in the presence of DMSO (Fig. 7.2). In fact, the trachea and 
oesophagus separate even in embryos that showed significant signs of ill health (which
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Fig. 7.1 Summary of developmental and growth data for embryos in utero and following 
culture for 18 hours from E l0.5
Box plots summarise somite numbers (a) and crown-rump (CR) length (b) data. The 
numbers above the vertical boxes denote the number of embryos examined for each 
group, (a) Somite numbers are comparable between the four groups with no statistically 
significant differences detected (unpaired t-test). (A) Crown-rump (CR) lengths are also 
comparable although the lengths in the z-vad-treated embryos are significantly longer 
than those of the in utero embryos (p=0.0016, unpaired t-test). Overall, these observations 
suggest no developmental or growth restriction in cultured embryos versus those in utero. 
Moreover, cultured embryos of the different treatment groups are comparable. It should 
be noted that at the beginning of the culture period (at El 0.5), the mean CR length was 
3.73 mm and the median somite number was 28.
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were not included in the data of this chapter), further suggesting that the in vitro model is 
a good experimental system to study foregut morphogenesis. The foregut morphology in 
cultured embryos (serum only & DMSO) is comparable to embryos growing in utero for 
the same length of time as the culture period, as is the progress of separation. Cranially, 
the laryngotracheal groove is a ventral evagination from the foregut lumen (Fig. 7.2a,b). 
Further caudally, the foregut exhibits lateral epithelial folds just above the level of 
tracheo-oesophageal separation (Fig. 7.2d,e). The process of separation starts at the level 
of the lung buds and proceeds cranially (Fig. 7.2g,h) and at its caudal end, the separated 
trachea has a flat, wide configuration, as it is about to separate itself into the two bronchi 
(Fig. 7.2k,1).
Tracheo-oesophageal morphology is disturbed in embryos cultured in the presence of z- 
vad (Fig. 7.2c,f,i,m). Whilst the development of the laryngotracheal groove at the cranial 
end of the foregut appears normal (Fig. 7.2c), the process of tracheo-oesophageal 
separation appears is affected. In the most severely abnormal embryos, tracheo- 
oesophageal separation appears to be severely delayed and is only observed over a few 
microns distance, just rostral to the level of the lung buds. In these embryos, the 
morphology of the undivided foregut also differs from that of in utero, serum or DMSO 
cultured embryos. In the latter, the lateral epithelial ridges appear to converge just ahead 
of the propagating wave of tracheo-oesophageal separation. In z-vad-treated embryos, by 
contrast, the foregut fails to form proper ridges and there is little evidence of convergence 
(Fig. 7.2f,i). This appearance is similar to that seen in Adriamycin-treated embryos 
(compare Figs. 7.2i and 3.6h). More subtle defects are seen in other z-vad-treated 
embryos. Here, tracheo-oesophageal separation has started at the level of the lung buds
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Fig. 7.2 Tracheo-oesophageal morphology in cultured embryos
Transverse sections, stained with Methyl Green, from embryos harvested at E l0.5 and 
cultured for 18 hours either in culture serum only (a,d,g,k), DMSO in culture serum 
(b,e,h,l) or in z-vad-FMK (diluted in DMSO) in culture serum (c,f,i,m). Sections are taken 
from four equivalent and progressively more caudal levels starting at the level of the 
laryngotracheal groove (Lt) down to the level of the emergence of the bronchopulmonary 
buds (Br). (a,b,c,) The development of the laryngotracheal groove is comparable between 
the three culture groups. (d,ej) More caudally, the undivided foregut (Fo) in serum only 
and DMSO-treated embryos exhibits approximating epithelial folds at the site of tracheo- 
oesophageal separation (arrowheads in d and e). In contrast, no clear evidence of 
epithelial folding or approximation is seen in the foregut of z-vad-treated embryos at an 
equivalent level (f)- (g,h,i) Further caudally, the trachea (Tr) and oesophagus (Oe) are 
separate structures in serum only and DMSO-treated embryos. In contrast, tracheo- 
oesophageal separation has been disturbed in z-vad-treated embryos. Despite the failure 
of separation, some epithelial approximation occurs at this level (arrow in i), although the 
widening shape of the ventral foregut suggests this is just cranial to the emergence of the 
bronchopulmonary buds. (k,l,m) In serum only and DMSO-treated embryos, the trachea 
has become wide and flat ventro-dorsally, where it is about to separate into the 
bronchopulmonary buds. Invagination occurs in the sagittal plane in the middle third of 
the trachea (arrows in k). In z-vad-treated embryos, the foregut almost ends in a 
trifurcation of oesophagus and two buds although the trachea does become separated from 
the oesophagus, about 15 micrometers rostral to the origin of the bronchopulmonary buds 
even in the worst affected embryos (inset in m). It should be noted that tracheo- 
oesophageal separation is variable in z-vad-treated embryos (Fig. 7.3b). Scale bar, 100 
pm
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and has progressed cranially, although the length of divided foregut is shorter than in 
control embryos, as if the separation process had stopped progressing. Formation of 
lateral epithelial ridges in these embryos was also abnormal rostral to the level of 
separation.
Quantitative analysis
Morphological analysis of z-vad-treated embryos showed that the process of tracheo- 
oesophageal separation had either failed almost completely or else its progression had 
been arrested. To further document the variation occurring in tracheo-oesophageal 
separation, following z-vad treatment, I studied the contribution of the divided and 
undivided segments to the total length of respiratory foregut, as described in Chapter 3 .1 
reasoned that, since tracheo-oesophageal morphology was comparable between the three 
groups of control embryos (in utero, serum only culture and DMSO-treated), it would be 
acceptable to compare the z-vad group with the cultured embryos. Furthermore, given 
that z-vad is diluted in DMSO, and that DMSO can itself have toxic effects, it would be 
desirable to use DMSO controls in the analysis.
When comparing z-vad-treated embryos with serum only and DMSO-treated controls, 
there is no significant difference in the total foregut length (Fig. 7.3a). In the z-vad- 
treated embryos, the undivided length is significantly longer than the divided length (p < 
0.0001) (Fig. 7.3b) whereas in the two control groups, there is no significant difference 
between divided and undivided segments (Fig. 7.3b). In contrast, the divided segment was 
significantly shorter (p values of 0.0004 and < 0.0001) and the undivided segment 
significantly longer (p values of 0.0004 and < 0.0001) in z-vad embryos compared to 
serum only and DMSO embryos respectively (Fig. 7.3b). Hence, the foregut in z-vad
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Fig. 7.3 Quantitative analysis of foregut components in El 0.5 embryos cultured for 18 
hours
Box plots show (a) total respiratory foregut length and (b) divided and undivided lengths 
separately. The numbers above the vertical boxes denote the number of embryos 
examined for each group, (a) There is no statistically significant difference in total 
foregut length between serum only, DMSO and z-vad-treated embryos. (A) In serum only 
and DMSO-treated embryos, the divided segment is of a similar length to the undivided 
segment showing that control embryos had reached approximately the midpoint of the 
tracheo-oesophageal separation process. In contrast, the undivided segment is 
significantly longer in z-vad-treated embryos compared to the divided segment (p < 
0.0001). Furthermore, the undivided segment is significantly longer in z-vad-treated 
embryos compared to both serum only cultured embryos (p= 0.0004) and DMSO-treated 
embryos (p = 0.0001). Conversely, the divided segment is significantly longer in both the 
serum only group (p= 0.0004) and the DMSO-treated group (p < 0.0001) when compared 
to z-vad-treated embryos.
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treated embryos lengthens but remains largely undivided, in contrast to controls embryos 
which achieve tracheo-oesophageal separation along approximately 50% of the length of 
the foregut.
7.2.2.2 - Programmed cell death in cultured embryos
The pattern of programmed cell death in embryos harvested from the pregnant mice at the 
E l0.5 + 18 hours time point (at approximately 09:00 on El 1.5) was comparable to that in 
the El 1.5 embryos described in Chapter 6. In the cranial foregut, apoptotic cells are 
concentrated in the ventral laryngotracheal groove whereas at more caudal levels, they are 
found in the dorsal, prospective-oesophageal part of the, as yet undivided, foregut. Dying 
cells are also found in the lateral epithelial ridges at the point of tracheo-oesophageal 
separation and, more caudally, small numbers persist in the separated oesophagus (data 
not shown).
The pattern of PCD in the foregut of embryos cultured in serum is comparable to that of 
embryos growing in utero (Fig. 7.4d,g,k). In keeping with the morphological tracheo- 
oesophageal similarity between these two groups, PCD is found to localise to the ventral 
laryngotracheal groove rostrally, to the dorsal epithelium more caudally and to the 
epithelial ridges at the point of separation (Fig. 7.4d,g). Apoptotic cells are found in the 
separated oesophagus and more caudally, in the middle portion of the tracheal epithelium, 
at the level of its bifurcation into the two main bronchi (Fig. 7.4k). The main difference 
between in utero embryos and those cultured in serum alone is that the cultured embryos 
have large numbers of apoptotic cells in the neural tube and neuroectoderm (Fig. 7.4a). 
This difference is striking, and is likely to be a consequence of the culture conditions.
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Fig. 7.4 Programmed cell death in cultured embryos
Immunohistochemistry for the PCD mediator cleaved caspase 3 on transverse sections 
from serum only, DMSO and z-vad-treated cultured embryos (harvested at E l0.5 and 
cultured for 18 hours). Sections were counterstained with methyl green. Sections are from 
equivalent levels for each culture group. (a,b,c) The neural tube (Nt) shows high levels of 
PCD in both serum and DMSO cultured embryos. The neural tube in embryos growing in 
utero has almost no PCD activity (data not shown) suggesting that the increased incidence 
of cell death in neural tubes of cultured embryos relates to the culture conditions. In sharp 
contrast, PCD is abolished in the neural tube of z-vad-treated embryos with the exception 
of occasional caspase 3 - stained cells (arrow in c). (d,ej) The epithelium of the 
laryngotracheal groove (Lt) is marked by caspase 3-positive cells (arrows in d and e) in 
sharp contrast to the laryngotracheal groove of z-vad-treated embryos (/) that lacks PCD 
completely. More caudally, PCD localises to the dorsal, oesophageal-prospective 
part of the undivided foregut (Fo) (arrows in g and h). At the level of tracheo-oesophageal 
separation, PCD is prominent at the approximating epithelial ridges (arrowheads, inset in 
g). There is no detectable PCD in the undivided foregut of z-vad-treated embryos. (k,l,m) 
At the level of the origin of the bronchopulmonary buds (Br), PCD marks the site of 
tracheal separation (arrows in k and 1) in serum and DMSO-treated embryos. The ‘near 
trifurcation’ into oesophagus (Oe) and bronchopulmonary buds (Br) seen in some z-vad 
treated embryos is completely devoid of PCD (m). Scale bar, 100 pm
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Embryos cultured in DMSO have patterns and levels of PCD in the foregut comparable to
serum-only culture controls and in utero embryos (Fig. 7.4b,e,h,l). The effect of exposure
to z-vad (diluted in DMSO) is a striking reduction in PCD in all embryos examined (Fig.
7.4c,f,i,m). This inhibition is most striking in the regions where
cultured embryos exhibit excessive cell death, namely the neural tube (Fig. 7.4c). The
developing foregut of z-vad treated embryos exhibits a complete lack of PCD (Fig.
7.4f,i,m).
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7.3 -  D iscussion
7.3.1 — Is the in vitro model reliable for the study of tracheo-oesophageal 
development?
The first priority in this chapter was to establish that the process of tracheo-oesophageal 
separation proceeds normally during the time window of the embryo culture period. The 
somite and crown-rump length data suggest that growth and development of cultured 
embryos is comparable to that of embryos growing in utero for the same time period. This 
finding is consistent with many other studies describing the technique of culture of post­
implantation embryos for between 24 and 48 hours (New et al., 1976) and confirms that 
even relatively advanced embryos, e.g E l0.5, can be cultured successfully (Cockcroft, 
1990). Loss of fetal curvature in cultured embryos could explain the observation that CR 
lengths appear longer in z-vad-treated embryos compared to embryos growing in utero. 
Whatever the mechanism, the finding reinforces the argument that the cultured embryos 
are not growth restricted. In addition to normal growth, tracheo-oesophageal development 
appears to proceed normally in cultured embryos. The morphology of the foregut is 
comparable to that of embryos growing in utero, and specifically, the process of tracheo- 
oesophageal separation progresses apparently normally. It should be noted that even in 
embryos that exhibited increasing signs of ill health, for example general and pericardial 
oedema, tracheo-oesophageal separation appeared to proceed normally. These 
observations suggest that tracheo-oesophageal separation is a process that lends itself to 
study via the in vitro embryo culture system. The period of the culture encompasses the 
critical point of initiation of separation and an overnight (18 h) culture period is sufficient 
for tracheo-oesophageal separation to progress to approximately 50% completion, while 
allowing overall satisfactory growth and development of the embryos.
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7.3.2 — Can we be confident about the inhibitory effect of z-vad?
The pan-caspase inhibitor z-vad has been an invaluable tool for the study of caspase- 
dependant programmed cell death in many organ systems (Susin et al., 1997; Coin et al., 
2000; Fauvel et al., 2001). It has been shown to inhibit apoptosis assessed by flow 
cytometry, DNA proteolysis and nucleosomal fragmentation, as well as block all the 
classical ultrastructural features of apoptosis including chromatin condensation, nucleolar 
disintegration and cytoplasmic vacuolation (Feamhead et al., 1995). In the specific 
culture system studied, the effect of 200 pM of the inhibitor abolished PCD as revealed 
by immunohistochemistry for cleaved caspase-3. This observation is most striking when 
z-vad-treated embryos are compared to other cultured embryos. In the latter group, the 
culture procedure appears to induce high levels of PCD in the more exposed organ- 
systems of the embryos, as is the case for the neural tube. This may be a direct effect of 
the culture medium on the embryo. In sharp contrast, z-vad-treated embryos show no 
evidence of PCD in these organ systems. Similarly, z-vad-treated embryos show no 
evidence of PCD in the developing foregut in contrast to control cultured embryos in 
which foregut PCD patterns conform to the pattern seen in the in utero embryos. These 
observations suggest that treatment with z-vad affects both physiological and culture- 
induced PCD. I conclude that the use of z-vad is an effective and reliable method to 
inhibit PCD in the midgestation embryo, enabling study of the effect of such inhibition on 
the development of the foregut.
One potential weakness of this inhibitory system is the fact that although most PCD 
depends on activation of the caspase pathway of cell death mediators, not all PCD is 
caspase dependent (Didenko et al., 2002; Jaattela, 2002; Donovan & Cotter, 2004;
Bursch, 2004). This raises the possibility that PCD may still be occurring in cells that are
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negative for cleaved caspase 3. In order to address this question, I would need to study 
PCD using an alternative technique. For example, the use of TUNEL staining should pick 
up all the cells that are caspase 3 positive as well as cells in which an alternative apoptotic 
pathway is used. The advantage of TUNEL would be that it actually demonstrates 
apoptosis by staining DNA strand breaks of the dying cells. Whereas it
would clearly be desirable to run concurrent TUNEL studies, or other methods, to 
supplement and consolidate the caspase 3 data, it is likely that the cleaved caspase 3 
distribution is a reliable marker for PCD. There are a number of reasons for this. There is 
no doubt that cells that stain positively for cleaved caspase 3 are in the process of 
undergoing PCD. Caspase 3 is an effector caspase and is found downstream in the 
pathway of caspase activation (Kumar & Harvey, 1995; Orth et al., 1996; Alnemri, 1997; 
Susin et al., 1997). Furthermore, there have been a number of studies reporting very 
good correlation between patterns of TUNEL and caspase 3 activation (Hoshi et al., 1998; 
Duan et al., 2003; Sharma et al., 2004; Arai et al., 2005). These studies also suggest that 
there is no significant difference in the number of TUNEL-positive and caspase 3-positive 
cells in many organ systems, including the midgestation mouse embryo.
7.3.3 — What is the significance of the effect of z-vad on foregut morphology?
When considering the effect of caspase inhibition on the development of the foregut and 
on tracheo-oesophageal separation and development, we should consider the role of PCD 
during normal development. The temporospatial pattern of PCD within the developing 
foregut is consistent with a role for PCD in marking the site of tracheo-oesophageal 
separation and, perhaps, playing a key role in effecting this process. From E l0.5 onwards, 
cells undergoing PCD are found at the dorsoventral boundary in the caudal end of the, as 
yet undivided, foregut and at the boundary between the separating lung buds and the
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foregut. During the next twelve hours, PCD changes dynamically and shifts exclusively to 
the dorsal foregut just ahead of the progressing front of tracheo-oesophageal separation 
whilst at the same time concentrating on the converging epithelial ridges at the very point 
of separation. Hence, there is a close correlation between the spatial localisation of PCD 
and tracheo-oesophageal separation, raising the real possibility of a causal connection. If 
the latter is correct, with PCD participating in the mechanism of epithelial separation, 
then one might expect that tracheo-oesophageal separation would be adversely affected, 
or abolished, by PCD inhibition. My results support this idea. In some embryos, virtually 
no separation takes place, whilst in others, separation is initiated but does not progress 
normally. The conclusion is that without PCD the process of tracheo-oesophageal 
separation cannot be maintained confirming the impression that it is required for the 
execution of epithelial separation.
Z-vad treated embryos with almost total failure of separation have a foregut that, whilst 
growing normally in length, fails to show the morphological evidence of converging 
epithelial ridges. This evidence supports a role of PCD in marking the site of epithelial 
folding and initiation of separation. Other z-vad treated embryos, however, showed a 
degree of separation, clearly demonstrating that the process was initiated. A plausible 
explanation for this is the timing of PCD inhibition. The findings of Chapter 6 showed 
that, at E l0.5, cells undergoing PCD are already localised within the foregut. The 
application of a caspase inhibitor at El 0.5 would have no effect on cells already far 
advanced in the apoptotic process, as they have already activated the downstream caspase 
3 effector and are destined to undergo PCD. Hence, such embryos would succeed in the 
early stages of separating their foregut. Once the z-vad is applied to these embryos, the 
epithelial separation process is arrested, in contrast to control cultured embryos which 
continue to separate their foregut. In contrast, embryos that are somewhat less advanced
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at the beginning of the experiment are the ones that are most likely to fail entirely in the 
separation process as z-vad is present prior to the onset of separation and so can prevent 
its initiation.
This explanation could form the basis of a model for the phenotypic variation of tracheo- 
oesophageal malformations. If we assume that interference with PCD in the foregut play 
a role in the embryogenesis of tracheo-oesophageal malformations, then the timing of this 
interference provides the key to the type of malformation. If an anti-apoptotic insult is 
applied early, it will result in complete failure of separation. If the insult is applied later, 
this will result in the separation process being arrested at a variable distance from the 
level of the lung buds resulting in variations of the ‘proximal fistula’ phenotype described 
in Chapter 3. In order to further support this hypothesis, culture experiments could apply 
z-vad at an earlier stage or allow the culture to proceed for longer periods. These are 
interesting experiments for future research.
7.3.4 — How specific is the effect of z-vad?
It is logical to attribute the effect of z-vad on foregut morphology to inhibition of PCD. It 
is important, however, to consider the possibility that z-vad may influence other cellular 
and molecular processes which, in turn, have a bearing on the process of separation. One 
such process is cell proliferation. This seems unlikely in view of the lack of any 
detectable foregut or general growth impairment in z-vad treated embryos. Furthermore, a 
non-specific interference with cell proliferation would not be expected to affect 
separation based on the evidence described in Chapter 6, which showed that cell 
proliferation is comparable between the dorsal and ventral parts of the foregut and the 
separated trachea and oesophagus. Nevertheless, it would be useful to study cell
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proliferation in the cultured embryos, to exclude this hypothetical mode of action of z-vad 
although this has been ruled out in previous studies (Weil et al., 1997).
It would also be important to establish whether z-vad has any effect, directly or indirectly, 
on the temporospatial expression of foregut patterning genes, in particular Shh. I have 
already established that both PCD and Shh expression are disturbed during failure of 
tracheo-oesophageal separation in Adriamycin-treated embryos. Furthermore, I have 
already shown that loss of Shh function in homozygous mutants results in a disturbed 
PCD pattern as well as failure of separation. Whilst it is clear that a complex interplay 
exists between gene expression and cell death, the overwhelming evidence of past studies 
suggests that cell death is controlled by gene expression, rather the other way round. The 
most parsimonious explanation, therefore, for the effect of z-vad on tracheo-oesophageal 
development is that PCD is necessary for epithelial separation. It remains to be 
determined whether PCD is also sufficient, per se, at the dorsoventral boundary of the 
foregut for physical separation of the tracheal and oesophageal components. Further 
experimental studies will be needed to test this idea.
PCD is involved in a number of similar morphogenetic systems. Whether PCD drives 
these morphogenetic processes, or is simply a necessary condition for them, is a matter of 
debate. During development of the palate, PCD in the medial edge epithelia is activated 
by contact of the palatal shelves and appears to be the primary process required for palatal 
fusion (Cuervo et al., 2002). PCD is also required for epithelial fusion during neural tube 
closure as shown by the failure of fusion of the neural folds in embryos treated with z- 
vad (Weil et al., 1997). Moreover, it has been suggested that PCD plays a role in the 
bending and rolling up of the neural folds as indicated by the failure of coming together 
of the folds in z-vad-treated embryos (Weil et al., 1997). This would suggest a more
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central role for PCD in this morphogenetic process. During cardiac development, PCD is 
associated with morphological remodeling and contributes to the fusion of the outflow 
tract ridges and the formation of the aortopulmonary septum (Sharma et al., 2004). 
Finally, PCD is required for the conversion of solid primordia into hollow tubes 
(Coucouvanis & Martin, 1995). In this system, however, PCD is the direct result of 
proapoptotic signals from neighbouring epithelial cells and its role is simply in cell 
removal and sculpting of these structures.
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7.4 -  Sum m ary
Tracheo-oesophageal development and separation can be reliably studied in embryos 
growing in vitro during the narrow embryological window between E l0.5 and El 1.5.
The pattern of developmental processes, including PCD, is comparable between embryos 
growing in vitro and in utero, making the in vitro model a useful tool to 
further study these processes in tracheo-oesophageal development. The addition of the 
pan-caspase inhibitor z-vad to the culture medium effectively abolishes caspase- 
dependent PCD. Embryos growing in the presence of the inhibitor grow normally 
compared to controls but have disturbed tracheo-oesophageal development. Whilst total 
foregut length in these embryos is comparable to controls, tracheo-oesophageal separation 
appears to become arrested, with most of the foregut length remaining undivided. This 
result supports the hypothesis that PCD is necessary for the initiation and execution of 
tracheo-oesophageal separation.
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CHAPTER 8 -  G e n e r a l  d is c u s s io n
8.1 -  General  rem arks
The study of the events that underlie the development of OA/TOF has been hampered by 
persisting controversies over the mechanisms of normal organogenesis. In this study, the 
development of a new model of tracheo-oesophageal malformations has focused attention 
on one aspect of foregut morphogenesis, namely tracheo-oesophageal separation. 
Through the parallel study of normal and abnormal foregut development, tracheo- 
oesophageal separation was studied in detail. It was shown that the foregut does indeed 
separate along the dorsoventral boundary between two different cell populations 
(respiratory and gastrointestinal). Separation was intricately linked to the dorsoventral 
expression pattern of the key developmental gene Sonic hedgehog. The manner in which 
the temporospatial pattern of expression of foregut patterning genes could influence 
separation is unclear but could include programmed cell death (PCD). The separating 
foregut exhibits a dorsoventral pattern of PCD consistent with it being a mediator of 
separation and, more importantly, separation was shown to be arrested when PCD was 
inhibited.
One of the most striking findings of this study was the repeated finding of failed 
separation in the various models of tracheo-oesophageal malformations. Treatment with 
the teratogen Adriamycin, loss of function of Shh and inhibition of PCD in cultured 
embryos had an easily identifiable and specific effect on the developing foregut: the 
persistence of an undivided foregut having a respiratory (ventral) and a gastrointestinal
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(dorsal) component. The study of these models could allow us to start putting together a 
plausible mechanism for tracheo-oesophageal separation.
8.2 -  Potential  pitfalls/  possible  im provem ents
8.2.1. — Experimental techniques
8.2.1.1 - Genotyping o f Shh mice
In this study, genotyping was not routinely used because of time constraints. Mice that 
were homozygous for the Shh mutation were distinguished from heterozygous or wild 
type Shh mice only on the basis of their gross morphology. This approach can be justified 
from previous studies, including work by others in my own lab, that have described gross 
morphological abnormalities in Shh'1' mice. In contrast, Shh+I~ heterozygous mice are 
morphologically normal and indistinguishable from genotypically normal mice (Chiang et 
al., 1996). The problem with the use of morphology alone to identify Shh'1' embryos, is 
that Shh+/' and Shh+/+ embryos were pooled together and subtle differences that might 
exist in foregut morphology between the two groups could not be assessed. Furthermore, 
even genotyping of the grossly abnormal Shh'1' embryos would be desirable for reasons of 
scientific completeness. Nevertheless, all control embryos in the Shh studies had a foregut 
morphology indistinguishable from CBA/Ca control embryos. Moreover, the 
abnormalities of foregut development in Shh null mutants, as described in this study, are 
consistent with previous work on the knockout (Litingtung et al., 1998; Chiang et al., 
1996) and almost certainly reflect the true effect of Shh null status on foregut 
development.
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8.2.1.2 - Immunohistochemistry controls
For all immunohistochemical studies, the validity of the findings was tested by using a 
secondary antibody without a primary antibody, in order to assess non-specific staining.
A more appropriate negative control would have been the use of a non-specific antibody 
raised against the host tissue. Nevertheless, all antibodies had been previously used and 
validated in other published studies and the patterns of antibody staining are consistent 
with those obtained previously.
8.2.2 — Interpretation of findings
8.2.2.1 - Interpreting tracheo-oesophageal malformations in the mouse 
Whereas it is reported that the majority of Adriamycin-treated rat embryos with tracheo- 
oesophageal malformations have defects closely matching the human ones, the 
Adriamycin-treated mice had more severe malformations with only a small minority 
conforming to the classic oesophageal atresia and distal tracheo-oesophageal fistula 
phenotype. One interpretation is that the mouse malformations resemble the rare human 
condition known as laryngotracheo-oesophageal cleft, whereas the rat malformation more 
closely corresponds to OA/TOF. It could be argued, therefore, that any comparisons 
between the two models (mouse and rat) and any conclusions derived from the study of 
the mouse model on the embryogenesis of OA/TOF, are not valid. However, irrespective 
of the differences in the near term phenotype between the two models, foregut 
morphology in the early stages of tracheo-oesophageal development is almost identical in 
the rat and mouse. An undivided foregut forms the basis of both rat and mouse 
malformations with, during subsequent development, the formation of a spectrum of 
tracheo-oesophageal malformations some of which closely resemble OA/TOF. Hence, by
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inference, human OA/TOF probably also forms as part of a spectrum of defects, the more 
severe of which might be lost in utero. Therefore, the Adriamycin-treated mouse appears 
to offer a satisfactory model for the study of the early events of faulty organogenesis that 
lead to OA/TOF and other tracheo-oesophageal malformations.
8.2.2.2 - Describing morphogenetic events
The mechanisms of development that are discussed in this thesis are based on 
interpretation of foregut morphology at specific time points in development, as derived 
from ‘still images’. In other words, inferences are drawn about continuous developmental 
processes based on ‘snapshots’ of these processes. Furthermore, interpretation o f ‘still 
images’ could be misleading unless it is fully appreciated that embryos, and specifically 
the foregut, alter structurally in a continuous manner throughout development, so that the 
spatial relationship between different structures does not remain constant. This is a 
particularly relevant consideration for the study of foregut lengths where the distance 
between specific reference points was used to assess foregut/tracheal length at different 
gestations. Admittedly, there are potential pitfalls if solely morphological data are used to 
describe developmental processes. However, in this particular study, every effort was 
made to standardise the different experiments. In other words, the developmental stages 
of embryos used in different experiments were comparable and consequently 
morphological observations could be checked against antibody or gene expression data 
from other stage-matched embryos. One example of this is the assessment of the length of 
the different foregut segments during development. In addition to the chosen reference 
points being easily reproducible (laryngotracheal groove, tracheal bifurcation), these were 
verified by contrasting with the Nkx2.1 data that confirmed the extent of the respiratory 
endoderm.
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8.3 -  Future w ork
Future work could build upon the findings of this study and concentrate on the molecular 
and cellular mechanisms of foregut separation. Although this would primarily involve the 
study of tracheo-oesophageal separation, it would have implications for other organ 
systems where similar morphogenetic processes take place. One such system is the 
hindgut where a similar separation takes place between the anorectal and genitourinary 
tracts. Moreover, defects in this process yield clinically important malformations 
including anorectal malformations (Kluth & Lambrecht, 1997b; Qi et al., 2002; Bai et al., 
2004). The mechanisms underlying this hindgut separation process remain controversial 
(Kluth & Lambrecht, 1997b; Paidas et al., 1999; Qi et al., 2000b; Rogers et al., 2002).
In order to enable experimental hypothesis-testing in future work, tracheo-oesophageal 
separation could be studied in appropriate culture systems that would allow relatively 
direct access to the foregut. This would provide the opportunity to alter molecular signals 
that are likely to contribute to separation. The present study has shown that tracheo- 
oesophageal separation can be reliably studied in whole embryos grown in vitro. The 
same in vitro model could be used to study other aspects of the separation process (see 
below). A major additional undertaking would be to develop of an organ culture model of 
foregut development, in order to allow a very close study of the events that underlie 
separation, as well as to offer opportunities for specific manipulation of the 
morphogenetic process.
Experiments that would appear to have high priority in future work might include the role 
of the notochord in tracheo-oesophageal separation. Using the whole embryo culture
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system, it might be possible to surgically remove or ablate the notochord in order to 
assess the effect on both foregut folding and separation as well as the effect on gene 
expression in the foregut. I would plan to specifically study Shh expression in view of the 
proven association of Shh with separation, the known role of the notochord as a source of 
a diffusible Shh signal, and evidence from other culture systems suggesting repression of 
endodermal Shh expression by the notochord (Hebrok et al., 2000; Hebrok et al., 1998).
If the foregut could be itself cultured successfully in vitro, it would be possible to 
recombine the notochord with the endoderm and study the pattern of endodermal gene 
expression and foregut morphogenesis. Alternatively, beads impregnated with diffusible 
signals could be placed near the developing foregut in intact embryos. In preliminary 
experiments, I have successfully placed beads around the foregut at the start of the whole 
embryo culture without interfering with embryo development or tracheo-oesophageal 
separation.
The changes in foregut configuration, with the development of converging epithelial 
ridges rostral to the level of tracheo-oesophageal separation, have been previously 
described and are well documented in the present study. Future work could study the 
cellular events that mediate this folding at the dorsoventral junction of the foregut. I have 
already demonstrated that increased levels of PCD occur at that point and that PCD is 
required for separation to proceed. One option would be to use electron microscopy to 
study any configurational change in the epithelial cells at that dorsoventral junction. One 
possibility is that changes in the ratio of basal to luminal diameter of epithelial cells could 
cause a change in the shape of the foregut bringing about epithelial folding. Such a 
change in cell shape could be caused by local changes in cell cycle as the basal 
localisation of S phase nuclei would lead to expansion of that part of the cell, as has been 
postulated for neuroepithelial bending at hinge points (Smith & Schoenwolf, 1987;
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Gerrelli & Copp, 1997). However, the lack of differential mitotic activity along the 
dorsoventral axis of the foregut in this study would not support this notion. Alternatively, 
it could be mediated by rearrangements of the cellular cytoskeleton, as has been 
demonstrated in single layer epithelium growing in culture (Graebert et al., 1997). One 
possibility would be to study the distribution of actin microfilaments using Phalloidin and 
the effect of disruption of microfilaments (e.g. using Cytochalasin D) on foregut 
development. Alternatively, I could use inhibitors of the Rho GTPase-dependant 
pathways to interfere with the arrangement and function of the actin filament systems 
during whole embryo or organ culture. Such a specific inhibitor is the exoenzyme C3 
from Clostridium botulinum (Kobayashi et al., 2001).
8.4 -  C onclusion
Within the constraints of experimental technique, this thesis has demonstrated that 
separation of the foregut along its dorsoventral boundary is a critical step in the 
development of the trachea and the oesophagus and that disturbance of this process leads 
to tracheo-oesophageal malformations. This work provides insight into both normal 
foregut development and pathogenesis of tracheo-oesophageal malformations and points 
the way to further experimental studies to elucidate molecular and cellular mechanisms 
that could ultimately identify targets for therapeutic intervention to prevent OA/TOF.
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